The VirtualToxLab is an in silico tool for predicting the toxic potential (endocrine and metabolic disruption, interference with the hERG ion channel) of drugs, chemicals and natural products. The toxic potential (TP) is derived from the normalized binding affinities towards a series of 16 proteins known to trigger adverse effects and weighted (→ wTP) using the standard deviations of the individual predictions as well as the quality of the underlying models — i.e. number, ratio and range of training and test compounds as well as the predictive r2 value of the very mQSAR model. The wTP is based solely on thermodynamic considerations and does not include any ADME (adsorption, distribution, metabolism, elimination) aspects. The wTP ranges from 0.0 (none) to 1.0 (extreme). The wTP is a complex, non-linear function that should not be overvalued but, instead, be interpreted as a toxic alert. Version 3.8 features Cheetah 2.0 (automated, flexible docking) that newly includes ligand–protein polarization terms in its directional force field.
Binding of 2-CF3-3,7,8-trichlorodibenzo-p-dioxin to the Aryl hydrocarbon receptor. Calculated binding affinity = 9.9 nM (exp. = 3.6 nM). Click on image to enlarge.
Target Proteins: Androgen receptor (AR), Aryl hydrocarbon receptor (AhR), Cytochrome P450 1A2 (CYP1A2), Cytochrome P450 2A13 (CYP2A13), Cytochrome P450 2C9 (CYP2C9), Cytochrome P450 2D6 (CYP2D6), Cytochrome P450 3A4 (CYP3A4), hERG, Estrogen receptor α (ERα), Estrogen receptor β (ERβ), Glucocorticoid receptor (GR), Liver X receptor (LXR), Mineralocorticoid receptor (MR), Peroxisome Proliferator-Activated receptor γ (PPARγ), Thyroid receptor α (TRα), Thyroid receptor β (TRβ).
| 1. Environmental chemicals |
| 2. Food additives and colorants |
| 3. Antibiotics |
| 4. Psychotropic drugs |
| 5. Blockbusters |
| 6. Withdrawn drugs |
| 7. Designer drugs |
| 8. Various drugs |
| 9. Vitamins |
| 10. Natural compounds |
| 11. Cosmetic chemicals |
| 12. Various chemicals |
| 13. Pesticides |
| 14. Miscellaneous compounds |
| 15. Doping: compounds banned by the NCAA |
Total number of listed compounds = 2,518 |
1. Environmental Chemicals
1 Toxic potential classes: **** (extreme: wTP > 0.800), *** (high: wTP > 0.700), ** (moderate: wTP > 0.500), * (low: wTP > 0.300), – (none: wTP ≤ 0.300)
Compound
Weighted toxic potential
wTP class1
Main target2
Comments
Anthracene
0.468
*
PAH: very toxic to aquatic organisms
Benzo[a]anthracene
0.656
**
AhR
PAH: polyaromatic hydrocarbon
Benzo[a]pyrene
0.690
**
AhR
PAH: genotoxic, cancerogenic
Benzil
0.220
–
photoinitiator: skin, eye and respiratory irritant
3-Benzylidene camphor (1R,4S/1S,4R)
0.293 / 0.395
*
UV absorber: endocrine disruptor
4,4'-Bis(dimethylamino)benzil
0.176
–
Bis(4-hydroxyphenyl)methane
0.485
*
2,3-Bis(4-methoxyphenyl)-2-butene
0.741
***
ERα
2,3-Bis(4-methoxyphenyl)-1,3-dimethylene-ethane
0.498
**
Bisphenol-A
0.540
**
ERβ
polymer additive: acute toxic in rats
Bisphenol-B
0.409
*
polymer additive: estrogenic activity
2,3-Bisphenyl-2-butene
0.283
*
–
Chalcone
0.443
*
antibacterial, antifungal, anti-inflammatory
Chrysene
0.649
**
AhR
PAH: tumorigenic in animals
Cocaine
0.459
*
stimulant: induces teratogenesis; genotoxic to cells
Coumestrol
0.668
**
ERβ
phytochemical
p-Cumate
0.108
–
Cumin alcohol
0.230
–
p-Cymene
0.149
–
DDT
0.418
*
synthetic pesticide: banned in most developed countries
Doxycycline
0.424
*
antibiotic: skin photosensitivity
Dibenzo[ah]anthracene
0.835
****
AhR
PAH: cancerogenic
4,4'-Dimethoxybenzil
0.475
*
4,4'-Dimethylbenzil
0.225
–
2,3-Diphenylbutane-2,3-diol (RR/SS)
0.137 / 0.158
–
2,3-Di-p-tolylbutane-2,3-diol (RR/SS)
0.225 / 0.174
–
17β-Estradiol
0.716
***
ERβ
female sex hormone
Ethanol
0.018
–
alcoholic beverages
Gestrinone
0.655
**
AR
synthetic steroid hormone
3,4,5,3',4',5'-Hexabromodiphenylether
0.510
**
AhR
flame retardant
1,2,3,4,7,8-Hexachlorodibenzofuran
0.772
***
AhR
environmental pollutant: teratogenic, mutagenic
Homosalate
0.309
*
UV absorber
2-Hydroxy-4-methoxybenzophenone
0.242
–
UV absorber: no reproductive toxicity in mice
Kaempferol
0.473
*
flavonoid
4-Methylbenzylidene camphor (1R,4S/1S,4R)
0.456 / 0.329
*
UV absorber: endocrine disruptor
3-Methylcholanthrene
0.750
***
AhR
PAH: carcinogenic in mice
Methyltrienolone
0.644
**
AR
anabolic steroid
Nicotine
0.317
*
tobacco alkaloid
Ochratoxin A
0.335
*
mycotoxin: carcinogen in rats and mice
Octocrylene (R/S)
0.367 / 0.378
*
UV absorber: evidence for malignant melanoma
Octyl-dimethyl-p-aminobenzoic acid (R/S)
0.184 / 0.172
–
UV absorber: no estrogenic activity in zebra fish
Octyl-methoxycinnamate (R/S)
0.210 / 0.262
–
UV absorber: estrogenic effects in laboratory animals
1,2,3,7,8-Pentachlorodibenzofuran
0.671
**
AhR
environmental pollutant: teratogenic, mutagenic
2,3,4,7,8-Pentachlorodibenzofuran
0.745
***
AhR
environmental pollutant: teratogenic, mutagenic
Perylene
0.629
**
AhR
PAH: hazardous pollutant, cancerogenic
Pyrene
0.480
*
PAH: toxic to aquatic organisms
Quercetin
0.435
*
flavonoid (flavonol)
2,2',6,6'-Tetrabromobisphenol-A
0.461
*
flame retardant
2,3,7,8-Tetrachlorodibenzo-p-dioxin
0.680
**
AhR
TCDD: carcinogen, chloracne
2,3,7,8-Tetrachlorodibenzofuran
0.697
**
AhR
environmental pollutant: teratogenic, mutagenic
Tetracycline
0.573
**
GR
antibiotic: skin photosensitivity
2,2',4,4'-Tetrahydroxybenzophenone
0.351
*
UV absorber: estrogenic activity in human cells
2-Trifluormethyl-3,7,8-trichlorodibenzo-p-dioxin
0.813
****
AhR
TCDD derivative: carcinogen
2 Highest contribution to the wTP (not necessarily identical with the target displaying the highest affinity); listed only for wTP ≥ 0.500
| Compound | Weighted toxic potential | wTP class | main Target | Comments |
| Acesulfame | 0.294 | – | calorie-free artificial sweetener | |
| Allylhexanoate | 0.062 | – | flavorant: no adverse effects in rats | |
| Amaranth | 0.377 | * | food dye: no serious toxic responses known | |
| Benzaldehyde | 0.134 | – | flavorant; CNS disturbance in rats | |
| Cyclamate | 0.216 | – | artificial sweetener: no clear evidence for toxicity | |
| Dulcin | 0.497 | * | artificial sweetener: carcinogenic properties | |
| E100 | 0.415 | * | food dye: unclear toxicity | |
| E102 | 0.080 | – | food dye: hyperactivity in children | |
| E104 | 0.504 | ** | AhR | food yellow 13: banned in the US and Japan |
| E105 | 0.260 | – | food dye: forbidden in US and Europe | |
| E110 | 0.188 | – | food yellow 6: hyperactivity in children | |
| E121 (Citrus Red 2) | 0.310 | * | food dye (orange skin only): carcinogen | |
| E122 (Azorubine) | 0.382 | * | food dye: forbidden in US and Europe | |
| E125 (Scarlet GN) | 0.395 | * | food dye (fruit peels and maraschino cherries only) | |
| E129 | 0.113 | – | food dye: developmental toxicity in rats | |
| E180 | 0.186 | * | food dye: banned in several countries | |
| Erythrosine | 0.198 | – | fluorone food dye: adverse effects in mice | |
| Ethoxyquin | 0.345 | * | antioxidant (used in spices to prevent color loss) | |
| Ethylmaltol | 0.183 | – | flavorant: no toxic effects in humans at low dosage | |
| Ethylpropionate | 0.014 | – | flavorant: eye, skin and respiratory tract irritation | |
| Heptyl-p-hydroxybenzoate | 0.484 | * | food additive: weak estrogen binder | |
| Hexamine (E239) | 0.157 | – | preservative (cheese) | |
| Isoamylacetate | 0.037 | – | flavorant; low toxicity | |
| Limonene | 0.097 | – | flavorant: skin irritant; no carcinogenicity/genotoxicity | |
| Maltitol | 0.526 | ** | ERβ | sugar substitute: weak genotoxic potential |
| Methylparabene | 0.493 | * | preservative for food, drugs, cosmetics: antifungal | |
| Methylsalicylate | 0.091 | – | flavorant: may cause fetal deformations | |
| Perillartine | 0.304 | * | artificial sweetener | |
| Propylgallate | 0.084 | – | antioxidant: growth retardation: no cancerogenicity | |
| Sorbitol | 0.289 | – | flavorant: no harmful effects in man | |
| Sucralose | 0.312 | * | artificial sweetener | |
| Xylitol | 0.436 | * | sugar substitute: no known toxicity |
| Compound | Weighted toxic potential | wTP class | Main target | Comments |
| Amoxicillin | 0.173 | – | β-lactam antibiotic | |
| Ampicillin | 0.088 | – | β-lactam antibiotic | |
| Benzylpenicillin | 0.303 | * | gold-standard penicillin: toxic effects (CNS) at high dosage | |
| Carbenicillin (R/S) | 0.260 / 0.184 | – | bactericidal, bacteriolytic | |
| Carfecillin (R/S) | 0.393 / 0.348 | * | β-lactam antibiotic | |
| Carumonam | 0.076 | – | monobactam antibiotic | |
| Cefacetrile | 0.297 | – | first-generation cephalosporin antibiotic | |
| Cefaclor | 0.168 | – | cephalosporin antibiotic | |
| Cefadroxil | 0.310 | * | broad-spectrum antibiotic | |
| Cefalexin | 0.266 | – | first-generation cephalosporin antibiotic | |
| Cefaloglycin | 0.228 | – | first-generation cephalosporin antibiotic | |
| Cefalotin | 0.204 | – | first-generation cephalosporin antibiotic | |
| Cefamandole | 0.190 | – | broad-spectrum cephalosporin antibiotic | |
| Cefapirin | 0.383 | * | first-generation cephalosporin antibiotic | |
| Cefatrizine | 0.087 | – | broad-spectrum cephalosporin antibiotic | |
| Cefazaflur | 0.233 | – | first-generation cephalosporin antibiotic | |
| Cefazedone | 0.210 | – | cephalosporin antibiotic | |
| Cefazolin | 0.177 | – | first-generation cephalosporin antibiotic | |
| Cefcapene | 0.282 | – | third-generation cephalosporin antibiotic | |
| Cefotaxime | 0.158 | – | third-generation cephalosporin antibiotic | |
| Cefprozil | 0.279 | – | cephalosporin antibiotic | |
| Ceftizoxime | 0.214 | – | third-generation cephalosporin antibiotic | |
| Chloramphenicol | 0.123 | – | bacteriostatic antimicrobal | |
| Chlortetracycline | 0.431 | * | tetracycline antibiotic | |
| Ciclacillin | 0.468 | * | aminopenicillin antibiotic | |
| Cinoxacin | 0.411 | * | quinolone antibiotic | |
| Ciprofloxacin | 0.511 | ** | GR | bacteriocidal: CYP450 inhibitor; not carcinogenic in mice |
| Clofoctol | 0.340 | * | bacteriostatic antibiotic | |
| Clometocillin (R/S) | 0.277 / 0.206 | – | penicillin antibiotic | |
| Clinafloxacin (R/S) | 0.351 / 0.485 | * | quinoline antibiotic | |
| Enoxacin | 0.494 | * | broad-spectrum antibiotic | |
| Enrofloxacin | 0.470 | * | fluoroquinolone antibiotic | |
| Ethionamide | 0.077 | – | tubercolosis antibiotic | |
| Faropenem | 0.275 | – | β-lactam antibiotic | |
| Flucloxacillin | 0.579 | ** | GR | narrow-spectrum β-lactam antibiotic |
| Flumequine (R/S) | 0.364 / 0.349 | * | first-generation antibiotic used in veterinary medicine | |
| Furazolidone | 0.150 | – | diarrhea/enteritis antibiotic | |
| Garenoxacin | 0.249 | – | quinolone antibiotic | |
| Gatifloxacin | 0.526 | ** | GR | fourth-generation fluroroquinolone antibiotic |
| Gemifloxacin (R/S) | 0.306 / 0.407 | * | quinolone antibacterial agent | |
| Grepafloxacin | 0.452 | * | quinoline antibacterial agent | |
| Ibafloxacin | 0.377 | * | quinoline antibiotic | |
| Imipenem | 0.240 | – | β-lactam antibiotic: causes nausea and vomiting | |
| Isoniazid | 0.025 | – | tubercolosis antibiotic | |
| Kanamycin | 0.321 | * | aminoglycoside antibiotic | |
| Levamisole | 0.509 | ** | GR | antihelminthic |
| Linezolid | 0.460 | * | antibacterial (multi-resistant) | |
| Lomefloxacin | 0.269 | – | fluoroquinone antibiotic | |
| Loracarbef (αL/βL/αD/βD) | 0.103 / 0.204 / 0.266 / 0.166 | – | carbacephem antibiotic: nephrotoxic | |
| Mafenide | 0.435 | * | sulfonamide | |
| Marbofloxacin | 0.406 | * | fluoroquinone antibiotic | |
| Mecillinam | 0.503 | ** | GR | penicillin antibiotic |
| Meclocycline | 0.503 | ** | 2C9 | tetracycline antibiotic |
| Metampicillin (R/S) | 0.174 / 0.282 | – | penicillin antibiotic | |
| Meticillin | 0.187 | – | narrow-spectrum β-lactam antibiotic | |
| Metronidazole | 0.037 | – | anti-anaerobic bacterial | |
| Mezlocillin | 0.341 | * | broad-spectrum penicillin antibiotic | |
| Minocycline | 0.491 | * | tetracycline antibiotic | |
| Moxifloxacin | 0.381 | * | fluoroquinolone antibiotic | |
| Nadifloxacin (R/S) | 0.387 / 0.407 | * | fluoroquinolone antibiotic | |
| Nafcillin | 0.319 | * | narrow-spectrum β-lactam antibiotic | |
| Nitrofurantoin | 0.250 | – | antibacterial | |
| Nitrofurazone | 0.330 | * | antibacterial for urinary-tract infections | |
| Norfloxacin | 0.518 | ** | GR | antibacterial: not mutagenic and carcinogenic in animals |
| Orbifloxacin | 0.556 | ** | GR | fluoroquinolone antibiotic |
| Ofloxacin (R/S) | 0.372 / 0.406 | * | against gonorrhea: various side effects | |
| Oxacillin | 0.274 | – | narrow-specturm β-lactam antibiotic | |
| Oxytetracycline | 0.439 | * | broad-spectrum tetracycline antibiotic | |
| Pazufloxacin | 0.215 | – | quinolone antibiotic | |
| Phenoxymethylpenicillin | 0.158 | – | orally active form of penicillin | |
| Prontosil | 0.642 | ** | ERβ | antibacterial: no toxic effects known |
| Pyrazinamide | 0.092 | – | against tuberculosis: hepatoxicity | |
| Pyrimethamine | 0.221 | – | treatment of protozoal infections (malaria) | |
| Rufloxacin | 0.420 | * | quinolone antibiotic | |
| Sarafloxacin | 0.578 | ** | GR | quinoline antibiotic |
| Sitafloxacin | 0.327 | * | fluoroquinoline antibiotic | |
| Sparfloxacin | 0.592 | ** | GR | fluoroquinolone antibiotic |
| Sulbactam | 0.105 | – | β-lactam antibiotic | |
| Sulbenicillin (R/S) | 0.272 / 0.383 | * | penicillin antibiotic | |
| Sulfacetamide | 0.245 | * | anti-inflammatory: thyroid malignancies in rats | |
| Sulfamethoxazole | 0.251 | – | bacteriostatic antibiotic | |
| Sulfanilamide | 0.185 | – | first discovered sulfonamide antibiotic (Nobel price in 1939) | |
| Talampicillin (R/S) | 0.362 / 0.516 | ** | GR | β-lactam antibiotic |
| Ticarcillin | 0.156 | – | β-lactam antibiotic | |
| Tinidazole | 0.315 | – | against protozoan infections: various side effects | |
| Tosufloxacin (R/S) | 0.435 / 0.399 | * | fluoroquinolone antibiotic | |
| Trimethoprim | 0.307 | – | bacteriostatic | |
| Xibornol | 0.364 | * | antibacterial |
| Compound | Weighted toxic potential | wTP class | Main target | Comments |
| Alprazolam | 0.391 | * | treatment of anxiety disorders, panic attacks | |
| Amitriptyline | 0.427 | * | antidepressant | |
| Bupropion (R/S) | 0.559 / 0.438 | ** | GR | atypical antidepressant |
| Buspirone | 0.459 | * | anxiolytic agent | |
| Clomipramine | 0.504 | ** | GR | antidepressant: various side effects |
| Desipramine | 0.477 | * | antidepressant: genotoxic | |
| Doxepin | 0.480 | * | psychotropic agent: various side effects | |
| Duloxetine | 0.567 | ** | GR | treatment of major depressive disorders |
| Escitalopram | 0.539 | ** | GR | treatment of depression and anxiety |
| Flunitrazepam | 0.278 | – | hypnotic drug; sedative, anxiolytic, amnestic: some side effects | |
| Fluoxetine (R/S) | 0.555 / 0.531 | * | antidepressant: various side effects | |
| Imipramine | 0.523 | ** | GR | antidepressant: various side effects |
| Lorazepam (R/S) | 0.395 / 0.379 | * | anxiolytic, sedative/hypnotic, anticonvulsant: various side effects | |
| Methylphenidate (R/S) | 0.422 / 0.448 | * | stimulant; ADHD: various side effects | |
| Mirtazapine | 0.616 | ** | GR | treatment of depression |
| Moclobemide | 0.109 | – | treatment of depression, social anxiety | |
| Modafinil | 0.184 | – | psychostimulant: various side effects, some severe | |
| Nikethamide | 0.140 | – | psychostimulans | |
| Nortriptyline | 0.585 | ** | GR | antidepressant |
| Paroxetine | 0.326 | * | antidepressant | |
| Reboxetine | 0.657 | ** | GR | antidepressant |
| Sertraline | 0.597 | ** | AR | antidepressant |
| Trazodone | 0.474 | * | sedative, anxiolytic, antidepressant | |
| Trimipramine (R/S) | 0.466 / 0.581 | ** | GR | antidepressant: various side effects |
| Venlafaxine (R/S) | 0.468 / 0.434 | * | antidepressant |
| Compound | Weighted toxic potential | wTP class | Main target | Comments |
| Amlodipine (R/S) | 0.651 / 0.596 | ** | GR | calcium-channel blocker: various side effects; not carcinogenic |
| Anastrozole | 0.120 | – | treatment of breast cancer | |
| Aripiprazole | 0.640 | ** | GR | treatment of schizophrenia |
| Atorvastatin | 0.285 | – | statin; cholesterol reducer: various side effects; not teratogenic | |
| Bicalutamide | 0.414 | * | antiandrogen; treatment of prostate cancer | |
| Budesonide | 0.723 | *** | GR | treatment of asthma and nasal polyposis |
| Candesartan | 0.170 | – | treatment of hypertension | |
| Carvedilol (R/S) | 0.441 / 0.553 | ** | GR | non-selective beta blocker |
| Celecoxib | 0.360 | * | NSAID (traetment of osteoarthritis) | |
| Cetirizine (R/S) | 0.365 / 0.287 | * | antihistamine | |
| Clopidogrel (R/S) | 0.221 / 0.195 | – | anti-platelet agent: various side effects; not teratogenic | |
| Donepezil (R/S) | 0.648 / 0.648 | ** | GR/hERG | reversible ACE inhibitor |
| Esomeprazole | 0.370 | * | proton-pump inhibitor: not toxic in rats (within therapeutic ranges) | |
| Ezetimibe | 0.396 | * | anti-hyperlipidemic drug | |
| Fenofibrate | 0.438 | * | cholesterol reducer | |
| Fluticasone | 0.466 | * | corticosteroid: low potential for systemic toxicity | |
| Gemcitabine | 0.105 | – | chemotherapeutic drug | |
| Irbesartan | 0.116 | – | treatment of hypertension | |
| Lansoprazole | 0.456 | * | proton-pump inhibitor: various side effects; carcinogenic in mice/rats | |
| Levofloxacin | 0.493 | * | fluoroquinolone antibiotic | |
| Memantine | 0.456 | * | Alzheimer's disease medication | |
| Metoprolol (R/S) | 0.479 / 0.394 | * | treatment of hypertension | |
| Montelukast | 0.447 | * | leukotriene receptor antagonist: some side effects; not toxic | |
| Olanzapine | 0.222 | – | antipsychotic: various side effects; evidence for teratogenicity | |
| Omeprazole | 0.314 | – | proton-pump inhibitor | |
| Pantoprazole | 0.152 | – | proton-pump inibitor: sporadic occurence of adenomas/carcinomas | |
| Pioglitazone | 0.157 | – | antihyperglycemic, antidiabetic drug | |
| Pregabalin | 0.220 | – | anticonvulsant drug | |
| Quetiapine | 0.279 | – | neuroleptic: various side effects | |
| Rabeprazole | 0.300 | * | proton-pump inibitor | |
| Raloxifene | 0.698 | ** | GR | prevention of osteoporosis |
| Risperidone | 0.522 | ** | GR | antipsychotic: mammary gland adenocarcinomas; not mutagenic |
| Rosuvastatin | 0.324 | * | treatment of hypercholesterolemia | |
| Salmeterol | 0.276 | – | β2-adrenergic receptor agonist: various side effects; not teratogenic | |
| Simvastatin | 0.483 | * | hypolipidemic drug | |
| Tamsulosin | 0.453 | * | treatment of benign prostatic hyperplasia | |
| Telmisartan | 0.414 | * | treatment of hypertension | |
| Tolterodine (R/S) | 0.381 / 0.492 | * | antimuscarinic drug | |
| Topiramate | 0.502 | ** | GR | anticonvulsant drug |
| Valaciclovir | 0.434 | * | antiviral drug |
| Compound | Weighted toxic potential | wTP class | Main target | Comments |
| Alosetron | 0.240 | – | 5HT3 antagonist | |
| Alpidem | 0.211 | – | anxiolytic drug | |
| Amineptine | 0.228 | – | antidepressant | |
| Benziodarone | 0.336 | * | vasodilator | |
| Buformin | 0.489 | * | antidiabetic drug: induces lactic acidosis | |
| Cerivastatin (3R,5S) | 0.322 | * | statin; cholesterol reducer | |
| Cisapride | 0.518 | ** | hERG | 5HT4 agonist |
| Danazol | 0.632 | ** | AR | synthetic steroid: increased risk for liver tumors |
| Diethylstilbestrol | 0.733 | *** | ERα | non-steroidal estrogen: teratogenic |
| Fenfluramine | 0.497 | * | anti-obesity drug: pulmonary hypertension | |
| Hydromorphone | 0.528 | ** | GR | analgesic |
| Levacetylmethadol | 0.533 | ** | GR | treatment of opioid addiction |
| LSD | 0.435 | * | semi-synthetic psychedelic drug: low toxicity | |
| Lumiracoxib | 0.238 | – | NSAID (COX-2) | |
| Methaqualone | 0.294 | – | sedative: several side effects (some severe) | |
| Mibefradil | 0.748 | *** | GR | treatment of hypertension, angina pectoris |
| Nimesulide | 0.305 | * | NSAID | |
| Nomifensine (R/S) | 0.304 / 0.319 | * | norepinephrine-dopamine reuptake inhibitor | |
| Pemoline (R/S) | 0.172 / 0.135 | – | ADHD, narcolepsy | |
| Phenformin | 0.485 | * | antidiabetic drug: induces lactic acidosis | |
| Phenylpropanolamine (1R,2S) | 0.343 | * | decongestant | |
| Repaglinide | 0.328 | * | treatment of type II diabetes | |
| Rofecoxib | 0.583 | ** | ERβ | non-steroidal anti-inflammatory drug: increased risk of heart attack |
| Tegaserod | 0.451 | * | treatment of IBS and constipation | |
| Temafloxacin | 0.401 | * | fluoroquinolone antibiotic | |
| Temazepam (R/S) | 0.285 / 0.392 | * | 3-hydroxy benzodiazepine: several side effects (some severe) | |
| Terfenadine (R/S) | 0.609 / 0.747 | *** | GR | antihistamine: cardiotoxic |
| Thalidomide (R/S) | 0.238 / 0.369 | * | sedative hypnotic: teratogenic | |
| Tienilic acid | 0.275 | – | uric acid lowering: hepatotoxic | |
| Tolrestat | 0.223 | – | aldose reductase inhibitor | |
| Triazolam | 0.401 | * | sedative: serious side effects | |
| Troglitazone (R/S) | 0.594 / 0.607 | ** | AhR | anti-diabetic, anti-inflammatory: hepatotoxic |
| Trovafloxacin | 0.505 | ** | GR | antibiotic |
| Ximelagatran | 0.435 | * | anticoagulant | |
| Zimelidine | 0.477 | * | selective serotonin reuptake inhibitor: neuropathic |
| Compound | Weighted toxic potential | wTP class | Main target | Comments |
| 2C-B | 0.510 | ** | GR | psychedelic: several side effects |
| 2C-C | 0.447 | * | psychedelic | |
| 2C-E | 0.382 | * | psychedelic: restricted used in several countries | |
| 2C-I | 0.505 | ** | hERG | recreational drug, entheogenic: illegal in the EU |
| 2C-T-2 | 0.428 | * | psychedelic, entheogenic | |
| 2C-T-21 | 0.311 | * | psychedelic | |
| 2C-T-7 | 0.433 | * | hallucinogenic: many side effects; can be lethal | |
| 4-Acetoxy-DIPT | 0.401 | * | hallucinogenic | |
| Allylescaline | 0.452 | * | psychedelic drug | |
| Benzylpiperazine | 0.439 | * | recreational drug: various side effects; renal toxicity | |
| BOH (R/S) | 0.398 / 0.452 | * | psychoactive drug (entactogen, psychedelic) | |
| 1-(3-Chlorophenyl)piperazine | 0.448 | * | 5-HT receptor agonist: some side effects | |
| Cyclopropylmescaline | 0.442 | * | psychedelic drug | |
| Desmethylprodine | 0.366 | * | opioid analgesic, recreational drug | |
| Diisopropyltryptamine | 0.220 | – | psychedelic, hallucinogenic: some side effects | |
| 2,5-Dimethoxy-4-bromoamphetamine | 0.579 | ** | GR | psychedelic, hallucinogenic |
| Dipropyltryptamine | 0.226 | – | psychedelic | |
| α-Ethyltryptamine (R/S) | 0.352 / 0.455 | * | psychoactive drug: withdrawn | |
| 5-MeO-AMT (R/S) | 0.452/ 0.568 | ** | GR | psychedelic: various side effects; can be fatal; illegal in the US |
| 5-MeO-DMT | 0.352 | * | psychedelic: various side effects; restricted used in several countries | |
| Methylbenzylpiperazine | 0.347 | * | stimulant drug | |
| 3,4-Methylenedioxyethylamphetamin (R/S) | 0.446 / 0.369 | * | MDEA: psychedelic, stimulant | |
| 3,4-Methylenedioxy-N-methylamphetamin (R/S) | 0.374 / 0.351 | * | MDMA: psychedelic, stimulant | |
| 3,4-Methylenedioxymethamphetamin (R/S) | 0.388 / 0.439 | * | Ecstasy: psychedelic, ampathogenic: possibly neurotoxic | |
| 3-Methylfentanyl | 0.479 | * | opioid analgesic: several side effects; has caused many deaths | |
| α-Methylfentanyl (R/S) | 0.335 / 0.537 | ** | GR | opioid analgesic: several (including severe) side effects |
| α-Methyltryptamine (R/S) | 0.543 / 0.453 | ** | hERG | antidepressant |
| 5-Methoxy-diisopropyltryptamin | 0.411 | * | psychedelic: endocrine disruptor; illegal in many countries | |
| Parafluorofentanyl | 0.557 | ** | GR | opioid analgesic: various side effects (some life-threatening) |
| α-Pyrrolidinopropiophenone (R/S) | 0.428 / 0.350 | * | stimulant drug | |
| Tenocyclidine | 0.374 | * | dissociative anesthetic drug | |
| Trifluoromethylphenylpiperazin | 0.359 | * | recreational drug: various side effects |
| Compound | Weighted toxic potential | wTP class | Main target | Comments |
| Abafungin | 0.625 | ** | GR | antifungal drug |
| Abanoquil | 0.371 | * | α1-adrenergic antagonist | |
| Abecarnil | 0.383 | * | anxiolytic drug | |
| Abiraterone | 0.740 | *** | ERα | under investigation for prostate cancer treatment |
| Abunidazole (R/S) | 0.228 / 0.098 | – | antifungal drug | |
| Acaprazine | 0.336 | * | nootropic drug | |
| Acemetacin | 0.224 | – | treatment of arthritis: moderate toxicity, not teratogenic | |
| Acenocoumarol (R/S) | 0.191 / 0.143 | – | anticoagulant | |
| Acepromazine | 0.498 | * | sedative, antiemetic drug | |
| Aceprometazine (R/S) | 0.478 / 0.484 | * | neuroleptic, antihistamine | |
| Acetazolamide | 0.342 | * | carbonic anhydrase inhibitor: not toxic | |
| Acetohexamide | 0.471 | * | treatment of diabetes mellitus type 2 | |
| Acetophenazine | 0.605 | ** | GR | antipsychotic |
| Aciclovir | 0.169 | – | analgesic | |
| Adafenoxate | 0.677 | ** | GR | nootropic in rats |
| Adapalene | 0.315 | * | treatment of acne and pilaris keratosis | |
| Afimoxifene | 0.469 | * | selective estrogen-receptor modulator | |
| Agomelatine | 0.241 | – | antidepressant | |
| Alaproclate (R/S) | 0.615 / 0.622 | ** | GR/hERG | antidepressant |
| Albendazole | 0.222 | – | treatment of worm infestations | |
| Alclofenac | 0.277 | – | NSAID | |
| Alclometasone | 0.403 | * | anti-inflammatory, antipruritic, antiallergic, vasoconstrictive agent | |
| Aldesulfone | 0.145 | – | treatment of leprosy | |
| Alfadolone | 0.568 | ** | ERβ | neuroactive steroid with hypnotic effects |
| Alfaxalone | 0.634 | ** | ERα | general anesthetic |
| Alfetamine (R/S) | 0.399 / 0.391 | * | antidepressant (not marketed) | |
| Alfentanil | 0.242 | – | analgesic drug (used as anesthesia in surgery) | |
| Alfuzosin | 0.489 | * | treatment of benign prostatic hyperplasia | |
| Alimemazine (R/S) | 0.562 / 0.367 | ** | GR | antipruritic drug |
| Alizapride | 0.379 | * | antiemetic drug | |
| Allantoin (R/S) | 0.238 / 0.373 | * | keratolytic agent: non-toxic | |
| Allobarbital | 0.213 | – | anticonvulsant | |
| Allopurinol | 0.117 | – | treatment of hyperuricemia | |
| Alminoprofen (R/S) | 0.182 / 0.240 | – | NSAID | |
| Almotriptan | 0.356 | * | treatment of migraine headaches | |
| Amantadine | 0.456 | * | antiviral and antiparkinsonian drug | |
| Amcinonide | 0.780 | *** | GR | corticosteroid |
| Amiloride | 0.282 | – | potassium-sparing diuretic | |
| Aminorex (R/S) | 0.256 / 0.178 | – | anorectic stimulant drug | |
| Amiodarone | 0.548 | ** | hERG | antiarrhythmic agent |
| Amitraz | 0.318 | * | antiparasitic drug | |
| Amlexanox | 0.281 | – | antiallergic, anti-inflammatory | |
| Amodiaquine | 0.587 | ** | GR | antimalarial and anti-inflammatory drug |
| Amoxapine | 0.683 | ** | GR | antidepressant drug |
| Amsacrine | 0.558 | ** | GR | antineoplastic agent |
| Anagrelide | 0.388 | * | treatment of chronic myeloid leukemia | |
| Anecortave | 0.327 | * | angiogenesis inhibitor | |
| Aniracetam | 0.249 | – | nootropic, more potent than piracetam: some side effects | |
| Anisindione | 0.342 | * | anticoagulant | |
| Antazolin | 0.538 | ** | GR | antihistamine drug |
| Apomorphine | 0.459 | * | dopaminergic agonist (D1/D2) | |
| Apraclonidine | 0.348 | * | treatment of glaucoma | |
| Aprinidine | 0.563 | ** | GR | antiarrhythmic agent |
| Asenapine | 0.542 | ** | GR | treatment of schizophrenia |
| Aspirin | 0.160 | – | antipyretic drug | |
| Astemizole | 0.688 | ** | hERG | antihistamine drug |
| Atovaquone | 0.423 | * | treatment of PCP, toxoplasmosis and malaria | |
| Azatadine | 0.512 | ** | GR | antihistamine |
| Azathioprine | 0.021 | – | immunosuppressant | |
| Baclofen (R/S) | 0.181 / 0.216 | – | spasticity treatment | |
| Balsalazide | 0.133 | – | treatment of inflammatory bowel disease | |
| Bamipine | 0.451 | * | antipruritic drug | |
| Barbital | 0.060 | – | first commercially marketed barbiturate | |
| Bendazac | 0.279 | – | NSAID | |
| Bendroflumethiazide (R/S) | 0.531 / 0.376 | ** | ERβ | treatment of hypertension |
| Bentiromide (R/S) | 0.164 / 0.135 | – | treatment of chronic pancreatis: withdrawn in the USA and Canada | |
| Benzatropine (cis/trans) | 0.517 / 0.628 | ** | GR | treatment of drug-induced parkinsonims, akathisia and acute dystonia |
| Benzbromarone | 0.610 | ** | GR | uricosuric agent, treatment of gout |
| Benzocaine | 0.270 | – | local anesthetic | |
| Benzoctamine | 0.526 | ** | GR | sedative, anxiolytic |
| Benzydamine | 0.410 | * | NSAID | |
| Bepridil (R/S) | 0.504 / 0.394 | ** | GR | treatment of angina |
| Betahistine | 0.233 | – | treatment of balance disorders | |
| Betamethasone | 0.459 | * | anti-inflammatory, immunosuppressive drug | |
| Betamipron | 0.284 | – | prevention of (panipenem-caused) nephrotoxicity | |
| Betanidine | 0.367 | * | sympatholytic drug | |
| Betaxolol (R/S) | 0.436 / 0.408 | * | treatment of hypertension and glaucoma | |
| Betazole | 0.466 | * | H2 receptor agonist | |
| Bevantolol (R/S) | 0.497/ 0.563 | ** | GR | calcium-channel blocker |
| Bexarotene | 0.473 | * | antienoplastic agent | |
| Bezafibrate | 0.344 | * | treatment of hyperlipidemia | |
| Bezitramide | 0.656 | ** | GR | analgesic drug |
| Bicifadine (RR/SS) | 0.427 / 0.425 | * | analgesic drug | |
| Biclotymol | 0.357 | * | phenolic antiseptic | |
| Bifonazole (R/S) | 0.466 / 0.363 | * | antifungal drug | |
| Binospirone (R/S) | 0.612 / 0.660 | ** | GR | partial 5HT1A agonist; anxiolytic effects |
| Biperiden (R/S) | 0.549 / 0.573 | ** | GR | antiparkisonian agent |
| Biricodar | 0.488 | * | treatment of ovarian cancer | |
| Bisacodyl | 0.210 | – | laxative drug | |
| Bisoprolol (R/S) | 0.362 / 0.446 | ** | GR | treatment of cardiovascular diseases |
| Bisoxatin | 0.367 | * | laxative drug | |
| Bitolterol (R/S) | 0.489 / 0.424 | * | treatment of asthma and COPD | |
| Blonanserin | 0.692 | ** | GR | antipsychotic drug |
| Bopindolol (R/S) | 0.590 / 0.512 | ** | GR | β-blocker; acts as prodrug for pindolol |
| Bornaprine (R/S) | 0.581 / 0.460 | ** | hERG | anticholinergic drug |
| Bosentan | 0.362 | * | treatment of pulmonary artery hypertension | |
| Bretazenil | 0.347 | * | anxiolytic drug | |
| Brifentanil | 0.272 | – | opioid analgesic | |
| Brimonidine | 0.407 | * | treatment of open-angle glaucoma or ocular hypertension | |
| Brinzolamide (R/S) | 0.583 / 0.522 | ** | GR | treatment of glaucoma or ocular hypertension |
| Brivudine | 0.260 | – | antiviral drug | |
| Brodimoprim | 0.199 | – | antibacterial drug | Brofaromine | 0.576 | ** | hERG | treatment of depression and anxiety |
| Bromazepam | 0.308 | * | anxiolytic drug; at higher doses sedative and hypnotic | |
| Bromazine (R/S) | 0.616 / 0.510 | ** | GR | antihistamine |
| Bromfenac | 0.253 | – | NSAID | |
| Bromhexine | 0.377 | * | mucolytic agent | |
| Bromopride | 0.287 | – | antiemetic drug | |
| Bromperidol | 0.698 | ** | GR | treatment of schizophrenia |
| Brompheniramine (R/S) | 0.496 / 0.315 | * | antihistamine | |
| Brotizolam | 0.210 | – | anxiolytic, anticonvulsant, sedative | |
| Broxaterol (R/S) | 0.273 / 0.346 | * | β-adrenergic agonist | |
| Broxyquinoline | 0.114 | – | anti-infective agent | |
| Bucolome | 0.241 | – | analgesic, anti-inflammatory | |
| Budipine | 0.490 | * | dopaminergic agent | |
| Budralazine | 0.334 | * | vasodilator | |
| Bufexamac | 0.308 | * | anti-inflammatory, analgesic | |
| Buflomedil | 0.387 | * | vasoactive drug (treatment of claudication) | |
| Bumadizone (R/S) | 0.230 / 0.281 | – | NSAID | |
| Bumetanide | 0.233 | – | loop diuretic: high plasma levels are toxic to animals | |
| Bunaftine | 0.537 | ** | GR | antiarrhythmic agent |
| Bunazosin | 0.391 | * | α1-antagonist | |
| Buparvaquone | 0.385 | * | antiprotozoal drug | |
| Bupivacaine | 0.395 | * | local anesthetic | |
| Busulfan | 0.278 | – | chemotherapy drug | |
| Butaclamol | 0.564 | ** | GR | antipsychotic |
| Butalamine | 0.581 | ** | GR | vasodilator |
| Butamirate (R/S) | 0.262 / 0.220 | – | cough suppressant | |
| Butaxamine | 0.263 | – | β2-selective blocker | |
| Butenafine | 0.511 | ** | GR | antifungal agent |
| Butoconazole (R/S) | 0.330 / 0.336 | * | antifungal agent | |
| Butriptyline (R/S) | 0.534 / 0.624 | ** | GR | antidepressant |
| Cabergoline | 0.434 | * | dopamine-receptor agonist | |
| Cadralazine (R/S) | 0.180 / 0.050 | – | treatment of hypertension | |
| Cafedrine (RR/RS/SR/SS) | 0.527 / 0.436 / 0.471 / 0.457 | ** | hERG | cardiac stimulant |
| Camazepam (R/S) | 0.192 / 0.175 | * | anxiolytic, anticonvulsant, sedative | |
| Camostat | 0.379 | * | serine protease inhibitor | |
| Candesartan | 0.295 | – | treatment of hypertension | |
| Canrenone | 0.578 | ** | ERα | metabolite of spironolactone |
| Captodiame (R/S) | 0.366 / 0.473 | * | anxiolytic drug | |
| Captopril | 0.187 | – | treatment of hypertension | |
| Carazolol (R/S) | 0.534 / 0.465 | ** | hERG | anxiolytic, anticonvulsant, sedative |
| Carbamazepine | 0.386 | * | anticonvulsant | |
| Carbazochrome (R/S) | 0.421 / 0.408 | * | antihemorrhagic agent | |
| Carbenoxolone | 0.104 | – | treatment of inflammation | |
| Carbidopa | 0.294 | – | treatment of Parkinson's disease | |
| Carbimazole | 0.146 | – | treatment of hyperthroidism | |
| Carbinoxamine (R/S) | 0.331 / 0.441 | * | antihistamine | |
| Carboquone (R/S) | 0.200 / 0.172 | – | chemotherapeutic agent | |
| Carbocromen | 0.393 | * | vasodilator | |
| Carbutamide | 0.259 | – | anti-diabetic drug | |
| Carbuterol (R/S) | 0.496 / 0.535 | ** | hERG | β2-agonist |
| Carfentanyl | 0.534 | ** | GR | opioid analgesic |
| Carisoprodol (R/S) | 0.331 / 0.239 | – | muscle relaxant | |
| Carmofur | 0.233 | – | antienoplastic agent | |
| Caroverine | 0.557 | ** | GR | treatment of gastrointestinal disorders |
| Carperidine | 0.281 | – | opioid analgesic | |
| Carprofen (R/S) | 0.411 / 0.256 | * | NSAID used by veterinarians | |
| Carteolol (R/S) | 0.612 / 0.607 | ** | GR | treatment of glaucoma |
| Celiprolol (R/S) | 0.487 / 0.382 | * | antihypertensive | |
| Centrophenoxine | 0.375 | * | nootropic (senile dementia, Alzheimer): some side effects | |
| Cetiedil (R/S) | 0.568 / 0.455 | ** | GR | vasodilator |
| Cetraxate | 0.212 | – | cytoprotective agent | |
| Cevimeline | 0.595 | ** | hERG | parasympathomimetic |
| Chiniofon | 0.417 | * | antiprotozoal agent | |
| Chlorambucil | 0.137 | – | chemotherapeutic drug | |
| Chlorbenzoxamine (R/S) | 0.563 / 0.643 | ** | GR | treatment of gastrointestinal disorders |
| Chlorcyclizine (R/S) | 0.724 / 0.405 | *** | GR | antihistamine |
| Chlormadinone | 0.520 | ** | ERα | proestrogen (added to contraceptives) |
| Chlormezanone (R/S) | 0.322 / 0.268 | * | anxiolytic | |
| Chloropyramine | 0.570 | ** | GR | first-generation antihistamine |
| Chloroquine (R/S) | 0.537 / 0.542 | ** | GR | treatment and prevention of malaria |
| Chlorothen | 0.487 | * | antihistamine | |
| Chlorothiazide | 0.101 | – | diuretic, antihypertensive | |
| Chlorotrianisene | 0.480 | * | synthetic estrogen | |
| Chlorphenamine (R/S) | 0.410 / 0.320 | * | first-generation antihistamine | |
| Chlorphenesin (R/S) | 0.192 / 0.335 | * | muscle relaxant | |
| Chlorphenoxamine (R/S) | 0.360 / 0.462 | * | antipruritic | |
| Chlorpromazine | 0.472 | * | treatment of schizophrenia | |
| Chlorpropamide | 0.264 | * | treatment of type-2 diabetes | |
| Chlorprothixene | 0.427 | * | antipsychotic drug | |
| Chlorzoxazone | 0.348 | * | muscle relaxant | |
| Ciclazindol (R/S) | 0.661 / 0.545 | ** | GR | antidepressant |
| Ciclesonide | 0.540 | ** | GR | treatment of obstructive airway diseases |
| Cicletanine (R/S) | 0.500 / 0.532 | ** | AR/AhR | low-ceiling diuretic drug |
| Ciclobendazole | 0.374 | * | antihelmintic drug | |
| Ciclonicate | 0.271 | – | vasodilating agent | |
| Ciclopirox | 0.163 | – | antifungal agent | |
| Cilansetron | 0.353 | * | 5HT3 antagonist | |
| Cilnidipine | 0.442 | * | 5HT3 antagonist | |
| Cilostazol | 0.369 | * | treatment of intermittent claudication | |
| Cimetidine | 0.183 | – | H2-receptor antagonist | |
| Cimoxatone (R/S) | 0.400 / 0.427 | * | antidepressant | |
| Cinacalcet | 0.655 | ** | GR | calcimimetic |
| Cinanserin | 0.465 | * | serotonin receptor antagonist | |
| Cinchocaine | 0.354 | * | local anesthetic | |
| Cinchophen | 0.390 | * | analgesic drug | |
| Cinnarizine (cis/trans) | 0.669 / 0.682 | ** | GR | treatment of motion sickness |
| Cinolazepam (R/S) | 0.251 / 0.309 | * | anxiolytic, anticonvulsant, sedative | |
| Cipemastat | 0.272 | – | anti-arthritis agent | |
| Ciramadol | 0.405 | * | opioid analgesic | |
| Cirazoline | 0.356 | * | α-adrenergic receptor agonist | |
| Clamoxyquine | 0.607 | ** | GR | antiamoebic, antidhiarrheal drug |
| Clebopride | 0.483 | * | antiemetic drug | |
| Clefamide | 0.324 | * | antiprotozoal agent | |
| Clemastine | 0.481 | * | antihistamine | |
| Clemizole | 0.514 | ** | GR | antihistamine |
| Clenbuterol (R/S) | 0.519 / 0.544 | ** | GR | bronchodilator, decongestant |
| Clentiazem (R/S) | 0.684 / 0.470 | ** | GR | calcium-channel blocker |
| Clevidipine | 0.261 | – | calcium-channel blocker | |
| Climazolam | 0.467 | * | anesthetic in veterinary medicine | |
| Clioquinol | 0.258 | – | antifungal and antiprotozoal drug | |
| Clobazam | 0.418 | * | anxiolytic drug | |
| Clobenzorex (R/S) | 0.347 / 0.356 | * | appetite suppressor (anorectic) | |
| Clobetasol | 0.448 | * | treatment of eczema and psoriasis | |
| Clobetasone | 0.469 | * | treatment of eczema | |
| Clobutinol (RR/RS/SR/SS) | 0.352 / 0.298 / 0.380 / 0.372 | * | cough suppressant | |
| Clocinizine (R/S) | 0.621 / 0.710 | *** | GR | antihistamine |
| Clodantoin (RR/RS/SR/SS) | 0.212 / 0.166 / 0.119 / 0.250 | – | drug used in gynecology | |
| Clofazimine | 0.745 | *** | GR | treatment of leprosy |
| Clofedanol (R/S) | 0.367 / 0.405 | * | cough suppressant | |
| Clofenciclan | 0.504 | ** | GR | stimulant drug |
| Clofibrate | 0.151 | – | lipid-lowering agent | |
| Clomethiazole | 0.126 | – | sedative, hypnotic | |
| Clomifene (E/Z) | 0.560 / 0.731 | ** | hERG/GR | selective estrogen receptor modulator |
| Clominorex (R/S) | 0.309 / 0.245 | * | appetite suppressant | |
| Clonazepam | 0.277 | – | anticonvulsant, anxiolytic | |
| Clonidine | 0.321 | * | antihypertensive | |
| Clonitazene | 0.663 | ** | GR | opioid analgesic |
| Cloperastine (R/S) | 0.583 / 0.640 | ** | GR | cough suppressant |
| Clopenthixol (cis/trans) | 0.489 / 0.527 | ** | GR | antipsychotic drug |
| Clorazepate (R/S) | 0.249 / 0.301 | * | anxiolytic, anticonvulsant, sedative | |
| Clorexolone | 0.314 | * | low-ceiling sulfonamide diuretic | |
| Clorgiline | 0.098 | – | antidepressant | |
| Cloricromen | 0.492 | * | platelet-aggregation inhibitor | |
| Clorindione | 0.437 | * | vitamin K antagonist | |
| Cloridarol (R/S) | 0.197 / 0.230 | – | vasodilator | |
| Cloroqualone | 0.268 | – | sedative, antitussive | |
| Clotrimazole | 0.260 | – | sedative, antitussive | |
| Cloxazolam (R/S) | 0.436 / 0.290 | – | anxiolytic, anticonvulsant, sedative | |
| Clozapine | 0.389 | * | antifungal medication | |
| CNQX (6-cyano-7-notroquinoxaline-2,3,-dione) | 0.198 | – | AMPA/kainate receptor antagonist | |
| Coluracetam | 0.333 | * | treatment of ischemic retinopathy: little or no toxicity | |
| Cortisol | 0.698 | ** | ERβ | steroid hormone: treatment of allergies and inflammation |
| Cortisone | 0.461 | * | steroid hormone: suppression of the immune system | |
| Cortivazol | 0.619 | ** | GR | glucocorticoid receptor agonist |
| Croconazole | 0.385 | * | antifungal agent | |
| Cromoglicic acid | 0.185 | – | mast-cell stabilizer | |
| Crotamiton | 0.135 | – | antipruritic | |
| Cyclandelate (R/S) | 0.258 / 0.273 | – | vasodilator | |
| Cyclazodone | 0.447 | * | stimulant drug | |
| Cyclizine | 0.461 | * | GR | antihistamine |
| Cyclobenzaprine | 0.538 | ** | GR | antidepressant |
| Cyclofenil | 0.230 | * | estrogen receptor modulator | |
| Cycloguanil | 0.318 | * | antimalarial drug | |
| Cyclomethycaine | 0.550 | ** | GR | local anesthetic |
| Cyclopentolate (R/S) | 0.359 / 0.250 | * | mydriatic and cycloplegic agent | |
| Cypenamine (1R,2S/1S,2R) | 0.473 / 0.501 | ** | GR | stimulant drug |
| Cyprazepam | 0.427 | * | benzodiazepin (not approved for sale in the US) | |
| Cyproheptadine | 0.509 | ** | GR | antihistamine |
| Cyproterone | 0.495 | * | antiandrogen (treatment of precocious puberty) | |
| Dacemazine | 0.361 | * | antispasmodic, antitussive | |
| Dantrolene | 0.221 | – | muscle relaxant | |
| Dapiprazole | 0.484 | * | mydriasis-reversing agent | |
| Dapoxetine | 0.482 | * | short-acting SSRI drug | |
| Dapsone | 0.450 | * | treatment of leprae | |
| Darifenacin | 0.587 | ** | GR | treatment of urinary incontinence |
| Darodipine | 0.230 | – | calcium channel blocker | |
| Darunavir | 0.456 | * | treatment of HIV infection | |
| Daunorubicin | 0.462 | * | treatment of acute myeloid and lymphocytic leukemia | |
| Decoquinate | 0.236 | – | coccidiostatic agent | |
| Deferasirox | 0.218 | – | treatment of thalassaemia major | |
| Deferiprone | 0.059 | – | rationally-designed iron chelator | |
| Dehydroepiandrosterone | 0.627 | ** | ERα | cholesterol metabolite: liver tumor inducer |
| Delapril | 0.358 | * | ACE inhibitor | |
| Delavirdine | 0.400 | * | reverse transcriptase inhibitor | |
| Demecolcine | 0.544 | ** | GR | chemotherapeutic agent |
| Denopamine | 0.363 | * | treatment of angina | |
| Deptropine | 0.666 | ** | GR | antihistamine with anticholinergic properties |
| Deracoxib | 0.379 | * | NSAID | |
| Desloratadine | 0.556 | ** | hERG | treatment of allergies |
| Desogestrel | 0.595 | ** | AR | used in hormonal contraceptives |
| Desomorphine | 0.417 | * | opiate analogue | |
| Desonide | 0.515 | ** | GR | treatment of eczema and dermatitis |
| Desoximetasone | 0.398 | * | psychoactive drug | |
| Desoxipipradrol | 0.484 | * | treatment of various skin conditions (rashes, itching, redness) | |
| Detomidine | 0.111 | – | large-animal sedative primarily used in horses | |
| Devapamil (R/S) | 0.357 / 0.643 | ** | GR | calcium channel blocker |
| Devazepide | 0.434 | * | treatment of dyspepsia, gastroparesis and gastric reflux | |
| Dexamethasone | 0.332 | * | anti-inflammatory, immunosuppressant drug | |
| Dexbrompheniramine | 0.354 | * | antihistamine | |
| Dexfenfluramine | 0.411 | * | anorectic drug | |
| Dexibuprofen | 0.314 | * | NSAID | |
| Dexketoprofen | 0.299 | – | NSAID | |
| Dexmedetomidine | 0.186 | – | sedative medication | |
| Dexmethylphenidate | 0.433 | * | treatment of ADHD | |
| Dexrazoxane | 0.376 | * | protection against cardiotoxic side effects of anthracyclines | |
| Dextromoramide (R/S) | 0.382 / 0.363 | * | opioid analgesic | |
| Dextromethorphan | 0.615 | ** | GR | antitussive drug |
| Dezocine | 0.579 | ** | hERG | opioid analgesic |
| Diacerein | 0.283 | – | treatment of osteoarthritis | |
| Diampromide (R/S) | 0.449 / 0.456 | * | opioid analgesic | |
| Diazepam | 0.321 | * | anxiolytic, anticonvulsant, sedative | |
| Diazoxide | 0.369 | * | treatment of hypertension and insulinoma | |
| Dibenzepin | 0.444 | * | antidepressant | |
| Dibrompropamidine | 0.457 | * | antiseptic, disinfectant | |
| Dibunate | 0.425 | * | cough suppressant | |
| Diclazuril (R/S) | 0.498 / 0.596 | ** | GR | cocciodiostat |
| Diclofenac | 0.243 | – | analgesic: some side effects | |
| Dicoumarol | 0.264 | – | anticoagulant (Vitamin K antagonist) | |
| Dicycloverine | 0.393 | * | anticholinergic drug | |
| Didanosine | 0.313 | * | reverse transcriptase inhibitor | |
| Dienestrol | 0.560 | ** | ERβ | treatment of vulvar atrophy and atrophic vaginitis |
| Dienogest | 0.510 | ** | AR | oral contraceptive |
| Diethylcarbamazine | 0.057 | – | antihelmintic drug | |
| Diethylthiambutene (R/S) | 0.362 / 0.479 | * | opioid analgesic | |
| Difemerine | 0.472 | * | antimuscarinic | |
| Difenoxin | 0.711 | *** | GR | opioid analgesic |
| Diflunisal | 0.163 | – | generic NSAID | |
| Dihydrocodeine | 0.602 | ** | GR | opioid analgesic |
| Dihydroxyphenylglycine (DHPG) | 0.423 | * | mGluRS agonist | |
| Diisopromine | 0.351 | * | neutralizes spastic conditions of the biliary tract | |
| Diloxanide furoate | 0.156 | – | antiprotozoal drug | |
| Diltiazem | 0.505 | ** | GR | treatment of hypertension, angina pectoris |
| Dimefline | 0.780 | *** | GR | respiratory stimulant |
| Dimethoxanate | 0.489 | * | cough suppressant | |
| Diminazene | 0.248 | – | treatment of Trypanosmiasis | |
| Diphenhydramine | 0.402 | * | antihistamine, antiemetic, sedative, hypnotic | |
| Diphenylpyraline | 0.448 | * | antihistamine with psychostimulant properties | |
| Dipivefrine (R/S) | 0.291 / 0.248 | * | treatment of glaucoma | |
| Dipyridamole | 0.177 | – | inhibits thrombus formation | |
| Ditazole | 0.224 | – | platelet-aggregation inhibitor | |
| Dithranol | 0.310 | * | treatment of psoriasis | |
| Dizocilpine | 0.248 | – | anticonvulsant | |
| Dobutamine (R/S) | 0.490 / 0.528 | ** | ERβ | treatment of heart failure and cardiogenic shock |
| Dofetilide | 0.625 | ** | GR | class III antiarrhythmic agent |
| Dolasetron | 0.654 | ** | GR | treatment of nausea/vomiting following chemotherapy |
| Domperidone | 0.629 | ** | GR | antidopaminergic drug |
| Dorzolamide (R/S) | 0.615 / 0.442 | ** | GR; | treatment of glaucoma, ocular hypertension |
| Dosulepin | 0.564 | ** | GR | antidepressant |
| Dotarizine | 0.575 | ** | GR | vasodilator |
| Doxazosin (R/S) | 0.242 / 0.368 | * | treatment of hypertension | |
| Doxefazepam (R/S) | 0.251 / 0.204 | – | anxiolytic, anticonvulsant, sedative | |
| Doxofylline | 0.240 | – | treatment of asthma | |
| Doxylamine (R/S) | 0.349 / 0.370 | * | short-term sedative | |
| Dronedarone | 0.629 | ** | GR | treatment of cardiac arrhythmias |
| Droperidol | 0.362 | * | antiemetic, antipsychotic | |
| Dropropizine (R/S) | 0.138 / 0.263 | – | cough suppressant | |
| Drospirenone | 0.685 | ** | ERβ | oral contraceptive |
| Drotaverine | 0.486 | * | antispasmodic drug | |
| Drotebanol | 0.414 | * | cough suppressant | |
| Droxicam | 0.394 | * | NSAID | |
| Droxypropine | 0.478 | * | cough suppressant | |
| Dutasteride | 0.738 | *** | GR | treatment of benign prostatic hyperplasia |
| Dyclonine | 0.399 | * | oral anesthetic (throat lozenges) | |
| Dydrogesterone | 0.649 | ** | ERβ | progesterone hormone |
| Ebastine | 0.639 | ** | GR | antihistamine |
| Econazole (R/S) | 0.269 / 0.308 | * | antifungal medication | |
| Efaroxan (R/S) | 0.294 / 0.424 | * | &alpha2-blocker | |
| Eflornithine | 0.420 | * | treatment of African trypanosomiasis | |
| Efloxate | 0.413 | * | GR | vasodilator |
| Efonidipine (R/S) | 0.496 / 0.647 | ** | GR | calcium channel blocker |
| Elesclomol | 0.140 | – | chemotherapy adjuvant | |
| Eletriptan | 0.739 | *** | GR | treatment of migraine headaches |
| Elfazepam | 0.340 | * | sedative, anxiolytic | |
| Eliprodil (R/S) | 0.461 / 0.542 | ** | GR | neuroprotective, anticonvulsant |
| Ellipticine | 0.412 | * | anticancer drug | |
| Eltrombopag | 0.241 | – | treatment of thrombocytopenia | |
| Embramine (R/S) | 0.556 / 0.357 | ** | GR | antihistamine |
| Embutramide | 0.340 | * | sedative drug | |
| Emedastine | 0.431 | * | antihistamine | |
| Emopamil (R/S) | 0.370 / 0.520 | ** | GR | calcium channel blocker |
| Enadoline | 0.646 | ** | GR | selective κ-opioid agonist |
| Enalaprilate | 0.230 | – | treatment of hypertension | |
| Encainide (R/S) | 0.580 / 0.479 | ** | GR | antiarrhythmic agent |
| Endralazine | 0.323 | * | treatment of hypertension | |
| Enoximone | 0.540 | ** | ERβ | treatment of congestive heart failure |
| Ensaculin | 0.514 | ** | GR | treatment of dementia |
| Entacapone | 0.072 | – | treatment of Parkinson's disease | |
| Entecavir | 0.310 | * | treatment of hepatitis B | |
| Epalrestat | 0.355 | * | treatment of diabetic neuropathy | |
| Eperisone (R/S) | 0.381 / 0.413 | * | antispasmodic drug | |
| Epinastine (R/S) | 0.660 / 0.410 | ** | GR | antihistamine |
| Epirizole | 0.313 | * | NSAID | |
| Epirubicin | 0.370 | * | chemotherapeutic drug | |
| Eplerenone | 0.615 | ** | GR | treatment of chronic heart failure |
| Eprosartan (cis/trans) | 0.345 / 0.348 | * | treatment of high blood pressure | |
| Eprazinone (RR/RS/SR/SS) | 0.558 / 0.584 / 0.474 / 0.638 | ** | GR | mucolytic drug |
| Erdosteine (R/S) | 0.069 / 0.056 | – | mucolytic drug | |
| Ergonovine | 0.634 | ** | GR | medical use in obstetrics |
| Esmolol (R/S) | 0.289 / 0.271 | – | β1-receptor blocker | |
| Estazolam | 0.270 | – | anxiolytic, anticonvulsant, sedative | |
| Estramustine | 0.344 | * | treatment of prostate cancer | |
| Estrone sulfate | 0.361 | * | sulfated estrone (estrogenic hormone) | |
| Etacrynic acid | 0.208 | – | loop diuretic | |
| Etafedrine (RR/RS/SR/SS) | 0.265 / 0.319 / 0.296 / 0.356 | * | bronchodilator | |
| Etafenone | 0.568 | ** | GR | vasodilator |
| Etamivan | 0.271 | – | respiratory stimulant | |
| Etaqualone | 0.303 | * | sedative and hypnotic properties | |
| Etazolate | 0.232 | – | anxiolytic drug | |
| Ethadione | 0.091 | – | anticonvulsant | |
| Ethenzamide | 0.181 | – | analgesic, NSAID | |
| Ethinamate | 0.049 | – | sedative-hypnotic medication | |
| Ethinylestradiol | 0.833 | **** | ERβ | oral contraceptive |
| Ethisterone | 0.703 | *** | ERα | progestogen hormone |
| Ethoheptazine (R/S) | 0.411 / 0.405 | * | opioid analgesic | |
| Ethosuximide (R/S) | 0.062 / 0.062 | – | anticonvulsant | |
| Ethotoin (R/S) | 0.162 / 0.262 | – | anticonvulsant | |
| Ethoxzolamide | 0.282 | – | treatment of glaucoma | |
| Ethylbiscoumacetate | 0.256 | – | vitamin K antagonist | |
| Ethylloflazepate (R/S) | 0.351 / 0.313 | * | anxiolytic, anticonvulsant, sedative | |
| Eticyclidine | 0.511 | ** | hERG | anesthetic, hallucinogenic |
| Etidocaine (R/S) | 0.540 / 0.404 | ** | GR | local anesthetic |
| Etifoxine (R/S) | 0.631 / 0.637 | ** | GR | anxiolytic, anticonvulsant |
| Etilefrine (R/S) | 0.158 / 0.179 | – | cardiac stimulant | |
| Etiracetam (R/S) | 0.059 / 0.040 | – | nootropic: mild side effects | |
| Etizolam | 0.205 | – | amnesic, anxiolytic, anticonvulsant, hypnotic, sedative | |
| Etodolac (R/S) | 0.221 / 0.219 | – | NSAID | |
| Etofamide | 0.299 | – | antiprotozoal drug | |
| Etofenamate | 0.188 | – | treatment of joint and muscular pain | |
| Etofibrate | 0.161 | – | hybrid drug: clofibrate and niacin | |
| Etomidate | 0.230 | – | general anesthetic, sedative | |
| Etonitazene | 0.518 | ** | GR | analgesic |
| Etonogestrel | 0.664 | ** | AR | hormonal contraceptive |
| Etoperidone | 0.314 | * | antidepressant | |
| Etoricoxib | 0.382 | * | COX-2 selective inhibitor | |
| Etoxadrol | 0.532 | ** | GR | dissociative anesthetic |
| Etravirine | 0.312 | * | treatment of HIV | |
| Etretinate | 0.395 | * | treatment of severe psioriasis | |
| Etybenzatropine | 0.617 | ** | GR | treatment of Parkinson's disease |
| Etymemazine (R/S) | 0.572 / 0.303 | ** | GR | antihistamine |
| Eupatilin | 0.475 | * | treatment of acid-related disorders | |
| Exemestane | 0.405 | * | treatment of breast cancer | |
| Fadrozole (R/S) | 0.251 / 0.284 | – | treatment of breast cancer | |
| Falipamil | 0.462 | * | calcium channel blocker | |
| Famciclovir | 0.123 | – | antiviral drug | |
| Famotidine | 0.302 | * | treatment of peptic ulcer disease | |
| Fananserin | 0.659 | ** | GR | sedative, antipsychotic |
| Fasoracetam (R/S) | 0.135 / 0.103 | – | nootropic | |
| Fasudil | 0.557 | ** | hERG | treatment of cerebral vasospasm |
| Febuxostat | 0.243 | – | treatment of hyperuricemia | |
| Fedrilate (R/S) | 0.458 / 0.415 | * | cough suppressant | |
| Felbamate | 0.031 | – | anticonvulsant | |
| Felbinac | 0.316 | – | NSAID | |
| Felodipine | 0.257 | – | calcium channel blocker | |
| Femoxetine | 0.759 | *** | GR | antidepressant |
| Fenbendazole | 0.414 | * | anthelmintic agent | |
| Fenbufen | 0.217 | – | NSAID | |
| Fendiline (R/S) | 0.574 / 0.634 | ** | AR / GR | calcium channel blocker |
| Fenpiprane | 0.528 | ** | GR | treatment of gastrointestinal disorders |
| Fenethylline (R/S) | 0.452 / 0.550 | ** | GR | stimulant drug |
| Fenobam | 0.269 | – | anxiolytic drug | |
| Fenoldopam (R/S) | 0.396 / 0.245 | – | dopamine D1A receptor agonist | |
| Fenoprofen (R/S) | 0.299 / 0.277 | – | NSAID | |
| Fenoterol (RR/RS/SR/SS) | 0.371 / 0.431 / 0.418 / 0.378 | * | asthma medication | |
| Fenoverine | 0.477 | * | antispasmodic drug | |
| Fenozolone (R/S) | 0.466 / 0.499 | * | stimulant drug | |
| Fenoxazoline | 0.284 | – | nasal preparation | |
| Fenproporex (R/S) | 0.398 / 0.453 | * | appetite suppressant | |
| Fenquizone (R/S) | 0.420 / 0.543 | ** | AhR | diuretic |
| Fenretinide | 0.142 | – | treatment of cancer, cystic fibrosis, arthritis, acne, psoriasis | |
| Fenspiride | 0.668 | * | GR | treatment of certain respiratory diseases |
| Fentanyl | 0.423 | ** | opioid analgesic | |
| Fentiazac | 0.343 | * | treatment of joint and muscular pain | |
| Fenticonazole (R/S) | 0.470 / 0.345 | * | antifungal drug | |
| Feprazone | 0.349 | * | treatment of joint and muscular pain | |
| Fexofenadine (R/S) | 0.444 / 0.484 | * | antihistamine | |
| Finasteride | 0.688 | ** | AR | antiandrogen: birth defects, depression |
| Fipexide | 0.488 | * | nootropic (senile dementia): adverse reactions, out of use | |
| Flavoxate | 0.610 | ** | GR | anticholinergic drug; muscle relaxant |
| Flecainide | 0.588 | ** | GR | antiarryhthmic agent |
| Fleroxacin | 0.364 | * | antibacterial drug | |
| Flesinoxan | 0.306 | * | anxiolytic drug | |
| Fletazepam | 0.186 | – | sedative, anxiolytic | |
| Flibanserin | 0.422 | * | antidepressant; lifestyle drug | |
| Flopropione | 0.147 | – | antispasmodic drug | |
| Florantyrone | 0.450 | * | treatment of biliary dyskinesia | |
| Florfenicol | 0.214 | – | treatment of bovine respiratory disease | |
| Flosequinan | 0.225 | – | vasodilator | |
| Fluacizine | 0.551 | ** | GR | antidepressant |
| Flubendazole | 0.378 | * | anthelmintic | |
| Fluconazole | 0.019 | – | antifungal drug | |
| Fludiazepam | 0.320 | * | anxiolytic, anticonvulsant, sedative | |
| Fludorex (R/S) | 0.520 / 0.419 | ** | GR | appetite suppressant |
| Fludrocortisone | 0.412 | * | synthetic corticosteroid | |
| Fludroxycortide | 0.781 | *** | GR | synthetic steroid (anti-inflammatory drug) |
| Flufenamic acid | 0.197 | – | NSAID | |
| Fluindione | 0.376 | * | vitamin K antagonist | |
| Flumazenil | 0.295 | – | benzodiazepine antidote | |
| Flumedroxone | 0.462 | * | corticosteroid (treatment of migraine) | |
| Flumetasone | 0.381 | * | corticosteroid (treatment of otitis externa) | |
| Fluminorex (R/S) | 0.336 / 0.299 | * | appetite suppressant | |
| Flunarizine | 0.580 | ** | GR | prophylaxis of migraine |
| Flunisolide | 0.548 | ** | GR | corticosteroid (treatment of allergic rhinitis) |
| Flunixin | 0.156 | – | NSAID | |
| Flunoxaprofen | 0.356 | * | NSAID | |
| Fluocortin | 0.357 | * | corticosteroid | |
| Fluocortolone | 0.471 | * | glucocorticoid (treatment of hemorrhoids) | |
| Fluorometholone | 0.608 | ** | ERα | corticosteroid (used after laser-based refractive surgery) |
| Fluorouracil | 0.111 | – | antimetabolite (cancer treatment) | |
| Flupentixol (E/Z) | 0.544 / 0.447 | * | antipsychotic drug | |
| Fluphenazine | 0.557 | ** | GR | antipsychotic drug |
| Flupirtine | 0.519 | ** | AhR | analgesic |
| Fluproquazone | 0.468 | * | analgesic, antipyretic, anti-inflammatory | |
| Flurbiprofen (R/S) | 0.372 / 0.335 | * | NSAID | |
| Fluspirilene | 0.605 | ** | GR | treatment of schizophrenia |
| Flutamide | 0.237 | – | antiandrogen, treatment of prostate cancer | |
| Flutazolam (R/S) | 0.257 / 0.300 | * | sedative, muscle relaxant, anticonvulsant, anxiolytic | |
| Flutemazepam (R/S) | 0.279 / 0.477 | * | sedative, anxiolytic | |
| Flutoprazepam | 0.374 | * | sedative, hypnotic, anxiolytic, anticonvulsant | |
| Flutrimazole (R/S) | 0.329 / 0.521 | ** | GR | antifungal agent |
| Folinic acid (RR/SR) | 0.167 / 0.187 | – | adjuvant used in cancer chemotherapy | |
| Formestane | 0.355 | * | treatment of breast cancer | |
| Forodesine | 0.328 | * | treatment of chronic lymphocytic leukemia | |
| Fosazepam | 0.377 | * | sedative, anxiolytic | |
| Fosfestrol | 0.116 | – | antienoplastic agent | |
| Fosinopril | 0.492 | * | treatment of hypertension | |
| Fosphenytoin | 0.324 | * | treatment of epileptic seizures | |
| Frovatriptan | 0.656 | ** | GR | treatment of migraine headaches |
| Furethidine (R/S) | 0.440 / 0.663 | ** | GR | opioid analgesic |
| Furfenorex (R/S) | 0.179 / 0.212 | – | appetite suppressant | |
| Furosemide | 0.235 | – | loop diuretic: renal toxicity in rats | |
| Gabapentin | 0.446 | * | treatment of epilepsy | |
| Gabexate | 0.268 | – | treatment of pancreatitis | |
| Gaboxadol | 0.138 | – | experimental sleeping pill | |
| Gacyclidine | 0.444 | * | neuroprotective agent | |
| Galantamine | 0.438 | * | treatment of Alzheimer's disease: gastrointestinal syndromes | |
| Gallamine | 0.483 | * | muscle relaxant | |
| Gallopamil (R/S) | 0.571 / 0.331 | ** | GR | calcium channel blocker |
| Ganaxolone | 0.648 | ** | GR | sedative, anxiolytic, anticonvulsant |
| Ganciclovir | 0.086 | – | antiviral drug | |
| Gapicomine | 0.424 | * | coronary vasodilator | |
| Gedocarnil | 0.350 | * | anxiolytic drug | |
| Gefitinib | 0.547 | ** | GR | treatment of certain types of cancer |
| Gemfibrozil | 0.274 | – | lipid-level lowering drug | |
| Gepefrine (R/S) | 0.285 / 0.283 | – | cardiac stimulant | |
| Gestodene | 0.499 | * | hormonal contraceptive | |
| Gilutensin | 0.564 | ** | GR | treatment of hypotension |
| Girisopam | 0.424 | * | anxiolytic drug | |
| Glibenclamide | 0.492 | * | antidiabetic drug | |
| Glimepiride | 0.579 | ** | hERG | antidiabetic drug |
| Glipizide | 0.338 | * | antidiabetic drug | |
| Gliquidone | 0.437 | * | antidiabetic drug | |
| Glutethimide (R/S) | 0.143 / 0.221 | – | hypnotic sedative | |
| Glyclopyramide | 0.327 | * | antidiabetic drug | |
| Granisetron | 0.610 | ** | hERG | treatment of nausea and vomiting following chemotherapy |
| Griseofulvin | 0.259 | – | antifungal drug | |
| Guaifenesin (R/S) | 0.343 / 0.420 | * | expectorant drug | |
| Guanadrel (R/S) | 0.369 / 0.451 | * | antihypertensive agent | |
| Guanabenz | 0.472 | * | antihypertensive drug | |
| Guanoxan (R/S) | 0.332 / 0.602 | ** | GR | sympatholytic drug |
| Halazepam | 0.368 | * | anxiolytic, anticonvulsant, sedative, muscle relaxant | |
| Halcinonide | 0.785 | *** | GR | corticosteroid (treatment of certain skin conditions) |
| Halofantrine (R/S) | 0.707 / 0.395 | *** | GR | treatment of malaria |
| Halofuginone | 0.615 | ** | GR | coccidiostat |
| Halometasone | 0.509 | ** | GR | corticosteroid |
| Haloperidol | 0.585 | * | treatment of schizophrenia | |
| Haloprogin | 0.271 | – | treatment of athlete's foot and other fungal infections | |
| Haloxazolam (R/S) | 0.247 / 0.280 | – | anxiolytic | |
| Hexacyclonate | 0.037 | – | treatment of hyperlipoproteinemia | |
| Hexapropymate | 0.078 | – | hypnotic/sedative drug | |
| Hexobarbital (R/S) | 0.242 / 0.215 | – | hypnotic/sedative agent | |
| Hexylcaine (R/S) | 0.454 / 0.574 | ** | GR | local anesthetic |
| Histapyrrodine | 0.561 | ** | GR | antihistamine with anticholinergic properties |
| Homochlorcyclizine (R/S) | 0.523 / 0.634 | ** | GR | antiallergic drug |
| Huperzine A | 0.592 | ** | hERG | neuroprotective effects: low toxicity |
| Hycanthone | 0.451 | * | schistosomicide | Hydralazine | 0.168 | – | vasodilator |
| Hydrochlorothiazide | 0.332 | * | diuretic drug | |
| Hydrocodone | 0.699 | ** | GR | semi-synthetic opioid |
| Hydroflumethiazide | 0.251 | – | diuretic | |
| Hydromorphinol | 0.442 | * | morphine derivative (sedative, analgesic) | |
| Hydroxychloroquine (R/S) | 0.495 / 0.444 | * | antimalarial drug | |
| Hydroxydione | 0.469 | * | general anesthetic | |
| Hydroxypethidine | 0.514 | ** | GR | opioid analgesic |
| Hydroxyurea | 0.170 | – | antienoplastic drug | |
| Hydroxyzine (R/S) | 0.196 / 0.226 | – | first-generation antihistamine | |
| Hymecromone | 0.594 | ** | ERβ | used in bile therapy |
| Ibopamine | 0.313 | * | sympathomimetic | |
| Ibudilast | 0.227 | – | anti-inflammatory drug | |
| Ibuprofen (R/S) | 0.236 / 0.249 | – | NSAID; treatment of arthritis, fewer | |
| Ibuproxam (R/S) | 0.204 / 0.275 | – | NSAID | |
| Iclaprim (R/S) | 0.385 / 0.472 | * | treatment of skin and tissue infections | |
| Iclazepam | 0.238 | – | sedative, anxiolytic | |
| Idazoxan (R/S) | 0.240 / 0.272 | – | antidepressant (not marketed) | |
| Idoxuridine | 0.423 | * | antiviral drug | |
| Ifenprodil (RR/RS/SR/SS) | 0.608 / 0.397 / 0.488 / 0.417 | ** | GR | selective inhibitor of the NMDA receptor |
| Iloperidone | 0.610 | ** | GR | investigational antipsychotic |
| Imatinib | 0.000 | – | treatment of CML and GISTs: various side effects | |
| Imidafenacin | 0.453 | * | urinary antispasmodic | |
| Imidapril | 0.134 | – | antihypertensive | |
| Imiquimod | 0.242 | – | immune-response modifier | |
| Imolamine | 0.487 | * | vasodilator | |
| Impromidine | 0.437 | * | histamine H2 receptor agonist | |
| Imuracetam | 0.348 | * | nootropic drug | |
| Inamrinone | 0.311 | * | treatment of congestive heart failure | |
| Indanorex (R/S) | 0.450 / 0.263 | – | appetite suppressant | |
| Indapamide (R/S) | 0.282 / 0.320 | * | diuretic | |
| Indatraline | 0.601 | ** | GR | monoamine reuptake inhibitor |
| Indecainide | 0.543 | ** | GR | antiarrhythmic agent |
| Indeloxazine | 0.501 | ** | hERG | antidepressant, anticonvulsant |
| Indinavir | 0.368 | * | treatment of HIV infection and AIDS | |
| Indobufen (R/S) | 0.290 / 0.356 | * | platelet aggregation inhibitor | |
| Indomethazine | 0.438 | * | NSAID | |
| Indoprofen (R/S) | 0.287 / 0.405 | * | NSAID | |
| Indoramin | 0.556 | ** | GR | α-1 selective adrenoreceptor antagonist |
| Iprazochrome (R/S) | 0.412 / 0.389 | * | antimigraine agent | |
| Ipriflavone | 0.598 | ** | AhR | prevention of osteoporosis |
| Iprindole | 0.588 | ** | GR | antidepressant |
| Iproclozide | 0.154 | – | antidepressant | |
| Iproniazid | 0.027 | – | antidepressant | |
| Ipsapirone | 0.474 | * | anxiolytic | |
| Irinotecan | 0.000 | – | treatment of colon cancer | |
| Isavuconazole | 0.220 | – | antifungal drug | |
| Isoaminile (RR/RS/SR/SS) | 0.314 / 0.280 / 0.278 / 0.289 | * | cough suppressant | |
| Isobromindione | 0.360 | * | treatment of gout | |
| Isocarboxazid | 0.173 | – | treatment of resistant depression | |
| Isoconazole (R/S) | 0.225 / 0.308 | * | antifungal drug | |
| Isoetarine (RR/RS/SR/SS) | 0.313 / 0.407 / 0.279 / 0.474 | * | β2-receptor antagonist | |
| Isoprenaline (R/S) | 0.436 / 0.419 | * | sympathomimetic | |
| Isosorbide mononitrate | 0.298 | – | treatment of angina pectoris | |
| Isothipendyl (R/S) | 0.518 / 0.521 | ** | GR | antipruritic drug |
| Isotretinoin | 0.244 | – | retinoid; treatment of severe acne | |
| Ispronicline | 0.518 | ** | GR | treatment of dementia and Alzheimer's disease: well tolerated |
| Isradipine | 0.221 | – | treatment of high blood pressure | |
| Istradefylline | 0.229 | – | treatment of Parkinson's disease | |
| Itopride | 0.456 | * | treatment of functional dispepsia | |
| Ivabradine | 0.450 | * | antianginal drug | |
| Kebuzone | 0.330 | * | NSAID | |
| Ketamine (R/S) | 0.181 / 0.241 | – | analgesic, anesthetic | |
| Ketanserin | 0.366 | * | antihypertensive | |
| Ketazolam (R/S) | 0.339 / 0.382 | * | anxiolytic, anticonvulsant, sedative, muscle relaxant | |
| Ketobemidone | 0.463 | * | treatment of severe pain | |
| Ketoconazole | 0.431 | * | antifungal drug | |
| Ketoprofen (R/S) | 0.181 / 0.433 | – | NSAID | |
| Ketorolac (R/S) | 0.334 / 0.225 | – | NSAID | |
| 15-Ketosterol | 0.706 | *** | ERα | potential anti-atherosclerotic agent |
| Ketotifen | 0.596 | ** | GR | treatment of allergic reactions; prevention of asthma attacks |
| Lamotrigine | 0.125 | – | anticonvulsant drug | |
| Latanoprost | 0.244 | – | treatment of glaucoma, ocular hypertension | |
| Lefetamine | 0.402 | * | psychoactive drug (stimulant and analgesic) | |
| Leflunomide | 0.319 | * | treatment of rheumatoid and psoriatic arthritis | |
| Lerisetron | 0.505 | ** | GR | antinauseant |
| Letrozole | 0.158 | – | treatment of hormonally-responsive breast cancer | |
| Levallorphan | 0.367 | * | general anesthetic | |
| Levetiracetam | 0.133 | – | treatment of epilepsy | |
| Levobunolol (S) | 0.311 | * | beta blocker, treatment of glaucoma | |
| Levobupivacaine | 0.443 | * | local anesthetic | |
| Levocabastine | 0.456 | * | treatment of allergic conjunctivitis | |
| Levocetirizine | 0.424 | * | non-sedative antihistamine | |
| Levodropropizine | 0.144 | – | cough suppressant | |
| Levomepromazine | 0.445 | * | neuroleptic drug | |
| Levonantradol | 0.329 | * | antiemetic, analgesic | |
| Levonordefrin | 0.283 | – | topical nasal decongestant | |
| Levonorgestrel | 0.588 | ** | AR | hormonal contraceptive |
| Levorphanol | 0.357 | * | opioid medication: treatment of severe pain | |
| Levosimendan | 0.177 | – | treatment of congestive heart failure | |
| Levothyroxine | 0.449 | * | treatment of hyperthyroidism | |
| Lidocaine | 0.459 | * | local anesthetic | |
| Lidoflazine | 0.657 | ** | GR | calcium channel blocker |
| Linopirdine | 0.455 | * | psychostimulant, nootropic | |
| Liothyronine | 0.628 | ** | TRβ | thyroid hormone: various side effects |
| Lisinopril | 0.378 | * | treatment of hypertension, congestive heart failure | |
| Lobenzarit | 0.172 | – | treatment of arthritis | |
| Lofendazam | 0.434 | * | sedative, anxiolytic | |
| Lofentanil | 0.535 | ** | GR | opioid analgesic |
| Lofexidine (R/S) | 0.424 / 0.268 | * | short-acting antihypertensive | |
| Lomerizine | 0.359 | * | treatment of migraine | |
| Lomustine | 0.100 | – | chemotherapeutic agent | |
| Lonazolac | 0.261 | – | NSAID | |
| Lonidamine | 0.316 | * | chemotherapeutic agent | |
| Loperamide | 0.511 | ** | GR | treatment of diarrhea |
| Lopirazepam (R/S) | 0.192 / 0.262 | – | anxiolytic, hypnotic properties (never marketed) | |
| Loprazolam | 0.307 | * | anxiolytic, anticonvulsant, sedative, muscle relaxant | |
| Loratadine | 0.241 | – | antiallergic, non-sedating | |
| Lorcainide | 0.659 | ** | GR | antiarrhythmic agent |
| Loreclezole | 0.226 | – | sedative, anticonvulsant | |
| Lornoxicam | 0.336 | * | NSAID | |
| Losartan | 0.171 | – | treatment of hypertension | |
| Loviride (R/S) | 0.212 / 0.229 | – | treatment of HIV | |
| Loxapine | 0.145 | – | treatment of schizophrenia | |
| Loxoprofen (RR/RS/SR/SS) | 0.268 / 0.283 / 0.291 / 0.220 | – | NSAID | |
| Lubeluzole (R/S) | 0.458 / 0.580 | ** | GR | treatment of stroke |
| Lumefantrine (RE/RZ/SE/SZ) | 0.578 / 0.480 / 0.656 / 0.651 | ** | GR | antimalarial drug |
| Lurosetron | 0.300 | * | serotonin 5-HT3 receptor antagonist | |
| Mabuterol (R/S) | 0.529 / 0.567 | ** | GR | β-adrenergic agonist |
| Malotilate | 0.219 | – | treatment of liver disease | |
| Manidipine | 0.361 | * | calcium channel blocker | |
| Maprotiline | 0.591 | ** | GR | antidepressant drug |
| Masoprocol | 0.720 | *** | ERβ | antienoplastic drug |
| Mazindol (R/S) | 0.592 / 0.603 | ** | AR/GR | CNS stimulant |
| Mebendazole | 0.353 | * | treatment of worm infestations | |
| Mebeverine (R/S) | 0.563 / 0.492 | ** | GR | antispasmodic drug |
| Mebhydrolin | 0.621 | ** | GR | antihistamine |
| Mebutamate (R/S) | 0.191 / 0.053 | – | sedative, anxiolytic with antihypertensive effects | |
| Mecamylamine | 0.383 | * | treatment of hypertension | |
| Meclizine (R/S) | 0.317 / 0.397 | * | antihistamine | |
| Meclofenamic acid | 0.380 | * | treatment of joint and muscular pain | |
| Meclonazepam | 0.344 | * | sedative, anxiolytic | |
| Mecloqualone | 0.311 | * | sedative, hypnotic, anxiolytic | |
| Medazepam | 0.327 | * | anxiolytic, anticonvulsant, sedative, muscle relaxant | |
| Medetomidine (R/S) | 0.176 / 0.121 | – | surgical anesthetic and analgesic | |
| Medifoxamine | 0.299 | – | antidepressant | |
| Medrysone | 0.495 | * | synthetic corticosteroid used in ophthalmology | |
| Mefenamic acid | 0.380 | * | NSAID | |
| Mefenorex (R/S) | 0.437 / 0.354 | * | appetite suppressant | |
| Mefloquine | 0.622 | ** | hERG | antimalarial drug |
| Mefruside | 0.265 | – | treatment of edema and hypertension | |
| Megestrol | 0.446 | * | treatment of advanced breast/endometrium carcinoma | |
| Meladrazine | 0.102 | – | antispasmodic used in urology | |
| Melitracen | 0.398 | * | antidepressant | |
| Meloxicam | 0.285 | – | NSAID | |
| Melperone | 0.397 | * | antipsychotic drug | |
| Melphalan (R/S) | 0.435 / 0.527 | ** | ERβ | chemotherapeutic drug |
| Menitrazepam | 0.305 | * | sedative, anticonvulsant, muscle relaxant, anxiolytic | |
| Mephenesin (R/S) | 0.368 / 0.119 | * | muscle relaxant | |
| Mephenoxalone (R/S) | 0.282 / 0.219 | – | anxiolytic drug | |
| Mephenytoin (R/S) | 0.116 / 0.121 | – | anticonvulsant | |
| Mephentermine | 0.358 | * | cardiac stimulant | |
| Mepitiostane | 0.664 | ** | GR | anabolic steroid |
| Mepivacaine | 0.393 | * | local anesthetic | |
| Mepixanox | 0.630 | * | respiratory stimulant | |
| Meprobamate | 0.177 | – | anxiolytic drug | |
| Meprotixol (R/S) | 0.486 / 0.583 | ** | GR | cough suppressant |
| Meprylcaine | 0.494 | * | local anesthetic | |
| Meptazinol (R/S) | 0.413 / 0.368 | * | opioid analgesic used in obstetrics | |
| Mepyramine | 0.470 | * | first-generation antihistamine | |
| Mequinol | 0.225 | – | treatment of liver spots | |
| Mequitazine | 0.586 | ** | GR | antihistamine |
| Mercaptopurine | 0.081 | – | immunosuppressive drug | |
| Mesalazine | 0.180 | – | NSAID | |
| Mesoridazine (R/S) | 0.594 / 0.452 | * | treatment of schizophrenia | |
| Mestanolone | 0.681 | ** | AR | 17α-methylated version of DHT |
| Mesterolone | 0.647 | ** | AR | orally applicable androgen (DHT derivative) |
| Mestranol | 0.720 | *** | ERα | oral contraceptive |
| Mesuximide (R/S) | 0.218 / 0.219 | – | anticonvulsant | |
| Metaclazepam (R/S) | 0.232 / 0.231 | – | anxiolytic drug | |
| Metamizole | 0.352 | * | NSAID; powerful painkiller, fewer reducer | |
| Metaraminol | 0.406 | * | treatment of hypotension | |
| Metaxalone (R/S) | 0.246 / 0.211 | – | muscle relaxant | |
| Metenolone | 0.602 | ** | ERβ | anabolic steroid |
| Methandriole | 0.720 | *** | ERβ | anabolic steroid |
| Methcathinone (R/S) | 0.326 / 0.318 | * | psychoactive stimulant | |
| Methapyrilene | 0.338 | * | antihistamine with sedative effects | |
| Metharbital | 0.094 | – | anticonvulsant | |
| Methazolamide | 0.380 | * | treatment of glaucoma | |
| Methdilazine (R/S) | 0.490 / 0.415 | * | antihistamine | |
| Methimazole | 0.000 | – | antithyroid drug | |
| Methocarbamol (R/S) | 0.148 / 0.200 | – | treatment of muscle spasms | Methoxamine (RR/RS/SR/SS) | 0.391 / 0.336 / 0.509 / 0.442 | ** | hERG | treatment of supraventicular tachycardia |
| Methotrexate | 0.222 | – | antifolate drug | |
| Methoxsalen | 0.318 | * | treatment of psoriasis, eczema | Methoxyphedrine (R/S) | 0.299 / 0.393 | * | stimulant drug | Methoxyphenamine (R/S) | 0.367 / 0.296 | * | NSAID |
| Methyldopa | 0.545 | ** | hERG | antihypertensive drug |
| Methylpentynol (R/S) | 0.114 / 0.017 | – | hypnotic/sedative with anticonvulsant effects | |
| Methylphenobarbital (R/S) | 0.321 / 0.321 | * | sedative, anxiolytic, anticonvulsant | |
| Methylprednisolone | 0.517 | ** | ERα | treatment of bronchial inflammation or acute bronchitis |
| Methysergide | 0.414 | * | treatment of migraine headaches | |
| Meticrane | 0.279 | – | diuretic drug | |
| Metirosine | 0.219 | – | antihypertensive drug | |
| Metitepine (R/S) | 0.553 / 0.477 | ** | GR | antipsychotic drug |
| Metixene | 0.576 | ** | GR | anti-parkinson drug |
| Metizoline | 0.331 | * | nasal preparation | |
| Metoclopramide | 0.302 | * | antiemetic drug | |
| Metolazone (R/S) | 0.418 / 0.399 | * | thiazide diuretic | |
| Metyrapone | 0.241 | – | treatment of hypercortisolism | |
| Mexiletine (R/S) | 0.346 / 0.479 | * | antiarrhythmic agent | |
| Mianserin (R/S) | 0.618 / 0.490 | ** | GR | antidepressant with antihistaminic/hypnosedative effects |
| Mibolerone | 0.678 | ** | AR | potent anabolic steroid |
| Miconazole | 0.547 | ** | AhR | antifungal agent |
| Midazolam | 0.413 | * | anxiolytic, amnesic, hypnotic, anticonvulsant | |
| Miglitol | 0.338 | * | antidiabetic drug | |
| Miglustat | 0.345 | * | treatment of Type 1 Gaucher disease | |
| Milnacipran | 0.347 | * | antidepressant | |
| Milrinone | 0.256 | – | management of heart failure | |
| Minaprine | 0.390 | – | antidepressant | |
| Minaxolone | 0.492 | * | general anesthetic | |
| Mirfentanil | 0.451 | * | analgesic (μ-opioid receptor antagonist) | |
| Miroprofen (R/S) | 0.296 / 0.296 | – | NSAID | |
| Misoprostol | 0.299 | – | prevention of NSAID-induced gastric ulcers; abortifacient | |
| Mitiglinide | 0.284 | – | treatment of type-2 diabetes | |
| Mitotane (R/S) | 0.269 / 0.424 | * | treatment of adrenocortical carcinoma | |
| Mitoxantrone | 0.472 | * | antienoplastic agent | |
| Mitozolomide | 0.123 | – | antienoplastic agent | |
| Mivazerol | 0.035 | – | α-adrenergic agonist | |
| Mizolastine | 0.395 | * | non-sedating antihistamine | |
| Mizoribine | 0.260 | – | immunosuppressive drug | |
| Mofebutazone (R/S) | 0.315 / 0.229 | * | treatment of joint and muscular pain | |
| Mofezolac | 0.288 | – | NSAID | |
| Molindone (R/S) | 0.203 / 0.222 | – | treatment of schizophrenia | |
| Mometasone furoate | 0.746 | *** | GR | treatment of eczema, psoriasis, hay fewer, asthma |
| Monatepil (R/S) | 0.621 / 0.539 | ** | GR | calcium channel blocker |
| Monobenzone | 0.654 | ** | ERβ | topical drug for medical depigmentation |
| Morclofone | 0.406 | * | cough suppressant | |
| Moricizine | 0.499 | * | antiarrhythmic drug | |
| Morinamide | 0.068 | – | treatment of tuberculosis | |
| Morniflumate | 0.417 | * | NSAID | |
| Morpheridine | 0.644 | ** | GR | opioid analgesic drug |
| Morphine | 0.342 | ** | opioid analgesic drug: neurotoxic | |
| Mosapramine (R/S) | 0.132 / 0.517 | ** | GR | antipsychotic drug |
| Mosapride | 0.297 | – | treatment of irritable bowel syndrome | |
| Moxastine | 0.462 | * | antihistamine | |
| Moxaverine | 0.395 | * | treatment of gastrointestinal disorders | |
| Moxisylyte | 0.311 | * | treatment of erectile dysfunction | |
| Moxonidine | 0.299 | – | antihypertensive drug | |
| Mozavaptan (R/S) | 0.630 / 0.623 | ** | GR | treatment of hyponatremia |
| Muzolimine (R/S) | 0.155 / 0.138 | – | diuretic drug | |
| Mycophenolic acid | 0.243 | – | immunosuppressant drug | |
| Nabilone | 0.471 | * | synthetic cannabinoid | |
| Nabumetone | 0.467 | * | NSAID | |
| Nadolol (R/S) | 0.362 / 0.386 | * | treatment of high blood pressure, migraine and chest pain | |
| Nafamostat | 0.233 | – | anticoagulant | |
| Naftifine | 0.561 | ** | GR | antifungal drug |
| Naftopidil (R/S) | 0.373 / 0.375 | * | treatment of high blood pressure | |
| Nalbuphine | 0.622 | ** | GR | synthetic opioid (analgesic) |
| Nalidixic acid | 0.313 | * | bacteriostatic | |
| Naloxone | 0.518 | ** | GR | treatment of opioid overdose |
| Naltrexone | 0.436 | * | management of alcohol/opioid dependence | |
| Naphazoline | 0.430 | * | vasoconstrictor | |
| Naproxen (R/S) | 0.261 / 0.346 | * | NSAID: gastrointestinal disturbances | |
| Naratriptan | 0.526 | ** | GR | treatment of migraine headaches |
| Nateglinide | 0.235 | – | treatment of type 2 diabetes | |
| Nealbarbital | 0.161 | – | sedative, hypnotic | |
| Nebracetam (R/S) | 0.467 / 0.342 | * | antidepressant | |
| Necopidem | 0.247 | – | sedative, anxiolytic | |
| Nedocromil | 0.327 | * | treatment of asthma | |
| Nefazodone | 0.593 | ** | GR | antidepressant; withdrawn |
| Nefiracetam | 0.277 | – | nootropic: testicular toxicity in rats | |
| Nefopam (R/S) | 0.472 / 0.632 | ** | GR | analgesic drug |
| Neltenexine | 0.654 | ** | GR | mucolytic drug |
| Nepafenac | 0.277 | – | NSAID | |
| Nepicastat | 0.445 | * | treatment of congestive heart failure | |
| Nepinalone (R/S) | 0.435 / 0.506 | ** | GR | cough suppressant |
| Nerisopam | 0.402 | * | anxiolytic, neuroleptic | |
| Neticonazole | 0.185 | – | antifungal drug | |
| Nevirapine | 0.205 | – | treatment of HIV infections and AIDS | |
| Nialamide | 0.173 | – | antidepressant | |
| Niaprazine (R/S) | 0.565 / 0.456 | ** | GR | sedating antihistamine |
| Nicardipine (R/S) | 0.610 / 0.530 | ** | GR | treatment of high blood pressure and angina |
| Nicergoline | 0.749 | *** | GR | treatment of senile dementia |
| Niclosamide | 0.537 | ** | GR | anthelmintic drug (teniacide) |
| Nicorandil | 0.372 | * | treatment of angina | |
| Nifedipine | 0.197 | – | calcium-channel blocker; antianginal: mild side effects | |
| Nifekalant | 0.555 | ** | anti-arrhythmic agent | |
| Nifenazone | 0.155 | – | treatment of joint and muscular pain | |
| Niflumic acid | 0.253 | – | treatment of joint and muscular pain | |
| Nifuratel (R/S) | 0.127 / 0.072 | – | drug used in gynecology | |
| Nifuroxazide | 0.384 | * | treatment of colitis and diarrhea | |
| Nifurtimox (R/S) | 0.285 / 0.244 | – | treatment of Chagas disease and sleeping sickness | |
| Nifurtoinol | 0.242 | – | treatment of urinary tract infections | |
| Nifurzide | 0.224 | – | anti-infective agent | |
| Nilutamide | 0.229 | – | treatment of prostate cancer | |
| Nilvadipine (R/S) | 0.330 / 0.235 | * | calcium-channel blocker | |
| Nimetazepam | 0.368 | * | powerful hypnotic drug | |
| Nimodipine (R/S) | 0.310 / 0.223 | – | calcium-channel blocker | |
| Nimorazole | 0.175 | – | antiinfective agent | |
| Niperotidine (E/Z) | 0.473 / 0.543 | ** | GR | antihistamine |
| Niridazole | 0.165 | – | schistosomicide | |
| Nisoxetine (R/S) | 0.409 / 0.371 | * | antidepressant | |
| Nitazoxanide | 0.217 | – | antiprotozoal agent | |
| Nitisinone | 0.333 | * | treatment of hereditary tyrosinemia type 1 | |
| Nitrazepam | 0.267 | – | powerful hypnotic drug | |
| Nitroxoline | 0.261 | – | antibiotic drug | |
| Nizofenone | 0.535 | ** | GR | psychostimulant, nootropic |
| Nocodazole | 0.333 | * | antienoplastic agent | |
| Nolatrexed | 0.168 | – | thymidylate synthase inhibitor | |
| Nonabine (RR/RS/SR/SS) | 0.298 / 0.299 / 0.273 / 0.406 | * | antiemetic drug | |
| Norcodeine | 0.555 | ** | GR | opiate analogue |
| Nordazepam | 0.367 | * | anticonvulsant, anxiolytic, muscle relaxant, sedative | |
| Norfenefrine (R/S) | 0.449 / 0.293 | – | cardiac stimulant | |
| Norgestimate | 0.593 | ** | ERα | hormonal contraceptive |
| Norgestrienone | 0.631 | ** | AR | progestogen hormone |
| Normethadone | 0.497 | * | cough suppressant | |
| Normorphine | 0.551 | ** | GR | major metabolite of morphine |
| Ocfentanil | 0.537 | ** | GR | opioid analgesic |
| Ocinaplon | 0.350 | * | anxiolytic drug | |
| Octodrine (R/S) | 0.431 / 0.339 | * | stimulant drug | |
| Olopatadine | 0.276 | – | antihistamine | |
| Olprinone | 0.302 | * | cardiotonic agent | |
| Olsalazine | 0.271 | – | treatment of inflammatory bowel disease | |
| Oltipraz | 0.174 | – | schistosomicide | |
| Omapatrilat | 0.410 | * | antihypertensive agent | |
| Omoconazole | 0.383 | * | antifungal drug | |
| Ondansetron (R/S) | 0.335 / 0.363 | – | antiemetic: few side effects | |
| Opipramol | 0.490 | * | anxiolytic drug | |
| Orciprenaline (R/S) | 0.323 / 0.316 | * | bronchodilator | |
| Ormeloxifene | 0.534 | ** | GR | non-steroidal oral contraceptive |
| Ornidazole (R/S) | 0.133 / 0.097 | – | treatment of protozoan infections (poultry industry) | |
| Orphenadrine (R/S) | 0.507 / 0.372 | ** | GR | anticholinergic drug |
| Oseltamivir | 0.541 | ** | GR | antiviral drug: several adverse reactions |
| Oxabolone | 0.623 | ** | AR | anabolic steroid |
| Oxaceprol | 0.240 | – | NSAID (treatment of osteoarthritis) | |
| Oxametacin | 0.466 | * | NSAID | |
| Oxamniquine (R/S) | 0.491 / 0.562 | ** | GR | antihelmintic with schistosomicidal activity |
| Oxantel | 0.419 | * | antihelmintic | |
| Oxaprotiline (R/S) | 0.512 / 0.500 | ** | GR | antidepressant |
| Oxatomide | 0.452 | * | antihistamine | |
| Oxaprozin | 0.285 | – | NSAID | |
| Oxazepam (R/S) | 0.499 / 0.364 | * | anxiolytic, anticonvulsant, sedative | |
| Oxcarbazepine | 0.515 | ** | hERG | anticonvulsant |
| Oxetorone | 0.618 | ** | GR | antimigraine agent |
| Oxibendazole | 0.374 | * | treatment of worm infestations in horses and pets | |
| Oxiconazole | 0.347 | * | antifungal medication | |
| Oxidopamine | 0.314 | * | dopamine derivative (neurotransmitter analogue) | |
| Oxilorphan | 0.488 | * | opioid antagonist | |
| Oxiracetam (R/S) | 0.077 / 0.147 | – | nootropic: safe compound, not toxic | |
| Oxodipine | 0.164 | – | calcium channel blocker | |
| Oxolamine | 0.332 | * | cough suppressant | |
| Oxomemazine (R/S) | 0.547 / 0.456 | ** | GR | antihistamine |
| Oxpheneridine (R/S) | 0.460 / 0.511 | ** | GR | opioid analgesic |
| Oxprenolol (R/S) | 0.375 / 0.298 | * | treatment of angina pectoris | |
| Oxybutynin (R/S) | 0.305 / 0.389 | * | anticholinergic medication | |
| Oxycinchophen | 0.362 | * | antirheumatic agent | |
| Oxyclozanide | 0.365 | * | antihelmintic agent | |
| Oxycodone | 0.552 | ** | GR | opioid analgesic |
| Oxyfedrine (RR/RS/SR/SS) | 0.459 / 0.508 / 0.539 / 0.483 | ** | hERG | vasodilator |
| Oxymetazoline | 0.263 | – | decongestant | |
| Oxymorphone | 0.466 | * | semi-synthetic opioid analgesic | |
| Oxypertine | 0.458 | * | antipsychotic | |
| Oxyphenbutazone (R/S) | 0.289 / 0.336 | * | antiemetic: few side effects | |
| Oxyphencyclimine (R/S) | 0.443 / 0.488 | * | antimuscarinic drug | |
| Oxyphenisatine | 0.375 | * | laxative | |
| Ozagrel | 0.299 | – | improvement of motor coordination | |
| Pagoclone (R/S) | 0.385 / 0.342 | * | anxiolytic drug | |
| Paliperidone (R/S) | 0.556 / 0.422 | ** | GR | atypical antipsychotic |
| Palonosetron | 0.702 | *** | GR | treatment of chemotherapy-induced nausea and vomiting |
| Pamaquine (R/S) | 0.262 / 0.525 | ** | GR | treatment of malaria |
| Panadiplon | 0.273 | – | anxiolytic drug | |
| Paracetamol | 0.285 | – | analgesic drug, antipyretic: non carcinogenic | |
| Parahydroxyamphetamine (R/S) | 0.397 / 0.415 | * | nervous stimulant (alkaloid; occurs also in plants) | |
| Paramethadione (R/S) | 0.052 / 0.055 | – | anticonvulsant | |
| Paramethasone | 0.434 | * | anti-inflammatory drug | |
| Pargyline | 0.197 | – | antihypertensive drug | |
| Pefloxacin | 0.574 | ** | GR | treatment of life-threatening bacterial infections |
| Pemirolast | 0.174 | – | anti-allergic drug | |
| Pempidine | 0.316 | – | ganglionic blocker | |
| Penbutolol (R/S) | 0.603 / 0.545 | ** | GR | treatment of high blood pressure |
| Penciclovir | 0.377 | * | treatment of herpes virus infections | |
| Penicillamine | 0.389 | * | pharmaceutical chelator | |
| Pentamidine | 0.213 | – | antimicrobal medication | |
| Pentifylline | 0.086 | – | vasodilator | |
| Pentoxifylline | 0.200 | – | treatment of intermittent claudication and vascular dementia | |
| Pentoxyverine | 0.347 | * | cough suppressant | |
| Pergolide | 0.451 | * | treatment of Parkinsons's disease | |
| Perhexiline (R/S) | 0.515 / 0.622 | ** | GR | antianginal agent: frequent adverse effects |
| Periciazine | 0.524 | ** | ERβ | antipsychotic drug |
| Perospirone | 0.532 | ** | GR | antipsychotic drug |
| Perphenazine | 0.415 | * | antipsychotic drug | |
| Pethidine | 0.425 | * | analgesic drug | |
| Phanquinone | 0.317 | * | antiprotozoal agent | |
| Phenacemide | 0.373 | * | anticonvulsant | |
| Phenacetin | 0.252 | – | analgesic | |
| Phenadoxone (R/S) | 0.378 / 0.418 | * | opioid analgesic | |
| Phenampromide (R/S) | 0.510 / 0.326 | ** | GR | opioid analgesic |
| Phenazone | 0.244 | – | analgesic: hepatotoxic | |
| Phenazopyridine | 0.313 | * | local analgesic (urinary tract infections) | |
| Phencyclidine | 0.463 | ** | GR | anesthetic agent: hallucinogenic/neurotoxic |
| Phenelzine | 0.312 | * | antidepressant drug | |
| Pheneridine | 0.365 | * | opioid analgesic | |
| Pheneturide (R/S) | 0.292 / 0.493 | * | anticonvulsant | |
| Phenibut (R/S) | 0.422 / 0.181 | * | improvement of neurological functions: low toxicity | |
| Phenindamine (R/S) | 0.529 / 0.384 | ** | GR | antihistamine |
| Phenindione | 0.419 | * | anticoagulant | |
| Pheniprazine (R/S) | 0.437 / 0.462 | * | antidepressant | |
| Pheniramine (R/S) | 0.490 / 0.412 | * | antihistamine | |
| Phenobarbital | 0.325 | * | anticonvulsant | |
| Phenoxybenzamine (R/S) | 0.357 / 0.358 | * | anti-hypertensive | |
| Phenpentermine (R/S) | 0.484 / 0.453 | * | anorectic drug; acts also as diuretic | |
| Phenprobamate | 0.082 | – | skeletal muscle relaxant | |
| Phenprocoumon (R/S) | 0.367 / 0.368 | * | anticoagulant drug | |
| Phenpromethamine (R/S) | 0.422 / 0.329 | * | stimulant drug (banned by the World Antidoping Agency) | |
| Phensuximide (R/S) | 0.201 / 0.147 | – | anticonvulsant | |
| Phentolamine | 0.502 | ** | ERβ | vasodilator |
| Phenylbutazone | 0.272 | – | antiepileptic: teratogen; possibly carcinogenic | |
| Phenylephrine | 0.372 | * | decongestant | |
| Phenylpiracetam (R/S) | 0.078 / 0.106 | – | nootropic: low toxicity | |
| Phenyltoloxamine | 0.344 | * | antihistamine with sedative and analgesic effects | |
| Phenytoin | 0.300 | * | antiepileptic: teratogen; possibly carcinogenic | |
| Phetharbital | 0.329 | * | anticonvulsant, sedative | |
| Pholcodine | 0.599 | ** | GR | opioid cough suppressant |
| Piberaline | 0.203 | – | stimulant and antidepressant | |
| Picamilon | 0.211 | – | nicotinyl-GABA: low toxicity | |
| Picenadol (R/S) | 0.516 / 0.409 | ** | GR | opioid analgesic |
| Pidotimod | 0.248 | – | immunostimulant | |
| Pilocarpine | 0.209 | – | treatment of glaucoma, xerostomia | |
| Pimethixene | 0.560 | ** | GR | treatment of hyperactivity, anxiety, sleep disorders |
| Pimobendan (R/S) | 0.373 / 0.511 | ** | GR | inotropic, vasodilator |
| Pimozide | 0.679 | ** | GR | antipsychotic drug |
| Pinacidil (R/S) | 0.445 / 0.414 | * | vasodilator | |
| Pinazepam | 0.362 | * | anxiolytic, anticonvulsant, sedative, muscle relaxant | |
| Pindolol (R/S) | 0.322 / 0.274 | * | treatment of angina pectoris and hypertension | |
| Pipazetate | 0.533 | ** | hERG | cough suppressant |
| Pipequaline | 0.536 | ** | hERG | anxiolytic drug |
| Piperidolate (R/S) | 0.466 / 0.555 | ** | GR | antimuscarinic drug |
| Piperocaine (R/S) | 0.312 / 0.475 | * | local anesthetic | |
| Pipradrol | 0.594 | ** | GR | CNS stimulant |
| Piracetam | 0.000 | – | nootropic, dietary supplement: only mild side-effects | |
| Pirbuterol (R/S) | 0.525 / 0.509 | ** | GR | treatment of asthma |
| Pirenzepine | 0.536 | ** | GR | treatment of peptic ulcers |
| Piretanide | 0.245 | – | diuretic | |
| Piribedil | 0.239 | – | treatment of Parkinson's disease | |
| Pirlindole (R/S) | 0.623 / 0.463 | ** | GR | antidepressant |
| Pirisudanol | 0.342 | * | psychostimulant | |
| Piroheptine (R/S) | 0.556 / 0.596 | ** | GR | treatment of Parkinson's disease |
| Piroxicam | 0.222 | – | NSAID | |
| Pirprofen (R/S) | 0.194 / 0.259 | – | NSAID | |
| Pizotifen | 0.541 | ** | GR | treatment of migraine headaches |
| Pleconaril | 0.287 | – | antiviral drug (asthma) | |
| Polythiazide (R/S) | 0.311 / 0.456 | * | diuretic | |
| Practolol (R/S) | 0.412 / 0.245 | * | treatment of cardiac arrhythmias | |
| Pramipexole | 0.341 | * | treatment of Parkinson's disease | |
| Pramiracetam | 0.322 | * | nootropic: safe compound | |
| Pranoprofen (R/S) | 0.307 / 0.339 | * | NSAID | |
| Pravadoline | 0.453 | * | NSAID | |
| Prazepam | 0.211 | – | anxiolytic, anticonvulsant, sedative | |
| Praziquantel | 0.238 | – | anthelmintic effective against flatworms | |
| Prazosin | 0.366 | * | antihypertensive: some side effects | |
| Prednicarbate | 0.743 | *** | GR | topical corticosteroid |
| Prednisolone | 0.619 | ** | ERβ | active metabolite of Prednisone (treatment of inflammation and AID) |
| Prednisone | 0.496 | * | synthetic corticosteroid drug | |
| Pridinol | 0.484 | * | muscle relaxant | |
| Prilocaine (R/S) | 0.516 / 0.355 | ** | GR | local anesthetic |
| Procarbazine | 0.106 | – | antienoplastic agent | |
| Prodine (αax/αeq/βax/βeq) | 0.508 / 0.648 / 0.579 / 0.340 | ** | GR | opioid analgesic |
| Profenamine (R/S) | 0.382 / 0.201 | * | treatment of Parkinson's disease | |
| Proguanil | 0.411 | * | prophylactic antimalarial drug | |
| Promethazine (R/S) | 0.444 / 0.386 | * | antihistamine, antiemetic, sedative | |
| Propafenone (R/S) | 0.542 / 0.556 | ** | GR | anti-arrhythmic medication |
| Propofol | 0.200 | – | anesthesia agent | |
| Propranolol (R/S) | 0.482 / 0.502 | ** | GR | treatment of hypertension |
| Propylthiouracil | 0.022 | – | treatment of hyperthyroidism | |
| Prostanozol | 0.595 | ** | AR | anabolic steroid |
| Pseudoephedrine | 0.201 | – | decongestant | |
| Pyrantel | 0.219 | – | antinematodal agent | |
| Pyrithyldione | 0.022 | – | hypnotic, sedative | |
| Pyritinol | 0.008 | – | treatment of chronically impaired brain function | |
| Pyrovalerone (R/S) | 0.413 / 0.461 | * | stimulant drug (fatigue, lethargy); appetite suppressant | |
| Quazepam | 0.215 | * | treatment of insomnia | |
| Quinbolone | 0.643 | ** | AR | anabolic steroid |
| Quinethazone (R/S) | 0.356 / 0.287 | * | treatment of hypertension | |
| Quinestrol | 0.685 | ** | ERα | treatment of breast and prostate cancer |
| Quinidine | 0.498 | * | antiarrhythmic agent | |
| Quinisocaine | 0.605 | ** | GR | antipruritic agent |
| Quinpirole | 0.344 | * | dopamine D2/D3 receptor agonist | |
| Quipazine | 0.589 | ** | GR | serotonin receptor agonist (5HT2A,, 5HT3) |
| Rabeprazole | 0.277 | – | proton pump inhibitor | |
| Racecadotril (R/S) | 0.278 / 0.505 | ** | ERβ | antidiarrheal drug |
| Raclopride | 0.159 | – | neuroleptic (treatment of schizophrenia) | |
| Rafoxanide | 0.350 | * | antiparasitic agent | |
| Ramatroban | 0.293 | – | treatment of coronary artery disease | |
| Ramipril | 0.296 | – | treatment of hypertension | |
| Ramosetron | 0.478 | * | treatment of nausea an vomiting | |
| Ranitidine | 0.495 | * | treatment of peptic ulcer disease | |
| Ranolazine (R/S) | 0.435 / 0.240 | * | antianginal medication | |
| Rasagiline | 0.181 | – | irreversible MAO inhibitor: safe; possible drug interactions | |
| Razobazam | 0.163 | – | produces nootropic effects | |
| Rebamipide (R/S) | 0.536 / 0.307 | ** | GR | treatment of Behçet's disease |
| Reclazepam | 0.392 | * | sedative, anxiolytic | |
| Remacemide (R/S) | 0.570 / 0.425 | ** | hERG | sodium channel blocker |
| Remoxipride | 0.592 | ** | GR | antipsychotic drug |
| Rentiapril | 0.203 | – | ACE inhibitor | |
| Renzapride | 0.660 | ** | hERG | treatment of irritable bowel syndrome |
| Repirinast | 0.440 | * | antihistamine | |
| Ribavirin | 0.055 | – | antiviral drug | |
| Rilmazafone | 0.554 | ** | GR | sedative, hypnotic |
| Rilmenidine | 0.331 | * | treatment of hypertension | |
| Riluzole | 0.383 | * | treatment of amyotrophic lateral sclerosis | |
| Rimantadine (R/S) | 0.554 / 0.598 | ** | GR | antiviral drug |
| Rimcazole | 0.541 | ** | GR | anticonvulsant |
| Rimexolone | 0.575 | ** | GR | treatment of inflammation in the eye |
| Rimiterol | 0.404 | * | third-generation β2 agonist | |
| Rimonabant | 0.513 | ** | GR | anti-obesity drug (temporarily withdrawn from market) |
| Ripazepam | 0.215 | – | anxiolytic | |
| Risocaine | 0.190 | – | local anesthetic | |
| Ritanserin | 0.436 | * | treatment of schizophrenia | |
| Ritodrine | 0.403 | * | tocolytic drug | |
| Rivastigmine | 0.256 | – | treatment of dementia (Alzheimer and due to Parkinson's disease) | |
| Rizatriptan | 0.428 | * | treatment of migraine headaches | |
| Robalzotan | 0.281 | – | potential antidepressant | |
| Robenidine | 0.175 | – | coccidiostat | |
| Rociverine (R/S) | 0.565 / 0.352 | ** | GR | antimuscarinic |
| Roflumilast | 0.254 | – | treatment of inflammatory diseases of the lungs | |
| Rolicyclidine | 0.466 | * | anesthetic, hallucinogenic, sedative | |
| Rolipram (R/S) | 0.350 / 0.379 | * | NSAID | |
| Rolziracetam | 0.104 | – | nootropic drug | |
| Romifidine | 0.367 | * | sedative, anesthetic, analgesic (veterinary medicine) | |
| Ronifibrate | 0.305 | * | fibrate | |
| Ropinirole | 0.219 | – | treatment of Parkinson's disease | |
| Ropivacaine | 0.436 | * | local anesthetic | |
| Roquinimex | 0.226 | – | immunostimulant | |
| Rosiglitazone | 0.143 | – | anti-diabetic drug | |
| Rosoxacin | 0.332 | * | treatment of urinary tract infections | |
| Rubitecan | 0.341 | * | oral topoisomerase inhibitor (withdrawn) | |
| Rufinamide | 0.138 | – | anticonvulsant medication | |
| Rupatadine | 0.715 | *** | GR | antihistamine |
| Salbutamol (R/S) | 0.389 / 0.175 | * | treatment of asthma and COPD | |
| Salicylamide | 0.200 | – | analgesic and antipyretic properties | |
| Salsalate | 0.256 | – | NSAID | |
| Saripidem | 0.268 | – | sedative, anxiolytic | |
| Sarmazenil | 0.309 | * | anxiogenic, convulsant (veterinary medicine) | |
| Sarpogrelate (R/S) | 0.504 / 0.580 | ** | GR | treatment of many diseases (e.g. diabetes mellitus) |
| Secnidazole (R/S) | 0.110 / 0.067 | – | anti-infective drug | |
| Selegiline | 0.173 | – | treatment of Parkinson's disease, depression and senile dementia | |
| Selfotel | 0.290 | – | anticonvulsant, anxiolytic, analgesic | |
| Sematilide | 0.450 | * | antiarrhythmic agent | |
| Seratrodast (R/S) | 0.238 / 0.307 | * | treatment of asthma | |
| Sertaconazole (R/S) | 0.284 / 0.616 | ** | AhR | antifungal medication |
| Sertindole | 0.472 | * | treatment of schizophrenia | |
| Setastine (R/S) | 0.607 / 0.524 | ** | GR | antihistamine |
| Setiptiline | 0.550 | ** | GR | antidepressant |
| Sibutramine (R/S) | 0.354 / 0.286 | * | appetite suppressant | |
| Simfibrate | 0.244 | – | fibrate | |
| Sivelestat | 0.111 | – | treatment of acute respiratory failure | |
| Sofalcone | 0.299 | – | oral gastrointestinal medication | |
| Solabegron | 0.330 | * | treatment of overactive bladder and irritable bowel syndrome | |
| Sorivudine | 0.455 | * | antiviral drug | |
| Sotalol (R/S) | 0.479 / 0.489 | * | treatment of cardiac arrhythmias | |
| Spiperone | 0.629 | ** | GR | antipsychotic drug |
| Spiradoline | 0.715 | *** | GR | analgesic, diuretic, antitussive |
| Spironolactone | 0.539 | ** | MR | diuretic, antiandrogen |
| Stavudine | 0.333 | * | reverse transcriptase inhibitor | |
| Stepronin (R/S) | 0.243 / 0.192 | – | mucolytic | |
| Stiripentol (R/S) | 0.230 / 0.330 | * | treatment of epilepsy | |
| Sulconazole (R/S) | 0.331 / 0.207 | * | antifungal medication | |
| Styramate (R/S) | 0.165 / 0.087 | – | muscle relaxant, anticonvulsant | |
| Sufentanil | 0.330 | * | opioid analgesic drug | |
| Sulazepam | 0.1259 | – | sedative, muscle relaxant, hypnotic, anticonvulsant, anxiolytic | |
| Sulbentine | 0.201 | – | antifungal agent | |
| Sulfadiazine | 0.336 | * | sulfonamide antibiotic | |
| Sulfadimethoxine | 0.464 | * | sulfonamide antibiotic | |
| Sulfadimidine | 0.348 | * | sulfonamide antibiotic | |
| Sulfadoxine | 0.308 | * | ultra-long lasting sulfonamide (malaria) | |
| Sulfafurazole | 0.316 | * | sulfonamide antibiotic | |
| Sulfalene | 0.456 | * | sulfonamide antibiotic | |
| Sulfamerazine | 0.472 | – | sulfonamide antibiotic | |
| Sulfamethizole | 0.203 | – | sulfonamide antibiotic | |
| Sulfamethoxypyridazine | 0.341 | * | sulfonamide antibiotic | |
| Sulfametomidine | 0.488 | * | sulfonamide antibiotic | |
| Sulfametoxydiazine | 0.384 | * | sulfonamide antibiotic (leprae, urinary tract infections) | |
| Sulfametrole | 0.316 | * | sulfonamide antibiotic | |
| Sulfamoxole | 0.262 | – | sulfonamide antibiotic | |
| Sulfaperin | 0.501 | ** | 2C9 | sulfonamide antibiotic |
| Sulfaphenazole | 0.388 | * | sulfonamide antibiotic | |
| Sulfapyridine | 0.226 | – | antibacterial drug | |
| Sulfasalazine | 0.295 | – | treatment of inflammatory bowel disease | |
| Sulfathiazole | 0.236 | – | short-acting sulfa drug | |
| Sulfinpyrazone | 0.414 | * | treatment of gout | |
| Sulfisomidine | 0.230 | – | sulfonamide antibiotic | |
| Sulforidazine (R/S) | 0.617 / 0.668 | ** | GR | antipsychotic drug |
| Sulindac | 0.433 | * | NSAID for acute or chronic inflammations | |
| Sulpiride (R/S) | 0.343 / 0.333 | * | treatment of schizophrenia and depression | |
| Sultiame | 0.274 | – | anticonvulsant | |
| Sumatriptan | 0.562 | ** | GR | treatment of migraine headaches |
| Suproclone (R/S) | 0.424 / 0.381 | * | sedative, anxiolytic | |
| Suprofen (R/S) | 0.338 / 0.204 | * | NSAID | |
| Suriclone (R/S) | 0.376 / 0.387 | * | sedative, anxiolytic | |
| Suritozole | 0.113 | – | cognition enhancer (investigational) | |
| Suxibuzone | 0.328 | * | treatment of joint and muscular paint | |
| Tacalcitol | 0.242 | – | treatment of psoriasis | |
| Tacrine | 0.521 | ** | GR | treatment of Alzheimer's disease |
| Talastine | 0.496 | * | antihistamine | |
| Talbutal (R/S) | 0.328 / 0.198 | * | short to intermediate-acting barbiturate | |
| Talipexole | 0.181 | – | treatment of Parkinsons's disease | |
| Talopram (R/S) | 0.488 / 0.533 | ** | GR | antidepressant |
| Tamoxifen | 0.590 | ** | ERα | selective estrogen receptor modulator: carcinogenic, thromboembolism |
| Tasosartan | 0.152 | – | angiotensin II receptor antagonist | |
| Tazarotene | 0.302 | * | treatment of psoriasis, acne and sun-damaged skin | |
| Teclozan | 0.198 | – | antiprotozoal agent | |
| Tedisamil | 0.454 | * | antiarrhythmic for atrial fibration and flutter | |
| Tegafur (R/S) | 0.203 / 0.263 | – | treatment of cancer (prodrug) | |
| Temozolomide | 0.174 | – | treatment of astrocytoma (brain tumor) | |
| Tenidap | 0.477 | * | NSAID | |
| Tenonitrozole | 0.204 | – | antiprotozoal agent | |
| Tenoxicam | 0.388 | * | NSAID | |
| Tepoxalin | 0.294 | – | NSAID | |
| Terazosin (R/S) | 0.408 / 0.319 | * | treatment of hypertension along with BPH | |
| Terbinafine | 0.473 | * | antifungal drug | |
| Terbutaline (R/S) | 0.396 / 0.291 | * | bronchodilator | |
| Terizidone (RR/RS/SS) | 0.181 / 0.154 / 0.216 | – | treatment of tuberculosis | |
| Terodiline (R/S) | 0.452 / 0.417 | * | antispasmodic drug used in urology | |
| Tertatolol (R/S) | 0.588 / 0.403 | ** | GR | treatment of hypertension |
| Tetrabenazine | 0.381 | * | treatment of hyperkinetic movement disorder | |
| Tetracaine | 0.508 | ** | GR | local anesthetic |
| Tetrahydrozoline (R/S) | 0.257 / 0.446 | * | vasoconstrictor (eye drops, nasal sprays): toxic at over dosage | |
| Tetrazepam | 0.290 | – | anxiolytic, muscle relaxant | |
| Thenalidine | 0.511 | ** | GR | antipuritic drug |
| Thenyldiamine | 0.335 | * | antihistamine | |
| Theodrenaline (R/S) | 0.417 / 0.359 | * | cardiac stimulant | |
| Theophylline | 0.238 | – | treatment of COPD, Asthma: toxic by interaction with other drugs | |
| Thialbarbital | 0.176 | – | sedative drug | |
| Thiamphenicol | 0.287 | – | veterinary antibiotic | |
| Thiethylperazine | 0.462 | * | treatment of nausea and vomiting | |
| Thioacetazone | 0.382 | * | treatment of tuberculosis | |
| Thiocarlide | 0.471 | * | treatment of tuberculosis | |
| Thioguanine | 0.185 | – | treatment of cancer (antimetabolite) | |
| Thioridazine (R/S) | 0.529 / 0.521 | ** | GR | treatment of schizophrenia and psychosis |
| Thonzylamine | 0.560 | ** | GR | antihistamine, antipuritic |
| Tiagabine | 0.367 | * | anticonvulsive medication | |
| Tianeptine (R/S) | 0.231 / 0.299 | – | antidepressant, anxiolytic | |
| Tiapride | 0.308 | * | neuroleptic agent | |
| Tiaprofenic acid (R/S) | 0.365 / 0.336 | * | NSAID | |
| Tibolone | 0.555 | ** | ERβ | hormone-replacement therapeutic |
| Ticlatone | 0.296 | – | antifungal agent | |
| Ticlopidine | 0.337 | * | antiplatelet drug | |
| Tidiacic (RR/RS/SR/SS) | 0.200 / 0.003 / 0.151 / 0.219 | – | hepatoprotective drug | |
| Tiflorex (R/S) | 0.481 / 0.420 | * | appetite suppressant | |
| Tifluadom (R/S) | 0.481 / 0.445 | * | analgesic, diuretic, sedative, appetite stimulant | |
| Tilbroquinol | 0.297 | – | antiprotozoal agent | |
| Tiletamine (R/S) | 0.207 / 0.179 | – | dissociative anesthetic (veterinary medicine) | |
| Tilisolol (R/S) | 0.468 / 0.558 | ** | hERG | treatment of hypertension and angina pectoris |
| Tilorone | 0.528 | ** | GR | orally active interferon inducer |
| Timiperone | 0.637 | ** | GR | neuroleptic drug |
| Timolol | 0.408 | * | treatment of high blood pressure | |
| Tioconazole (R/S) | 0.172 / 0.427 | * | antifungal medication | |
| Tipepidine | 0.300 | * | cough suppressant | |
| Tiratricol | 0.606 | ** | TRβ | thyroid hormone analogue |
| Tirofiban | 0.376 | * | antiplatelet drug | |
| Tiropramide (R/S) | 0.575 / 0.579 | ** | GR | antispasmodic |
| Tisopurine | 0.108 | – | treatment of gout | |
| Tixocortol | 0.482 | * | intestinal anti-inflammatory and decongestant | |
| Tizanidine | 0.321 | * | muscle relaxant | |
| Tocainide (R/S) | 0.561 / 0.330 | ** | hERG | antiarrhythmic agent |
| Tofisopam (R/S) | 0.416 / 0.508 | ** | GR | anxiolytic drug: not approved in US/Canada |
| Tolazamide | 0.334 | * | oral blood-glucose lowering drug (type-2 diabetes) | |
| Tolazoline | 0.357 | * | vasodilator; treatment of acrocyanosis | |
| Tolbutamide | 0.260 | – | management of type-2 diabetes | |
| Tolcapone | 0.259 | – | treatment of Parkinson's disease; hepatotoxic | |
| Tolciclate | 0.375 | * | antifungal medication | |
| Tolfenamic acid | 0.301 | * | NSAID | |
| Tolmetin | 0.312 | * | treatment of arthritis: several side effects; toxic to rats | |
| Tolnaftate | 0.382 | * | over-the-counter antifungal agent | |
| Toloxatone (R/S) | 0.354 / 0.409 | * | antidepressant | |
| Tolperisone (R/S) | 0.556 / 0.415 | ** | GR | muscle relaxant |
| Tolpropamine (R/S) | 0.402 / 0.479 | * | antihistamine used as an antipruritic | |
| Toltrazuril | 0.402 | * | coccidiostat | |
| Topotecan | 0.400 | * | chemotherapy agent: some side effects | |
| Torasemide | 0.406 | * | loop diuretic | |
| Toremifene | 0.634 | ** | ERβ | selective estrogen receptor modulator |
| Tracazolate | 0.253 | – | anxiolytic drug | |
| Tramadol | 0.498 | * | analgesic | |
| Tramazoline | 0.434 | * | nasal preparation | |
| Tranexamic acid | 0.262 | – | antifibrinolytic agent | |
| Tranilast | 0.257 | – | antiallergic drug | |
| Tranylcypromine | 0.396 | * | antidepressant | |
| Trapidil | 0.137 | – | vasodilator | |
| Trefentanil | 0.420 | * | opioid analgesic | |
| Trepibutone | 0.097 | – | treatment of gastrointestinal disorders | |
| Trestolone | 0.623 | ** | AR | hormonal male contraceptive |
| Triamcinolone | 0.494 | * | treatment of rhinoplasy and severe hay fewer | |
| Triamterene | 0.256 | – | potassium-sparing diuretic | |
| Triapine | 0.185 | – | under investigation for cancer treatment | |
| Trichlormethiazide (R/S) | 0.261 / 0.364 | * | treatment of edema | |
| Triethylenemelamine | 0.082 | – | drug used in chemotherapy | |
| Triflubazam | 0.342 | * | sedative, anxiolytic | |
| Trifluoperazine | 0.488 | * | treatment of schizophrenia | |
| Trifluperidol | 0.480 | * | antipsychotic drug (mania, schizophrenia) | |
| Triflupromazine | 0.451 | * | antipsychotic drug | |
| Trifluridine | 0.367 | * | antiviral drug (herpes) | |
| Triflusal | 0.178 | – | platelet-aggregation inhibitor | |
| Trihexyphenidyl (R/S) | 0.572 / 0.568 | ** | GR | antiparkinsonian drug |
| Trilostane | 0.372 | * | treatment of Cushing's syndrome | |
| Trimazosin | 0.382 | * | sympatholytic drug | |
| Trimebutine (R/S) | 0.584 / 0.566 | ** | GR | antimuscarinic |
| Trimecaine | 0.338 | * | local anesthetic | |
| Trimetazidine | 0.311 | * | treatment of angina pectoris | |
| Trimethadione | 0.083 | – | anticonvulsant | |
| Trimethobenzamide | 0.216 | – | antiemetic (prevention of nausea and vomiting) | |
| Trimetozine | 0.323 | * | anxiolytic drug | |
| Trimetrexate | 0.407 | * | treatment of pneumocystis pneumonia | |
| Tripelennamine | 0.403 | * | antipruritic and antihistamine | |
| Triprolidine | 0.444 | * | over-the-counter antihistamine | |
| Tritoqualine (RR/RS/SR/SS) | 0.413 / 0.365 / 0.359 / 0.408 | * | antihistamine | |
| Tropatepine | 0.641 | ** | GR | anti-parkinson drug |
| Tropicamide (R/S) | 0.137 / 0.181 | – | parasympatholytic (used for eye examinations) | |
| Troxipide (R/S) | 0.538 / 0.332 | ** | GR | treatment of gastroesophageal reflux disease |
| Tulobuterol (R/S) | 0.321 / 0.469 | * | β2-adrenergic receptor agonist | |
| Ufenamate | 0.405 | * | topical analgesic | |
| Uldazepam | 0.412 | * | sedative, anxiolytic | |
| Ulobetasol | 0.513 | ** | GR | corticosteroid |
| Uramustine | 0.413 | * | chemotherapeutic drug | |
| Urapidil | 0.455 | * | sympatholytic drug | |
| Valdecoxib | 0.437 | * | treatment of osteoarthritis and rheumatoid arthritis | |
| Valnoctamide (RR/RS/SR/SS) | 0.087 / 0.031 / 0.041 / 0.055 | – | sedative, hypnotic | |
| Valofane (RR/RS/SR/SS) | 0.522 / 0.332 / 0.415 / 0.360 | ** | hERG | |
| Valproic acid | 0.156 | – | anticonvulsant | |
| Valpromide | 0.052 | – | treatment of epilepsy | |
| Valsartan | 0.000 | – | treatment of hypertension | |
| Vanoxerine | 0.589 | ** | GR | treatment of cocaine dependence |
| Varenicline | 0.463 | * | treatment of smoking addiction | |
| Vedaclidine (R/S) | 0.449 / 0.293 | * | analgesic drug | |
| Vernakalant | 0.640 | ** | GR | investigational drug (atrial fibrillation) |
| Vesnarinone | 0.372 | * | cardiotonic agent | |
| Vigabatrin (R/S) | 0.264 / 0.066 | – | anticonvulsant | |
| Viloxazine (R/S) | 0.364 / 0.336 | * | antidepressant | |
| Viminol (six isomers) | 0.292–0.589 | ** | GR | opioid analgesic |
| Vinburnine | 0.354 | * | vasodilator | |
| Vinconate | 0.366 | * | nootropic | |
| Vinpocetine | 0.351 | * | nootropic, neuroprotective: no adverse reactions reported | |
| Voglibose | 0.375 | * | treatment of diabetes mellitus | |
| Voriconazole | 0.068 | – | antifungal medication | |
| Vorinostat | 0.536 | ** | ERβ | treatment of cutaneous T cell lymphoma |
| Vorozole (R/S) | 0.164 / 0.317 | * | antienoplastic agent | |
| Xaliproden | 0.483 | * | treatment of Alzheimer's disease | |
| Xamoterol (R/S) | 0.364 / 0.359 | * | cardiac stimulant | |
| Xanomeline | 0.232 | – | nasal decongestant | |
| Xipamide | 0.274 | – | diuretic drug | |
| Xorphanol | 0.484 | * | opioid analgesic | |
| Xylazine | 0.220 | – | sedative, anesthetic, muscle relaxant, analgesic (veterinary medicine) | |
| Xylometazoline | 0.419 | * | treatment of Alzheimer's disease and schizophrenia | |
| Zacopride (R/S) | 0.600 / 0.409 | ** | GR | anxiolytic, nootropic, antiemetic |
| Zalcitabine | 0.239 | – | reverse transcriptase inhibitor | |
| Zaleplon | 0.296 | – | sedative, hypnotic | |
| Zalospirone | 0.529 | ** | GR | antidepressant |
| Zanamivir | 0.376 | * | neuroamidase inhibitor | |
| Zapizolam | 0.147 | – | sedative, anxiolytic | |
| Zatosetron | 0.537 | ** | GR | antinauseant, anxiolytic |
| Zidovudine | 0.015 | – | treatment of HIV | |
| Zileuton (R/S) | 0.420 / 0.607 | ** | hERG | treatment of asthma |
| Zinterol (R/S) | 0.629 / 0.434 | ** | GR | β-adrenergic agonist |
| Ziprasidone | 0.451 | * | atypical antipsychotic drug | |
| Zofenopril | 0.135 | – | treatment of hypertension | |
| Zolazepam | 0.186 | – | veterinary anesthetic | |
| Zolmitriptan | 0.450 | * | treatment of migraine | |
| Zolpidem | 0.147 | – | treatment of insomnia; anticonvulsant, muscle relaxant | |
| Zomepirac | 0.257 | – | antipyretic (withdrawn from market) | |
| Zonisamide | 0.336 | * | anticonvulsant | |
| Zopiclone (R/S) | 0.326 / 0.219 | * | treatment of insomnia | |
| Zotepine | 0.415 | * | treatment of schizophrenia | |
| Zuclopenthixol | 0.402 | * | antipsychotic neuroleptic drug | |
| Zylofuramine | 0.572 | ** | GR | appetite suppressant (never marketed) |
| Compound | Weighted toxic potential | wTP class | Main target | Comments |
| Vitamin A | 0.422 | * | retinoid: acute and liver toxicity at high doses | |
| Vitamin B2 | 0.261 | – | riboflavin: not orally toxic | |
| Vitamin B3 | 0.254 | – | nicotinic acid: low toxicity at pharmacological doses | |
| Vitamin B5 | 0.033 | – | pantothenic acid: unlikely toxic | |
| Vitamin B6 | 0.205 | – | cofactor: safe at dosages less than 200 mg/day | |
| Vitamin B9 | 0.154 | – | folic acid: not toxic | |
| Vitamin C | 0.284 | – | L-ascorbate: not toxic | |
| Vitamin D2 | 0.565 | ** | GR | ergocalciferol: conflicting toxicity data |
| Vitamin D3 | 0.505 | ** | GR | cholecalciferol: toxic at high over dosage |
| Vitamin E | 0.313 | * | fat-soluble antioxidant: toxic effects only at high dosage | |
| Vitamin H (B7) | 0.254 | – | biotin: no adverse effects reported | |
| Vitamin L | 0.163 | – | anthranilic acid |
| Compound | Weighted toxic potential | wTP class | Main target | Comments |
| Abietic acid | 0.405 | * | resin acid | |
| Abscisic acid | 0.261 | – | plant hormone | |
| Acanthoic acid | 0.387 | * | natural COX-2 inhibitor (Rollina pitteri) | |
| Adenine | 0.010 | – | purine base | |
| Adrenaline | 0.280 | – | neurotransmitter | |
| Aflatoxin (B1/M1) | 0.521 / 0.357 | ** | ERβ | mycotoxin: extremely carcinogenic |
| Aloin (A/B) | 0.298 / 0.126 | – | naturally occurring bittering agent | |
| Alternariol | 0.277 | – | toxic metabolite of Alternaria fungi | |
| Anatoxin-a | 0.353 | * | cyanotoxin: acute neurotoxicity | |
| Androsterone | 0.503 | ** | ERβ | steroid hormone |
| Anethole | 0.408 | * | aromatic compound (anise, fennel) | |
| Angelicin | 0.288 | – | furocoumarin produced by a variety of plants | |
| Anisaldehyde | 0.223 | – | found in anise | |
| Anisomycin | 0.419 | * | antibioitic produced by Streptomyces griseolus | |
| Anthraquinone | 0.394 | * | anthracene derivative (aloe, henna, rhubarb) | |
| Apigenin | 0.589 | ** | ERα | flavone (parsley, celery) |
| Apiol | 0.410 | * | compound found in celery and parsley | |
| Arecoline | 0.162 | – | alkaloid found in the areca nut (Areca catechu) | |
| Artemisinin | 0.414 | * | sesquiterpene lactone (Artemisia annua) | |
| Asarone | 0.350 | * | ether found in acorus and asarum | |
| Asparagusic acid | 0.067 | – | metabolic precursor of odorous thiols (asparagus) | |
| Auxin | 0.279 | – | phytohormone | |
| Azealic acid | 0.123 | – | saturated dicarboxylic acid (wheat, rye, barley) | |
| Betulin | 0.547 | ** | GR | naturally occurring triterpene (bark of birch tree) |
| Betulinic acid | 0.461 | * | naturally occurring triterpene (bark of birch tree) | |
| Biopterin (1R,2S) | 0.200 | – | coenzyme | |
| Boswellic acid (α/β) | 0.528 / 0.648 | ** | AhR/GR | pentacyclic triterpene found in Boswellia serrata |
| Brassinolide | 0.315 | * | plant steroid | |
| Brazilin | 0.432 | * | red pigment (brazilwood family) | |
| Bulbocapnine | 0.315 | * | alkaloid found in Corydalis> and Dicentra | |
| Cadinene (α/β/γ) | 0.397 / 0.364 / 0.325 | * | bicyclic sesquiterpene from essential oil-producing plants | |
| Cafestol | 0.535 | ** | ERβ | diterpene present in coffee |
| Caffeic acid | 0.267 | – | naturally occurring carcinogenic inhibitor | |
| Caffeine | 0.138 | – | stimulant: side effects at high dosage | |
| Camphor | 0.143 | – | terpenoid found in wood of the camphor laurel | |
| Camphoric acid (R,S) | 0.197 | – | oxidized form of camphor | |
| Camptothecin | 0.340 | * | quinoline alkaloid found in Camptotheca acuminata | |
| Cannabicyclol | 0.515 | ** | GR | non-psychoactive cannabinoid found in Cannabis sativa |
| Cannabidiol | 0.223 | – | psychoactive cannabinoid found in Cannabis sativa | |
| Cannabidivarin | 0.135 | – | non-psychoactive cannabinoid found in Cannabis sativa | |
| Cannabinol | 0.566 | ** | GR | non-psychoactive cannabinoid found in Cannabis sativa |
| Cannabivarin | 0.562 | ** | GR | non-psychoactive cannabinoid found in Cannabis sativa |
| Cantharidin | 0.263 | – | poisonous blister beetle secret | |
| Capsaicin | 0.223 | – | active compound of chili pepper | |
| Carene | 0.113 | – | monoterpene constituent of turpentine | |
| Carminic acid | 0.153 | – | hydroxianthrapurin (occurs in some scale insects) | |
| Carvacrol | 0.259 | – | monoterpenoid phenol (oregano) | |
| Carvone (R/S) | 0.202 / 0.183 | – | terpenoid found in many essential oils | |
| Catechol | 0.399 | * | catechin distillate | |
| Cathine | 0.474 | * | monoamine alkaloid (Catha edulis) | |
| Cathinone | 0.380 | * | monoamine alkaloid (Catha edulis) | |
| Chenodeoxycholic acid | 0.326 | * | bile acid | |
| 4-Chloroindole-3-acetic acid | 0.128 | – | plant hormone | |
| Cholesterol | 0.490 | * | required to build and maintain cell membranes | |
| Chorismic acid | 0.379 | * | biochemical intermediate in plants and microorganisms | |
| Chrysin | 0.461 | * | natural flavone (passion flower) | |
| Cinchonine | 0.482 | * | alkaloid | |
| Cinnamaldehyde | 0.155 | – | cinnamon flavor: low toxicity | |
| Cinnamic acid | 0.318 | * | obtained from oil of cinnamon | |
| Cinnamyl alcohol | 0.207 | – | present in cinnamon leaves | |
| Citral (A/B) | 0.095 / 0.047 | – | present in lemon myrtle and several other plants | |
| Citric acid | 0.126 | – | citrus and other fruits, vegetables | |
| Citrulline (R/S) | 0.452 / 0.331 | * | rind of watermelon | |
| Citrinin | 0.420 | * | mycotoxin | |
| Codeine | 0.388 | * | opium alkaloid | |
| Colchicine | 0.476 | * | highly poisonous natural product | |
| Combretastatin A-4 | 0.719 | *** | ERβ | natural stilbenoid phenol (Combretum caffrum) |
| Conessine | 0.500 | ** | hERG | steroid alkaloid (Apocynaceae family) |
| Coniine | 0.332 | * | alkaloid found in poison hemlock | |
| p-Coumaric acid | 0.335 | – | cinnamic-acid derivative (peanut, carrot, garlic) | |
| Coumarin | 0.225 | – | plant toxin | |
| Cubebol | 0.356 | * | sesquiterpene alcohol found in cubeb oil | |
| Cuminaldehyde | 0.173 | – | found in eucalyptus, nyrrh, cassia, cumin | |
| Curcumin | 0.581 | ** | ERβ | principal curcuminoid in turmeric (ginger family) |
| Cuscohygrine | 0.486 | * | pyrrolidine alkaloid found in coca | |
| Cyclopamine | 0.500 | ** | hERG | alkaloid: teratogen |
| Cyclopiazonic acid | 0.436 | * | fungal secondary metabolite | |
| Cytisine | 0.273 | – | alkaloid found in several Faboideae species | |
| Cytokinin | 0.282 | – | plant hormone | |
| Desoxycorticosterone | 0.660 | ** | ERα | mineralocorticoid excreted from the adrenal gland |
| Digalloylgallic acid | 0.238 | – | polyphenolic carbonic acid | |
| Digoxigenin | 0.436 | * | steroid found in Digitalis purpurea | |
| Dihydroactinidiolide | 0.204 | – | volatile terpene (black tea, mango, tobacco) | |
| 1,8-Dihydroxyanthrachinone | 0.302 | * | anthraglycoside (emodine) | |
| 1,8-Dihydroxyanthrone | 0.278 | – | anthraglycoside (emodine) | |
| Dillapiole | 0.365 | * | essential oil found in dill weed | |
| Dimethyltryptamine | 0.355 | * | naturally occurring tryptamine; potent psychedelic drug | |
| Diosgenin | 0.799 | *** | ERα | steroid sapogenin (Dioscorea wild yam) |
| Domoic acid | 0.202 | – | neurotoxin (red algeae) | |
| Ectocarpene | 0.144 | – | pheromone (brown algeae) | |
| Ectoine | 0.235 | – | protective substance in bacterial cells | |
| Elemicin | 0.313 | * | essential oil of nutmeg | |
| Ellagic acid | 0.688 | ** | ERβ | polyphenol antioxidant (fruits, vegetables) |
| Epibatidine | 0.448 | * | poisonous frog alkaloid | |
| Epicatechine | 0.723 | *** | ERβ | flavonoid (tea) |
| Epigallocatechine | 0.533 | ** | ERβ | flavonoid (tea) |
| Epinephrine | 0.321 | * | neurotransmitter | |
| Epitestosterone | 0.510 | ** | ERβ | natural steroid |
| Equilenin | 0.738 | *** | ERβ | horse steroid |
| Equilin | 0.707 | *** | ERβ | horse steroid |
| Equol | 0.736 | *** | ERα | isoflavandiol |
| Erdacin | 0.214 | – | highly active antioxidant | |
| Ergine | 0.457 | * | alkaloid of the ergoline family | Ergotamine | 0.643 | ** | GR | alkaloid of the ergot family |
| Estragole | 0.294 | – | found in tarragon, basil, pine oil, fennel, anise | |
| Estriol | 0.801 | **** | ERβ | female sex hormone | Estrone | 0.764 | *** | ERβ | estrogenic hormone secreted by the ovary | Etorphine | 0.634 | ** | GR | semi-synthetic opioid (poppy straw; Papaver orientale, bracteatum) |
| Eucalyptol | 0.187 | – | monoterpenoid found in Eucalyptus oil | Evodiamine | 0.272 | – | chemical extracted from the Evoida plant family |
| Fenchone | 0.100 | – | organic compound present in the oils of fennel | Ferruginol | 0.531 | ** | ERβ | diterpene (Sequoica semperivirens) |
| Ferujol | 0.259 | – | coumarin (Ferula jaschkeana | |
| Ferulic acid | 0.294 | – | phenolic phytochemical | |
| Flavin | 0.321 | * | riboflavin derivative | Forskolin | 0.477 | * | labdana diterpene (Coleus forsohili) |
| Gallic acid | 0.215 | – | organic acid (gallnuts, witch hazel, tea leaves) | |
| Genipin | 0.324 | * | active compound in gardenia fruit (→ TCM) | |
| Geosmin | 0.180 | – | organic compound (earthy taste) found in beets | |
| Geranic acid | 0.058 | – | pheromone | |
| Gestonorone | 0.529 | ** | ERα | progestagen hormone |
| Gingerol | 0.484 | * | active constituent of fresh ginger | |
| Gliotoxin | 0.368 | * | antibiotic produced by several species of fungi | |
| Glucuronolactone | 0.204 | – | glucose metabolite in the liver: low acute toxicity | |
| Glutamic acid (L/D) | 0.358 / 0.206 | * | swift excitatory neurotransmitter | |
| Glycyrrhetinic acid | 0.339 | * | triterpenoid (Licorice plant) | |
| Glycyrrhizol A | 0.493 | * | flavonoid (roots of the Chinese Licorice plant) | |
| Guaiacol | 0.191 | – | aromatic oil from guaiacum or wood cresote | |
| Guaiazulene | 0.338 | * | sesquiterpene (oil from guaiac and camomile) | |
| Guanacastepene A | 0.588 | ** | ERβ | diterpene (extracted from a Costa Rica fungus) |
| Gyromitrin | 0.033 | – | chemical present in Gyromithra mushrooms: possibly cancerogenic | |
| Haematoxylin | 0.370 | * | black pigment (logwood tree) | |
| Harmaline | 0.450 | * | psychoactive indole alkaloid | |
| Harmane | 0.419 | * | indole alkaloid | |
| Harmine | 0.695 | ** | GR | indole alkaloid: cytotoxic |
| Hasubanan | 0.435 | * | alkaloid (Stephania longa) | |
| Hasubanonine | 0.269 | – | alkaloid of the hasubanan family | |
| Hesperetin | 0.397 | * | bioflavonoid found in Citrus fruits | |
| Hippuric acid | 0.153 | – | carboxylic acid found in the urine of horses | |
| Hippuristanol | 0.632 | ** | ERα | molecule found in the coral Isis hippunis |
| Histamine | 0.313 | * | neurotransmitter | |
| L-Histidine | 0.318 | * | amino acid (essential for children) | |
| Homogentisic acid | 0.072 | – | metabolic breakdown product of Phe and Tyr | |
| Honokiol | 0.457 | * | biphenolic compound found in Magnolia grandifloris | |
| Hordenine | 0.411 | * | alkaloid of the Cactacaea family | |
| Hydrastatine (R/S) | 0.340 / 0.299 | * | alkaloid found in Hydrastis canadensis | |
| Hygrine | 0.290 | – | pyrrolidine alkaloid (coca leaves) | |
| Hyperforin | 0.356 | * | active constituent of Saint John's wort | |
| Hypericin | 0.479 | * | active constituent of Saint John's wort | |
| Hypoglycin | 0.133 | – | organic compound found un Blighia sapida | |
| Ibogaine | 0.362 | * | psychoactive compound found in Tabermanthe iboga | |
| Ibotenic acid | 0.328 | * | neurotoxin (mushrooms) | |
| Indole | 0.156 | – | degradation product of tryptophan | |
| Indole-3 acetic acid | 0.198 | – | phytohormone (auxin) | |
| Inosinic acid | 0.288 | – | nucleotide present in muscle and other tissues | |
| myo-Inositol | 0.524 | ** | ERβ | structural basis for secondary messengers |
| Ionone (α/β/γ) | 0.222 / 0.187 / 0.181 | – | aroma compounds found in a variety of essential oils | |
| Isatin | 0.170 | – | indole derivative found in many plants | |
| Jasmone | 0.176 | – | natural organic compound (jasmine flower) | |
| Kainic acid | 0.157 | – | marine acid present in some seaweed | |
| Khellin | 0.275 | – | vasodilator found in Ammi visnaga used by Egyptian folk medicine | |
| Kojic acid | 0.298 | – | chelation agent produced by Aspergillus oryzae | |
| Linamarin | 0.384 | * | cyanogenic glucoside (e.g. lima beans, flax) | |
| Lipoic acid | 0.118 | – | essential cofactor for many enzymes | |
| Lobeline (R/S) | 0.484 / 0.608 | ** | GR | natural alkaloid found in various Lobelia species |
| Longifolene | 0.184 | – | sesquiterpene found in pine resins | |
| Lotaustralin | 0.432 | * | cyanogenic glucoside (e.g. lima beans, roseroot) | |
| Luciferin | 0.222 | – | bioluminescent (firefly) | |
| Lupinine | 0.186 | – | alkaloid present in Leguminosae plants | |
| Luteolin | 0.551 | ** | ERβ | natural flavone (celery, green pepper, perilla and camomile tea) |
| Lysergol | 0.461 | * | ergoline alkaloid found in fungi | |
| Macromerine (R/S) | 0.316 / 0.302 | * | psychoactive compound from Coryphanta macromeris | |
| Melatonin | 0.277 | – | naturally occurring hormone | |
| Menadiol | 0.292 | – | vitamin K3 derivative | |
| Menthol (1R,2S,5R) | 0.179 | – | found in mint oils | |
| β-Methylamino-L-alanine | 0.149 | – | neurotoxin (cycad seeds) | |
| β-Methylphenethylamine | 0.330 | * | amphetamine-related compound found in many Acacia species | |
| Mimosine | 0.405 | * | alkaloid found in Mimosa species | |
| Mitomycin | 0.189 | – | lavendulea extract | |
| Moronic acid | 0.368 | * | triterpene found in sumac plants | |
| Muscimol | 0.286 | – | psychoactive alkaloid (mushrooms) | |
| Naringenin | 0.505 | ** | ERβ | flavonoid (grapefruit juice): inhibits CYP 1A2 |
| Nicotinamide | 0.121 | – | amide of vitamin B3 | |
| N-Nitrosonornicotine | 0.117 | – | nitrosamine found in tobacco: carcinogen | |
| Nonivamide | 0.462 | * | capsaicinoid present in chili peppers | |
| Nootkatone | 0.285 | – | sesquiterpene aromatic of grapefruit | |
| Norepinephrine | 0.397 | * | hormone and neurotransmitter | |
| Norpatchoulenol | 0.131 | – | terpenoid found in patchouli oil | |
| Noscapine | 0.410 | * | benzoisoquinoline alkaloid (Papaveraceae plants) | |
| Novobiocin | 0.000 | – | aminocoumarin antibiotic (Streptomyces niveus) | |
| Nuciferine | 0.349 | * | alkaloid found in Nymphaea caerulea | |
| Octopamine (R/S) | 0.348 / 0.264 | * | biogenic amine found in salivar glands of the octopus | |
| Orcin | 0.186 | – | found in many lichens | |
| L-Ornithine | 0.437 | * | amino acid | |
| Orotic acid | 0.220 | – | historically vitamin B13 | |
| Orselinic acid | 0.086 | – | organic acid found in lychens | |
| Papaverine | 0.375 | * | alkaloid found in poppy | |
| Paraxanthine | 0.263 | – | caffeine metabolite (in animals) | |
| Parietin | 0.356 | * | cortical pigment of lichens | |
| Patulin (R/S) | 0.213 / 0.118 | – | mycotocin: genotoxic; restricted use in several countries | |
| Paxilline | 0.494 | * | toxic, tremorgenic indole alkaloid | |
| Perillaldehyde | 0.134 | – | monoterpenoid found in perilla herb | |
| 2-Phenethylamine | 0.329 | * | monoamine alkaloid found e.g. in chocolate | |
| Phenylacetic acid | 0.025 | – | active auxin found in fruits | |
| L-Phenylalanine | 0.490 | * | natural amino acid | |
| Physostigmine | 0.312 | * | cholinesterase inhibitor alkaloid | |
| Plumbagin | 0.196 | – | naphtoquinone found in the plant genus Plumbago | |
| Progesterone | 0.633 | ** | AR | steroid hormone |
| Psilocin | 0.227 | – | hallucinogenic mushroom alkaloid | |
| Psilocybin | 0.418 | – | hallucinogenic found in psilocybin mushrooms | |
| Psoralen | 0.222 | – | furocoumarin | |
| Pterin | 0.196 | – | heterocyclic compound found in butterfly pigments | |
| Pterostilbene | 0.754 | *** | ERβ | stilbenoid found in blueberries and grapes |
| Pulegone | 0.205 | – | flavorant found in the essential oils of plants | |
| Purpurin | 0.303 | * | dye found in the roots of Rubia tinctorum | |
| Pyridoxine | 0.218 | – | Pyridoxol: vitamin B6-related related | |
| Pyroglutamic acid (R/S) | 0.246 / 0.072 | – | uncommon amino acid | |
| Quinic acid | 0.202 | – | crystalline acid obtained from cinchona bark and coffee beans | |
| Raspberry ketone | 0.465 | * | primary aroma compound of red raspberries | |
| Resveratrol | 0.537 | ** | ERβ | phytoalexin |
| Retronecine | 0.210 | – | pyrrolizidine alkaloid | |
| Rosaceae acid (E/Z) | 0.295 / 0.390 | * | cucurbitan derivative (Alnus acuminata) | |
| Rosmarinic acid | 0.399 | * | antioxidant found in many Lamiaceae herbs | |
| Rotenone | 0.521 | ** | GR | naturally occurring insecticide, piscicide, pesticide |
| Rutaecarpine | 0.443 | * | alkaloid found in Evodia rutaecarpa | |
| Rutin | 0.337 | * | ||
| Safranal | 0.214 | – | aroma compound of saffron | |
| Safrole | 0.373 | * | sassafras plant extract | |
| Salicylic acid | 0.104 | – | plant hormone | |
| Salvinorin A | 0.363 | * | psychotropic component of Salvia divinorum | |
| Samandaridine | 0.593 | ** | GR | toxic alkaloid produced by salamanders |
| Scoulerine | 0.494 | * | alkaloid found in opium poppy | |
| Serotonin | 0.351 | * | neurotransmitter | |
| Sesamol | 0.354 | * | phenolic component of sesame oil | |
| Shikimic acid | 0.344 | * | biochemical intermediate in plants | |
| Silibinin | 0.366 | * | main active constituent of silymarin (Silybum marianum) | |
| Sinapinic acid | 0.334 | * | phenylpropanoid found in L. Sinapi | |
| β-Sitosterol | 0.493 | * | phytosterol found in many plants, e.g. black cumin seed | |
| Sparteine | 0.590 | ** | GR | alkaloid (scotch broom, Lupinus mutabilis); antiarrhythmic agent |
| Spectinomycin | 0.606 | ** | GR | naturally occuring antibiotic (Streptomyces achromogenes) |
| Sterigmatocystin | 0.598 | ** | GR | dermatoxin poison |
| Streptozotocin | 0.165 | – | aminocyclitol antibiotic (Streptomyces spectabilis) | |
| Strychnine | 0.757 | *** | GR | alkaloid pesticide |
| Tangeritin | 0.688 | ** | ERβ | polymethoxylated flavone (tangerine, citrus peels) |
| Taurine | 0.381 | * | major bile constituent | |
| Tetrahydrobiopterin | 0.291 | – | essential cofactor to aromatic hydroxylases | |
| Tetrodotoxin | 0.277 | – | neurotoxin: slightly toxic to mice | |
| Theobromine | 0.188 | – | bitter alkaloid (cacao plant) | |
| Thymol | 0.192 | – | monoterpene phenol (thyme oil) | |
| L-Thyroxine | 0.556 | * | TRβ | thyroid hormone |
| Trioxsalen | 0.355 | * | furanocoumarin (Psoralea corylifolia) | |
| Umbelliferone | 0.201 | – | widespread product of the coumarin family | |
| Ursodiol | 0.421 | * | secondary bile acid | |
| Usnic acid | 0.315 | * | dibenzofuran derivative found in lichen | |
| Vanillin | 0.322 | * | primary component of vanilla bean extract | |
| Vincamine | 0.454 | * | indole alkaloid (Vinva minor); peripheral vasodilator | |
| Visnadine | 0.304 | * | natural vasodilator isolated from bishop's weed (Ammi visnaga) | |
| Vomitoxin | 0.191 | * | mycotoxin | |
| Xanthopterin | 0.208 | – | inhibits growth of lymphocytes | |
| Xantocillin | 0.621 | ** | ERβ | naturally occurring isocyanide (first isolated from Penicillum notatum) |
| Zingiberene | 0.319 | * | sesquiterpene (oil of ginger) |
| Compound | Weighted toxic potential | wTP class | Main target | Comments |
| Acetaminosalol | 0.303 | * | UV absorber | |
| Ambrox | 0.425 | * | perfume odorant | |
| Avobenzone | 0.384 | * | sunscreen | |
| Benzalphtalide | 0.428 | * | UV absorber | |
| Benzophenone | 0.316 | * | UV absorber in perfumes and soaps: not mutagenic | |
| Benzophenone-1 | 0.185 | – | UV absorber | |
| Benzophenone-2 | 0.337 | * | UV absorber | |
| Benzophenone-3 | 0.233 | – | UV absorber | |
| Benzophenone-4 | 0.261 | – | UV absorber | |
| Benzophenone-5 | 0.311 | * | UV absorber | |
| Benzophenone-6 | 0.282 | – | UV absorber | |
| Benzophenone-7 | 0.257 | – | UV absorber | |
| Benzophenone-8 | 0.230 | – | UV absorber | |
| Benzophenone-9 | 0.390 | * | UV absorber | |
| Benzophenone-10 | 0.307 | * | UV absorber | |
| Benzophenone-11 (R=H/CH3) | 0.297 / 0.213 | – | UV absorber | |
| Benzophenone-12 | 0.354 | * | UV absorber | |
| Benzylbenzoate | 0.321 | * | food additive in artificial flavors: may cause allergies | |
| Benzylsalicylate | 0.344 | * | cosmetic ingredient: low acute toxicity; possibly nephrotoxic | |
| Bornelone (keto/enol) | 0.256 / 0.189 | – | UV absorber | |
| 2-Bromo-2-nitropropane-1,3-diol | 0.072 | – | antimicrobial chemical agent: restricted use in Canada | |
| Bumetrizole | 0.452 | * | UV absorber | |
| Citronellol | 0.122 | – | perfumes, insect repellant (FDA: safe compound) | |
| Diazolidinylurea (R/S) | 0.430 / 0.250 | * | amine dialcohol: carcinogen; allergic reactions: carcinogen | |
| Dibenzoxazinylnaphtalene | 0.391 | * | UV absorber | |
| Dibenzylideneacetone | 0.430 | * | UV absorber | |
| Diethanolamine | 0.367 | * | amine dialcohol: inhibits fetal brain development in mice | |
| Diisopropylethylcinnamate | 0.156 | – | UV absorber | |
| Diisopropylmethylcinnamate | 0.150 | – | UV absorber | |
| Dimorpholinopyridazinone | 0.235 | – | UV absorber | |
| Diphenylpiperazinylbenzimidazole | 0.596 | ** | GR | UV absorber |
| 1,4-Dioxane | 0.174 | – | aprotic solvent: eye and respiratory tract irritant | |
| 2,6-di-tert-butyl-4-methylphenol | 0.219 | – | banned for food use in Japan, Sweden, Australia and US | |
| Di-tert-butylhydroxybenzylidene camphor (1R6R/1R6S) | 0.429 / 0.496 | * | UV absorber | |
| Drometrizole | 0.404 | * | UV absorber | |
| 4-Ethylamino-3-nitrobenzoic acid | 0.262 | – | UV absorber | |
| Ethylcinnamate | 0.240 | – | UV absorber | |
| Ethylmethoxycinnamate | 0.287 | – | UV absorber | |
| Ethylurocanate | 0.183 | – | UV absorber | |
| Eugenol | 0.557 | ** | ERβ | perfume odorant: over dosage causes various side effects |
| Evernyl | 0.279 | – | perfume odorant | |
| Farnesol | 0.161 | – | perfume additive | |
| Firsantol | 0.385 | * | perfume odorant | |
| Galaxolide (RR/RS/SR/SS) | 0.458 / 0.418 / 0.471 / 0.532 | ** | ERα | synthetic musk fragrance |
| Georgywood (RS/SR) | 0.349 / 0.364 | * | perfume odorant | |
| Geraniol | 0.021 | – | perfume odorant | |
| Hedione | 0.153 | – | perfume odorant | |
| Hydantoin | 0.039 | – | cosmetic chemical | |
| Isoeugenol | 0.465 | * | perfume odorant | |
| 4-Isopropylbenzylsalicylate | 0.411 | * | UV absorber | |
| Linalool (R/S) | 0.135 / 0.002 | – | soap, shampoo and lotion scent | |
| 4-Methylbenzylidenecamphor-sulfonic acid (1S,4R/1R,4S) | 0.393 / 0.339 | * | UV absorber | |
| 6-Methylcoumarin | 0.309 | * | perfume odorant | |
| 7-Methylcoumarin | 0.278 | – | perfume odorant | |
| Moxalone | 0.417 | * | perfume odorant | |
| Musk ketone | 0.355 | * | synthetic musk fragrance | |
| Musk xylene | 0.404 | * | synthetic musk fragrance | |
| Octrizole | 0.313 | * | UV absorber | |
| Oxobenzoxazinylnaphtalene sulfonanilide | 0.614 | ** | GR | UV absorber |
| Panthenol | 0.000 | – | humectant, emolient, moisturizer: not toxic in rats | |
| Propyleneglycol (R/S) | 0.083 / 0.106 | – | moisturizer: not carcinogenic or genotoxic | |
| 2-tert-butyl-4-hydroxianisole | 0.247 | – | antioxidant | |
| 3-tert-butyl-4-hydroxianisole | 0.304 | * | antioxidant | |
| tert-butyl-methoxydibenzomethane | 0.231 | – | UV absorber | |
| Tropional (R/S) | 0.271 / 0.278 | – | perfume odorant |
| Compound | Weighted toxic potential | wTP class | Main target | Comments |
| Acenaphthene | 0.273 | – | PAH: not carcinogenic | |
| Acenaphthoquinone | 0.252 | – | PAH: carcinogenic properties unclear | |
| Acenaphthylene | 0.322 | * | PAH | |
| Acetanilide | 0.176 | – | industrial chemical | |
| 2-Acetylaminofluorene | 0.476 | * | carcinogenic, mutagenic | |
| 2-Acetylamino-3,7,8-trichlorodibenzo-p-dioxin | 0.585 | ** | AhR | suspected hazardous pollutant |
| Acibenzolar | 0.101 | – | fungicide | |
| Acridine | 0.404 | * | ||
| Acridine orange | 0.335 | * | fluorescent dye | |
| Acridine yellow | 0.388 | * | fluorescent dye | |
| Adamantane | 0.098 | – | ||
| Adrenochrome (R/S) | 0.176 / 0.273 | – | pigment; hemeostatic properties | |
| 5-Aldoellipticine | 0.448 | * | ||
| Aldrin | 0.250 | – | insecticide | |
| Alizarin | 0.371 | * | antraquinone dye: not highly toxic | |
| Amidol | 0.079 | – | photographic developer | |
| 3'-Amino-α-naphthoflavone | 0.654 | ** | ERβ | |
| 4-Aminobenzoic acid | 0.251 | – | PABA; essential nutrient for some bacteria | |
| 4-Aminobiphenyl | 0.328 | * | azo dye | |
| 1-Amino-9-methoxyellipticine | 0.604 | ** | ERβ | |
| 4-Amino-2-methyl-1-naphthol | 0.282 | – | vitamin K3 derivative | |
| Aminothiazole | 0.099 | – | chemical intermediate with antibacterial activity | |
| 3-Amino-1,2,4-triazole | 0.074 | – | triazole herbicide | |
| 2-Amino-3,7,8-trichlorodibenzo-p-dioxin | 0.549 | ** | AhR | suspected hazardous pollutant |
| 7-Amino-2,3-dichlorodibenzo-p-dioxin | 0.397 | * | suspected hazardous pollutant | |
| Anisoylchloride (o/m/p) | 0.321 / 0.247 / 0.266 | * | acyl halide | |
| Anthrone | 0.382 | * | tricyclic aromatic hydrocarbon | |
| Atrazine | 0.304 | * | herbicide: teratogen in frogs; endocrine disruptor | |
| Auramine O | 0.203 | – | diarylmethane dye | |
| Aurin | 0.630 | ** | ERβ | pH indicator |
| Azobenzene | 0.387 | * | historically used as dye | |
| 3-Azo-5,11-diketoellipticine | 0.510 | ** | AhR | |
| 3-Azoellipticine | 0.533 | ** | AhR | |
| 4-Azo-8-methoxyellipticine | 0.545 | ** | AhR | |
| Azulene | 0.253 | – | monoterpene (isomer of naphtalene) | |
| Benomyl | 0.362 | * | fungicide | |
| Benzanthrone | 0.421 | * | aromatic hydrocarbon (dyestuff) | |
| Benzidine | 0.408 | * | carcinogenic aromatic amine | |
| Benzilic acid | 0.152 | – | ||
| Benzo[c]cinnoline | 0.340 | * | tricyclic aromatic compound | |
| Benzo[a]fluorene | 0.549 | ** | AhR | suspected hazardous pollutant |
| Benzo[b]fluorene | 0.549 | ** | AhR | suspected hazardous pollutant |
| Benzoic acid | 0.238 | – | food preservative | |
| Benzoin (R/S) | 0.204 / 0.131 | – | desyl alcohol | |
| Benzothiadiazine | 0.236 | – | industrial chemical | |
| Benzothiazole | 0.181 | – | industrial chemical | |
| Benzotriazole | 0.222 | – | corrosion inhibitor, aircraft deicer | |
| Benzoylchloride | 0.230 | – | chemical intermediate | |
| Benzoylperoxide | 0.181 | – | radical initiator | |
| Benzylbutylphthalate | 0.321 | * | plasticizer | |
| Benzylideneacetone | 0.205 | – | α,β-unsaturated ketone | |
| Bifenthrin (R/S) | 0.499 / 0.474 | * | insecticide | |
| 2,2'-Bipyridine | 0.286 | – | transition-metal chelator | |
| 1,8-Bis(dimethylamino)naphthalene | 0.311 | * | highly basic diamine | |
| Bis(2-ethylhexyl)phthalate (RR/RS/SR/SS) | 0.297 / 0.229 / 0.361 / 0.236 | * | plasticizer | |
| Bismarck brown Y | 0.223 | – | diazo dye used for tissue staining | |
| Bisphenol-AF5 | 0.481 | * | polymer additive | |
| Bisphenol-AP | 0.565 | ** | ERβ | polymer additive |
| Bisphenol-BP | 0.409 | * | polymer additive | |
| Bisphenol-C | 0.622 | ** | ERα | polymer additive |
| Bisphenol-E | 0.553 | ** | ERβ | polymer additive |
| Bisphenol-F | 0.523 | ** | ERβ | skin, eye and respiratory irritant |
| Bisphenol-FL | 0.375 | * | polymer additive | |
| Bisphenol-G | 0.498 | * | polymer additive | |
| Bisphenol-M | 0.735 | *** | ERα | polymer additive |
| Bisphenol-P | 0.625 | ** | ERα | polymer additive |
| Bisphenol-PH | 0.379 | * | polymer additive | |
| Bisphenol-S | 0.216 | – | polymer additive | |
| Bisphenol-T (R/S) | 0.514 / 0.461 | ** | ERα | polymer additive |
| Bisphenol-Z | 0.441 | * | polymer additive | |
| Bromocresol purple | 0.518 | ** | ERβ | pH indicator |
| Bromophenol blue | 0.513 | ** | GR | pH indicator, color marker dye |
| 7-Bromo-2,3-dichlorodibenzo-p-dioxin | 0.626 | ** | AhR | suspected hazardous pollutant |
| 8-Bromo-2,3-dichlorodibenzofuran | 0.581 | ** | AhR | suspected hazardous pollutant |
| 8-Bromomethyl-2,3,4-trichlorodibenzofuran | 0.553 | ** | AhR | suspected hazardous pollutant |
| 8-Bromo-2,3,4-trichlorodibenzofuran | 0.608 | ** | AhR | suspected hazardous pollutant |
| 2-Bromo-3,7,8-trichlorodibenzo-p-dioxin | 0.763 | *** | AhR | suspected hazardous pollutant |
| Butyrophenone | 0.204 | – | aromatic ketone | |
| Calcein (open form/hemi-acetal) | 0.041 / 0.022 | – | fluorescent dye | |
| Camphene | 0.145 | – | bicyclic monoterpene | |
| Caprolactam | 0.151 | – | organic monomer (nylon-6) | |
| Carbaryl | 0.239 | – | insecticide: toxic (cholinesterase inhibitor) | |
| Carbazole | 0.445 | * | antrachinone dye | |
| β-Carboline | 0.354 | * | organic amine | |
| Chinizarine | 0.270 | – | antrachinone dye | |
| 4-Chloroaniline | 0.144 | – | chlorinated derivative of aniline | |
| Chlorobenzene | 0.154 | – | aromatic organic compound | |
| 1-Chlorodibenzo-p-dioxin | 0.379 | * | suspected hazardous pollutant | |
| 2-Chlorodibenzofuran | 0.366 | * | suspected hazardous pollutant | |
| 3-Chlorodibenzofuran | 0.341 | * | suspected hazardous pollutant | |
| 8-Chlorotheophylline | 0.115 | – | xanthine derivative (stimulant properties) | |
| 2-Chloro-4-biphenylol | 0.500 | ** | ERβ | fungicide |
| 4-Chlorodibenzofuran | 0.413 | * | suspected hazardous pollutant | |
| p-Chlorocresol | 0.387 | * | antiseptic, preservative agent | |
| Chlorphenol red | 0.420 | * | pH indicator | |
| Chloroxylenol | 0.418 | * | antibacterial agent (soaps) | |
| Chlorpyrifos | 0.192 | – | organophosphate insecticide | |
| Chlorquinaldol | 0.370 | * | antiseptic, disinfectant | |
| Chlortoluron | 0.354 | * | herbicide | |
| Chromotropic acid | 0.378 | * | analytical agent (dye) | |
| Cinnoline | 0.198 | – | aromatic heterocyclic compound | |
| Cinoxate | 0.317 | * | ingredient of sunscreens | |
| Clofibric acid | 0.121 | – | herbicide | |
| Coronene | 0.722 | *** | AhR | PAH, occurs in carpathite |
| Cotinine | 0.122 | – | nicotine metabolite | |
| Coumaphos | 0.469 | * | ectoparasitizide | |
| Cubane | 0.022 | – | synthetic hydrocarbon | |
| 2-Cyano-3,7,8-trichlorodibenzo-p-dioxin | 0.722 | *** | AhR | suspected hazardous pollutant |
| 7-Cyano-2,3-dichlorodibenzo-p-dioxin | 0.675 | ** | AhR | suspected hazardous pollutant |
| Cyanuric acid | 0.282 | – | triazine (bleaches, disinfectants, herbicides) | |
| Cyanuric chloride | 0.136 | – | trimer of cyanogen chloride | |
| Cyclohexenone | 0.058 | – | versatile organic intermediate | |
| Cyclohexylamine | 0.366 | * | organic chemical | |
| Cyclohexylnitrite | 0.091 | – | chemical with antianginal properties | |
| Cyclonite (RDX) | 0.118 | – | explosive nitroamine | |
| Cypermethrin (cis/trans) | 0.439 / 0.328 | * | primarily used as an insecticide | |
| DABCO (1,4,diazabicyclo[2.2.2]octane) | 0.244 | – | chemical catalyst | |
| Dantron | 0.323 | * | anthraquinone derivative | |
| DAPI (4'6-diamino-2-phenylindole) | 0.344 | * | fluorescent stain | |
| 2-Deazo-5,11-diketoellipticine | 0.627 | ** | AhR | |
| 2-Deazoellipticine | 0.522 | ** | AhR | |
| Decabromodiphenylether | 0.576 | ** | GR | brominated flame retardant |
| N,N-Diethyl-meta-toluamide (DEET) | 0.160 | – | active ingredient in insect repellants | |
| Dehydroacetic acid | 0.410 | * | fungicide, bactericide | |
| Dehydrocholic acid | 0.533 | ** | GR | synthetic bile acid |
| 7,8-Dehydrorutaecarpine | 0.644 | ** | AhR | |
| Deltamethrin (cis/trans) | 0.400 / 0.306 | * | insecticide | |
| Dettol (p-chlorometaxylenol: PCMX) | 0.442 | * | antiseptic | |
| 3,3'-Diaminobenzidine | 0.272 | – | used to detect fingerprints in blood | |
| 3,4-Diaminodiphenylmethane | 0.183 | – | ||
| 4,4-Diaminodiphenylmethane | 0.138 | – | ||
| Dianin's compound (R/S) | 0.473 / 0.508 | ** | ERα | condensation isomer of Bisphenol A and acetone |
| Diatrizoic acid | 0.347 | * | radiocontrast agent | |
| Diazinon | 0.088 | – | insecticide | |
| Dibenzo[ac]anthracene | 0.755 | *** | AhR | suspected hazardous pollutant |
| Dibenzofuran | 0.309 | * | suspected hazardous pollutant | |
| 3-Dibenzofuranamine | 0.244 | – | suspected hazardous pollutant | |
| 2,5-Dichloro-4'-biphenylol | 0.698 | ** | ERβ | fungicide |
| 2,8-Dichlorodibenzo-p-dioxin | 0.500 | ** | AhR | suspected hazardous pollutant |
| 2,3-Dichlorodibenzofuran | 0.452 | * | suspected hazardous pollutant | |
| 2,6-Dichlorodibenzofuran | 0.473 | * | suspected hazardous pollutant | |
| 2,8-Dichlorodibenzofuran | 0.469 | * | suspected hazardous pollutant | |
| Dichlorodiphenyldichloroethylene (DDE) | 0.313 | * | DDT metabolite | |
| Dichlorophen | 0.358 | * | anticestodal agent | |
| Dieldrin | 0.217 | – | insecticide | |
| Difloxacin | 0.557 | ** | GR | quinolone |
| Diiodohydroxyquinoline | 0.236 | – | quinoline derivative | |
| 7,12-Dimethylbenzo[a]anthracene | 0.632 | ** | AhR | suspected hazardous pollutant |
| Dimethylbenzylamine | 0.237 | – | organic catalyst (for PU foams and resins) | |
| Dimethylterephtalate | 0.239 | – | chemical intermediate (polyester production) | |
| Dinoseb (R/S) | 0.191 / 0.276 | – | herbicide | |
| Dioxathion | 0.196 | – | insecticide | |
| Dioxybenzone | 0.194 | – | UVB and short-wave UVA blocker in sunscreens | |
| Diphenylacetylene | 0.363 | * | ||
| Diphenylketene | 0.186 | – | ||
| Diphenylmethane | 0.292 | – | ||
| Diphenylmethanol | 0.240 | – | used in perfumes | |
| Disperse Red 9 | 0.367 | * | Anthraquinone dye | |
| Disperse Red 11 | 0.472 | * | Anthraquinone dye | |
| Di-tertbutyl-dicarbonate | 0.023 | – | organic reagent | |
| Divinylbenzene (meta/para) | 0.253 / 0.246 | – | styrene derivative | |
| Dodecylbenzene | 0.210 | – | anionic detergent | |
| Droxidopa | 0.542 | ** | ERβ | synthetic amino acid |
| EDTA | 0.409 | * | chelating agent | |
| Eosin (B/Y) | 0.283/ 0.275 | – | fluorescent dye | |
| Ethacridine | 0.437 | * | ||
| 8-Ethyl-2,3,4-trichlorodibenzofuran | 0.635 | ** | AhR | suspected hazardous pollutant |
| Etofenprox | 0.541 | ** | ERα | insecticide |
| Fenoxycarb | 0.317 | * | insecticide | |
| Fenvalerate (RR/RS/SR/SS) | 0.448 / 0.313 / 0.319 / 0.309 | * | insecticide | |
| Fipronil | 0.194 | – | insecticide | |
| Flavanole | 0.441 | * | synthetic flavone | |
| Flavanone | 0.740 | *** | ERβ | synthetic flavone |
| Flavone | 0.453 | * | synthetic flavone | |
| Flavonole | 0.537 | ** | ERβ | synthetic flavone |
| Fluoranthene | 0.468 | * | PAH found in combustion products | |
| Fluorene | 0.348 | * | PAH used to make dyes, plastics, pesticides | |
| Fluorenone | 0.360 | * | oxidation product of fluorene | |
| Fluorescein | 0.251 | – | fluorophore commonly used in microscopy | |
| 7-Fluoro-2,3-dichlorodibenzo-p-dioxin | 0.625 | ** | AhR | suspected hazardous pollutant |
| 8-Fluoro-2,3-dichlorodibenzofuran | 0.550 | ** | AhR | suspected hazardous pollutant |
| Fluorone | 0.457 | * | basic skeleton for various chemicals | |
| 2-Fluoro-3,7,8-trichlorodibenzo-p-dioxin | 0.664 | *** | AhR | suspected hazardous pollutant |
| 8-Fluoro-2,3,4-trichlorodibenzofuran | 0.626 | ** | AhR | suspected hazardous pollutant |
| Formebolone | 0.638 | ** | ERβ | anabolic steroid |
| Fuchsine | 0.335 | * | magenta dye | |
| Furazabol | 0.651 | ** | AR | derivative of the anabolic steroid stanozolol |
| Furylfuramide | 0.115 | – | food preservative: withdrawn from market | |
| Gentisic acid | 0.129 | – | antioxidant excipient | |
| Gonan (cis/trans) | 0.437 / 0.465 | * | saturated, unsubstituted steran | |
| Glyphosate | 0.366 | * | systemic herbicide | |
| Hematein | 0.309 | * | oxidized derivative of haematoxylin | |
| HEPES | 0.452 | * | zwitterionic buffering agent | |
| 2,2',4,4',5,5'-Hexachlorobiphenyl | 0.490 | * | suspected hazardous pollutant | |
| 2,3,3',4,4',5-Hexachlorobiphenyl | 0.546 | ** | AhR | suspected hazardous pollutant |
| 2,3,3',4,4',5'-Hexachlorobiphenyl | 0.492 | * | suspected hazardous pollutant | |
| 2,3',4,4',5,5'-Hexachlorobiphenyl | 0.507 | ** | AR | suspected hazardous pollutant |
| 2,3',4,4',5',6-Hexachlorobiphenyl | 0.461 | * | suspected hazardous pollutant | |
| 1,2,3,4,7,8-Hexachlorodibenzo-p-dioxin | 0.699 | ** | AhR | suspected hazardous pollutant |
| 1,2,3,6,7,8-Hexachlorodibenzofuran | 0.706 | *** | AhR | suspected hazardous pollutant |
| 1,2,4,6,7,8-Hexachlorodibenzofuran | 0.605 | ** | AhR | suspected hazardous pollutant |
| 2,3,4,6,7,8-Hexachlorodibenzofuran | 0.711 | *** | AhR | suspected hazardous pollutant |
| Hexachlorophene | 0.372 | * | disinfectant | |
| Hexamidine | 0.273 | – | antiseptic, disinfectant | |
| Hydroquinone | 0.079 | – | reducing agent | |
| 7-Hydroxy-2,3-dichlorodibenzo-p-dioxin | 0.473 | * | suspected hazardous pollutant | |
| 8-Hydroxy-2,3-dichlorodibenzofuran | 0.373 | * | suspected hazardous pollutant | |
| 6α-Hydroxyestradiol | 0.755 | *** | ERβ | flavone |
| 8-Hydroxyquinoline | 0.229 | – | chelating agent | |
| Hydroxystilbamidine | 0.276 | – | fluorescent dye | |
| 2-Hydroxy-3,7,8-trichlorodibenzo-p-dioxin | 0.532 | ** | AhR | suspected hazardous pollutant |
| 8-Hydroxy-2,3,4-trichlorodibenzofuran | 0.426 | * | suspected hazardous pollutant | |
| Indanthrene blue RS | 0.556 | ** | GR | anthraquinone dye |
| Indene | 0.145 | – | flammable polyciclic hydrocarbon | |
| Indigo | 0.293 | – | indigo dye: banned in Norway | |
| Iobenzamic acid | 0.380 | * | contrast medium | |
| Iocetamic acid (R/S) | 0.101 / 0.173 | – | contrast medium | |
| Iodamide | 0.311 | * | contrast medium | |
| 7-Iodo-2,3-dichlorodibenzo-p-dioxin | 0.647 | ** | AhR | suspected hazardous pollutant |
| 2-Iodo-3,7,8-trichlorodibenzo-p-dioxin | 0.741 | *** | AhR | suspected hazardous pollutant |
| 8-Iodo-2,3-dichlorodibenzofuran | 0.497 | * | suspected hazardous pollutant | |
| 8-Iodo-2,3,4-trichlorodibenzofuran | 0.526 | ** | AhR | suspected hazardous pollutant |
| Iotalamic acid | 0.407 | * | contrast medium | |
| Isobenzofuran | 0.178 | – | ||
| Isoflavanoide | 0.599 | ** | ERβ | synthetic flavone |
| Isoindole | 0.200 | – | ||
| Isophtalic acid | 0.313 | * | ||
| 8-Isopropyl-2,3-dichlorodibenzofuran | 0.619 | ** | AhR | suspected hazardous pollutant |
| 8-Isopropyl-2,3,4-trichlorodibenzofuran | 0.696 | ** | AhR | suspected hazardous pollutant |
| Isoquinoline | 0.226 | – | ||
| Isosafrole | 0.414 | * | aromatic organic chemical | |
| Lipoamide | 0.158 | – | ||
| Lumiflavin | 0.530 | ** | ERβ | toxic product of the photolysis of vitamin B2 |
| Luminol | 0.191 | – | chemical exhibiting chemiluminescence | |
| Melamine | 0.024 | – | plastic material | |
| Menadione | 0.251 | – | aromatic ketone | |
| Merocyanine I | 0.185 | – | fluorescent dye | |
| 3'-Methoxy-4'-aminoflavone | 0.524 | ** | GR | |
| 7-Methoxycarbonyl-2,3-dichlorodibenzo-p-dioxin | 0.699 | ** | AhR | suspected hazardous pollutant |
| Methoxychlor | 0.544 | ** | ERβ | insecticide |
| 7-Methoxy-2,3-Dichlorodibenzo-p-dioxin | 0.622 | ** | AhR | suspected hazardous pollutant |
| 8-Methoxy-2,3-dichlorodibenzofuran | 0.676 | ** | AhR | suspected hazardous pollutant |
| 8-Methoxyellipticine | 0.522 | ** | AhR | |
| 9-Methoxyellipticine | 0.419 | * | ||
| 3'-Methoxy-4'-nitro-α-naphthoflavone | 0.727 | *** | AhR | |
| 3'-Methoxy-4'-nitroflavone | 0.522 | ** | AhR | |
| 2-Methoxy-3,7,8-trichlorodibenzo-p-dioxin | 0.713 | *** | AhR | suspected hazardous pollutant |
| 8-Methoxy-2,3,4-trichlorodibenzofuran | 0.620 | ** | AhR | suspected hazardous pollutant |
| 2-Methylbenzo[a]anthracene | 0.702 | *** | AhR | suspected hazardous pollutant |
| 5-Methylbenzo[a]anthracene | 0.695 | ** | AhR | suspected hazardous pollutant |
| 6-Methylbenzo[a]anthracene | 0.668 | ** | AhR | suspected hazardous pollutant |
| 7-Methylbenzo[a]anthracene | 0.650 | ** | AhR | suspected hazardous pollutant |
| 8-Methylbenzo[a]anthracene | 0.700 | *** | AhR | suspected hazardous pollutant |
| 11-Methylbenzo[a]anthracene | 0.674 | ** | AhR | suspected hazardous pollutant |
| 12-Methylbenzo[a]anthracene | 0.591 | ** | AhR | suspected hazardous pollutant |
| 7-Methyl-2,3-dichlorodibenzo-p-dioxin | 0.615 | ** | AhR | suspected hazardous pollutant |
| 8-Methyl-2,3-dichlorodibenzofuran | 0.523 | ** | AhR | suspected hazardous pollutant |
| 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine | 0.360 | * | neurotoxin | |
| 2-Methyl-3,7,8-trichlorodibenzo-p-dioxin | 0.670 | ** | AhR | suspected hazardous pollutant |
| 8-Methyl-2,3,4-trichlorodibenzofuran | 0.586 | ** | AhR | suspected hazardous pollutant |
| Michler's ketone | 0.351 | * | intermediate in the production of dyes | |
| Mirex | 0.354 | * | insecticide | |
| Naphtacenequinone | 0.618 | ** | AhR | |
| Naphtalene | 0.280 | – | PAH: carcinogenic in mice and rats | |
| α-Naphthoflavone | 0.514 | ** | AhR | |
| 1,4-Naphthoquinone | 0.205 | – | antibacterial and antitumor properties | |
| 1-Naphthylamine | 0.219 | – | aromatic amine | |
| Neutral red | 0.343 | * | eurhodin dye | |
| Nile red | 0.546 | ** | AhR | lipophilic stain |
| Nitrilotriacetic acid | 0.134 | – | chelating agent | |
| 3'-Nitro-α-naphthoflavone | 0.561 | ** | AhR | |
| 4'-Nitro-α-naphthoflavone | 0.625 | ** | AhR | |
| 7-Nitro-2,3-dichlorodibenzo-p-dioxin | 0.696 | ** | AhR | suspected hazardous pollutant |
| 2-Nitro-3,7,8-trichlorodibenzo-p-dioxin | 0.756 | ** | AhR | suspected hazardous pollutant |
| Nonylphenol (various isomers) | 0.403–0.606 | ** | ERβ | surfactant, spermicide |
| Norbolethone | 0.617 | ** | AR | anabolic steroid |
| 1,2,3,4,6,7,8,9-Octachlorodibenzo-p-dioxin | 0.727 | *** | AhR | suspected hazardous pollutant |
| Octabenzone | 0.469 | * | UV absorber | |
| Octachlorodperylene-diimide | 0.757 | *** | AhR | organic semiconductor |
| Octylphenol (linear/branched) | 0.518 / 0.531 | ** | ERβ | polymer additive, surfactant |
| Oil Blue A | 0.274 | – | anthraquinone dye | |
| Oil Yellow DE | 0.315 | * | azo dye | |
| Ovalene | 0.559 | ** | AhR | PAH |
| Oxolinic acid | 0.382 | * | quinoline antibiotic used in veterinary medicine | |
| Oxypurinol | 0.216 | – | xanthine oxidase inhibitor | |
| Padimate-A | 0.220 | – | used as UV filter in sunscreens | |
| Padimate-O (R/S) | 0.245 / 0.226 | – | used as UV filter in sunscreens | |
| Para Red | 0.232 | – | azo dye | |
| Pendimethalin | 0.176 | – | preemergent herbicide | |
| 2,3,3',4,4'-Pentachlorobiphenyl | 0.495 | * | suspected hazardous pollutant | |
| 2,3,4,4',5-Pentachlorobiphenyl | 0.514 | ** | AhR | suspected hazardous pollutant |
| 2,3',4,4',5-Pentachlorobiphenyl | 0.487 | * | suspected hazardous pollutant | |
| 2',3,4,4',5-Pentachlorobiphenyl | 0.508 | ** | 1A2 | suspected hazardous pollutant |
| 3,3',4,4',5-Pentachlorobiphenyl | 0.573 | ** | AhR | suspected hazardous pollutant |
| 1,2,3,4,7-Pentachlorodibenzo-p-dioxin | 0.657 | ** | AhR | suspected hazardous pollutant |
| 1,2,3,7,8-Pentachlorodibenzo-p-dioxin | 0.713 | *** | AhR | suspected hazardous pollutant |
| 1,2,4,7,8-Pentachlorodibenzo-p-dioxin | 0.628 | ** | AhR | suspected hazardous pollutant |
| 1,2,3,4,8-Pentachlorodibenzofuran | 0.615 | ** | AhR | suspected hazardous pollutant |
| 1,2,3,7,9-Pentachlorodibenzofuran | 0.619 | ** | AhR | suspected hazardous pollutant |
| 1,2,4,6,7-Pentachlorodibenzofuran | 0.570 | ** | AhR | suspected hazardous pollutant |
| 1,2,4,6,8-Pentachlorodibenzofuran | 0.571 | ** | AhR | suspected hazardous pollutant |
| 1,2,4,7,8-Pentachlorodibenzofuran | 0.637 | ** | AhR | suspected hazardous pollutant |
| 1,2,4,7,9-Pentachlorodibenzofuran | 0.531 | ** | AhR | suspected hazardous pollutant |
| 1,3,4,7,8-Pentachlorodibenzofuran | 0.690 | ** | AhR | suspected hazardous pollutant |
| Pentacene | 0.609 | ** | AhR | PAH |
| Permethrin (cis/trans) | 0.351 / 0.331 | * | insecticide, acaricide | |
| Phenanthrene | 0.468 | * | PAH found in cigarette smoke: known irritant | |
| Phenazine | 0.355 | * | parent substance of many dyestuffs | |
| Phenidone | 0.153 | – | photographic developer | |
| Phenol | 0.283 | – | antiseptic: developmental toxicity in animals | |
| Phenolphthalein | 0.536 | ** | ERα | titration dye |
| Phenothiazine | 0.391 | * | insecticide | |
| Phenothrin (E/Z) | 0.270 / 0.330 | * | insecticide | |
| Phenylacetylene | 0.197 | – | liquid analog of acetylene | |
| 7-Phenyl-2,3-dichlorodibenzo-p-dioxin | 0.808 | **** | AhR | suspected hazardous pollutant |
| 2-Phenylphenol | 0.238 | – | biocide, preservative | |
| 4-Phenyl-4-(1-piperidinyl)cyclohexanol | 0.427 | * | metabolite of phencyclidine | |
| N-(5-Phenylpyridin-2-yl)benzamide | 0.717 | *** | AhR | firefly luciferase inhibitor |
| Picene | 0.647 | ** | AhR | suspected hazardous pollutant |
| Picloram | 0.275 | – | herbicide | |
| Pipemidic acid | 0.606 | ** | GR | quinolone |
| Piromidic acid | 0.357 | * | quinolone | |
| Propoxur | 0.106 | – | insecticide | |
| Prostanozol | 0.615 | ** | AR | anabolic steroid |
| Purpuric acid | 0.289 | – | complexometric indicator | |
| Purpurine | 0.283 | – | antrachinone dye: cancerogenic in rats; cytotoxic | |
| Quinaldine | 0.233 | – | quinoline derivative | |
| Quinoxaline | 0.199 | – | isomer of quinazoline | |
| Setoperone | 0.633 | ** | GR | radioligand for studying neuropsychiatric disorders |
| Simazine | 0.265 | – | herbicide | |
| Skatole | 0.203 | – | found in coal tar, mammalian feces, beets | |
| Stenbolone | 0.714 | *** | AR | anabolic steroid |
| Styrene | 0.207 | – | aromatic hydrocarbon (precursor to polystyrene) | |
| Sudan I | 0.328 | * | azo dye | |
| Sudan II | 0.376 | * | azo dye | |
| Sudan III | 0.278 | – | azo dye | |
| Sulisobenzone | 0.280 | – | UV filter in sunscreens | |
| Temefos | 0.399 | * | larvicide | |
| 7-Tert.butyl-2,3-Dichlorodibenzo-p-dioxin | 0.741 | *** | AhR | suspected hazardous pollutant |
| 8-Tert.butyl-2,3-dichlorodibenzofuran | 0.659 | ** | AhR | suspected hazardous pollutant |
| 8-Tert.butyl-2,3,4-trichlorodibenzofuran | 0.709 | *** | AhR | suspected hazardous pollutant |
| Tetracene | 0.802 | **** | AhR | PAH |
| 2,2',4,4'-Tetrachlorobiphenyl | 0.429 | * | suspected hazardous pollutant | |
| 2,3,4,5-Tetrachlorobiphenyl | 0.495 | * | suspected hazardous pollutant | |
| 3,3',4,4'-Tetrachlorobiphenyl | 0.564 | ** | AhR | suspected hazardous pollutant |
| 3,4,4',5-Tetrachlorobiphenyl | 0.520 | ** | AhR | suspected hazardous pollutant |
| 1,2,3,4-Tetrachlorodibenzo-p-dioxin | 0.516 | ** | AhR | suspected hazardous pollutant |
| 1,3,7,8-Tetrachlorodibenzo-p-dioxin | 0.611 | ** | AhR | suspected hazardous pollutant |
| 1,2,3,6-Tetrachlorodibenzofuran | 0.572 | ** | AhR | suspected hazardous pollutant |
| 1,2,3,7-Tetrachlorodibenzofuran | 0.634 | ** | AhR | suspected hazardous pollutant |
| 1,2,4,8-Tetrachlorodibenzofuran | 0.451 | * | suspected hazardous pollutant | |
| 2,3,4,6-Tetrachlorodibenzofuran | 0.547 | ** | AhR | suspected hazardous pollutant |
| 2,3,4,7-Tetrachlorodibenzofuran | 0.700 | *** | AhR | suspected hazardous pollutant |
| 2,3,4,8-Tetrachlorodibenzofuran | 0.620 | ** | AhR | suspected hazardous pollutant |
| 2,3,6,8-Tetrachlorodibenzofuran | 0.634 | ** | AhR | suspected hazardous pollutant |
| Tetramethrin (cis/trans) | 0.250 / 0.305 | – | insecticide | |
| Tetrathiafulvalene | 0.224 | – | organosulfur compound | |
| Thiondigo | 0.346 | * | indigo dye | |
| Tosylchloramide | 0.174 | – | antiseptic, disinfectant | |
| 2,4,5-Trichlorophenoxyacetic acid | 0.333 | * | herbicide | |
| 1,2,4-Trichlorodibenzo-p-dioxin | 0.433 | * | suspected hazardous pollutant | |
| 2,3,7-Trichlorodibenzo-p-dioxin | 0.608 | ** | AhR | suspected hazardous pollutant |
| 1,3,6-Trichlorodibenzofuran | 0.502 | ** | AhR | suspected hazardous pollutant |
| 1,3,8-Trichlorodibenzofuran | 0.462 | * | suspected hazardous pollutant | |
| 2,3,4-Trichlorodibenzofuran | 0.531 | ** | AhR | suspected hazardous pollutant |
| 2,3,8-Trichlorodibenzofuran | 0.542 | ** | AhR | suspected hazardous pollutant |
| 2,6,7-Trichlorodibenzofuran | 0.588 | ** | AhR | suspected hazardous pollutant |
| Triclocarban | 0.566 | ** | AhR | anti-bacterial/fungal agent (soaps/disinfectants) |
| Triclosan | 0.173 | – | antibacterial and antifungal agent | |
| ortho-Tricresylphosphate | 0.310 | * | organophosphate compound | |
| Triphenylamine | 0.298 | – | electroluminescence compound | |
| Triphenylphosphate | 0.282 | – | plasticizer, flame retardant | |
| 7-Trifluoromethyl-2,3-dichlorodibenzo-p-dioxin | 0.707 | *** | AhR | suspected hazardous pollutant |
| 8-Trifluoromethyl-2,3,4-trichlorodibenzofuran | 0.662 | ** | AhR | suspected hazardous pollutant |
| 3,4',6-Trihydroxyflavone | 0.668 | ** | ERβ | flavone |
| Triphenylene | 0.471 | * | PAH (coal tar) | |
| Triphenylethylene | 0.425 | * | nonsteroidal antiestrogen | |
| Tropinone | 0.293 | – | synthetic alkaloid | |
| Vat Yellow 4 (Golden Yellow K) | 0.735 | *** | AhR | anthraquinone vat dye |
| Warfarin | 0.305 | * | anticoagulant: various side effects | |
| Xanthone | 0.383 | * | insecticide, ovicide |
| Compound | Weighted toxic potential | wTP class | Main target | Comments |
| Aminopyralid | 0.218 | – | non-toxic to birds, fish, honeybees | |
| Anabasine | 0.340 | * | insecticide | |
| Azoxystrobin | 0.221 | – | fungicide | |
| Beflubutamid | 0.274 | – | very low toxicity in animals | |
| Brodifacoum (cis/trans) | 0.450 / 0.538 | ** | GR | rodenticide: highly lethal anticoagulant poison |
| Bromethalin | 0.524 | ** | AR | rodenticide |
| Bromoxynil | 0.347 | * | moderate acute toxicity; possible carcinogen | |
| Captan | 0.234 | – | fungicide | |
| Carbendazim | 0.470 | * | WHO: unlikely to present hazard in normal use | |
| Carbofuran | 0.198 | – | high acute toxicity in humans | |
| Chlorophacinone (R/S) | 0.173 / 0.448 | – | rodenticide | |
| Clodinafop | 0.405 | * | slightly toxic | |
| Clofentezine | 0.331 | * | slight acute toxicity, possible carcinogen | |
| Clomazone | 0.263 | – | moderate acute toxicity | |
| Clopyralid | 0.310 | * | highly toxic | |
| Coumatetralyl | 0.357 | * | rodenticide; anticoagulant | |
| Crimidine | 0.206 | – | rodenticide | |
| Cyproconazole (RR/RS/SR/SS) | 0.113 / 0.000 / 0.078 / 0.003 | – | mice: carcinogenic; rats: developmental toxicity | |
| Cyprodinil | 0.353 | * | acute oral, dermal and inhalation toxicity (EPA: III–IV) | |
| Dicamba | 0.309 | * | acute toxicity (EPA: III) | |
| Dichlorprop | 0.219 | – | slight acute, high developmental toxicity | |
| Dicofol | 0.341 | * | miticide | |
| Difenacoum (cis/trans) | 0.297 / 0.401 | * | rodenticide; anticoagulant | |
| Difethialone | 0.335 | * | rodenticide; anticoagulant | |
| Diflubenzuron | 0.410 | * | slight acute toxicity | |
| Dimethenamid | 0.050 | – | moderate acute toxicity | |
| Dimethomorph (E/Z) | 0.451 / 0.411 | * | slight acute toxicity | |
| Dimoxystrobin | 0.232 | – | ||
| Diphenadione | 0.229 | – | rodenticide | |
| Diuron | 0.338 | * | slightly toxic to animals | |
| Endrin | 0.286 | – | insecticide | |
| Esfenvalerate | 0.375 | * | highly toxic to bees and fish | |
| Ethofumesate | 0.271 | – | no genotoxic/carcinogenic potential | |
| Fenamidone | 0.231 | – | not toxic to rodents | |
| Fenarimol | 0.319 | * | slightly toxic to mammals | |
| Fenhexamid | 0.349 | * | slightly toxic in rats | |
| Fenpropidin (R/S) | 0.321 / 0.329 | * | ||
| Flocoumafen | 0.509 | ** | GR | rodenticide; anticoagulant |
| Flonicamid | 0.071 | – | low acute toxicity | |
| Fluazinam | 0.595 | ** | AhR | |
| Fludioxonil | 0.389 | * | body-weight decrease; not cancerogenic | |
| Flurprimidol | 0.144 | – | endocrine disruptor in adrenal cortex and ovary | |
| Fuberidazole | 0.256 | – | moderate acute toxicity | |
| Imazalil | 0.169 | – | moderate acute toxicity; liver toxicity in animals | |
| Indandione | 0.252 | – | rodenticide; anticoagulant | |
| Iprodione | 0.499 | * | fungicide | |
| Isoproturon | 0.265 | – | slightly hazardous | |
| Isoxaflutole | 0.306 | * | slight acute toxicity; likely to be a carcinogen | |
| Mecoprop | 0.282 | – | slightly toxic; teratogenic to rats | |
| Metalaxyl | 0.158 | – | no mutagenic and teratogenic potential | |
| Metachlor (S) | 0.184 | – | ||
| Metazachlor | 0.114 | – | low acute, dermal, and inhalation toxicity | |
| Metconazole (RR/SS) | 0.140 / 0.241 | – | liver tumors in mice | |
| 2-Methyl-4-chlorophenoxyacetic acid | 0.129 | – | slightly toxic, restricted use | |
| Metrafenone | 0.270 | – | carcinogenic in mice | |
| Myclobutamil (R/S) | 0.186 / 0.280 | – | slight acute toxicity; toxic to aquatic organisms | |
| Myristicin | 0.328 | * | naturally occurring insecticide (nutmeg) | |
| α-Naphthylthiourea | 0.322 | – | rodenticide | |
| Napropamide (R/S) | 0.277 / 0.274 | – | slightly toxic (EPA: III) | |
| Parathion | 0.045 | – | insecticide | |
| Penconazole (R/S) | 0.132 / 0.217 | – | developmental toxicity in rats | |
| Pethoxamid | 0.180 | – | hepatotoxic in rats | |
| Phosacetim | 0.238 | – | rodenticide | |
| Pindone | 0.286 | – | rodenticide | |
| Procymidone | 0.348 | * | ||
| Propiconazole (RR/RS/SR/SS) | 0.219 / 0.155 / 0.173 / 0.290 | – | ||
| Propyzamide | 0.229 | – | slightly toxic | |
| Prosulfocarb | 0.142 | – | low dermal and inhalational toxicity | |
| Pymetrozine | 0.078 | – | low acute toxicity to humans | |
| Pyraflufen | 0.282 | – | highly toxic | |
| Pyridate | 0.306 | * | low toxicity in rats, rabbits, fish, wildlife | |
| Pyrimethanil | 0.420 | * | growth inhibition the of H. uvarum | |
| Pyrinuron | 0.326 | * | rodenticide | |
| Quimerac | 0.356 | * | ||
| Quinoxufen | 0.457 | * | ||
| Spirodiclofen | 0.459 | * | ||
| Spiroxamine | 0.468 | * | ||
| Sulcotrione | 0.284 | – | ||
| Tebufenozide | 0.222 | – | ||
| Tebufenpyrad | 0.247 | – | ||
| Teflubenzurone | 0.471 | * | ||
| Tepraloxydime (RE/RZ/SE/SZ) | 0.249 / 0.212 / 0.198 / 0.196 | – | ||
| Terbutylazine | 0.362 | * | ||
| Tetraconazole (R/S) | 0.205 / 0.164 | – | ||
| Tetramethylenedisulfotetramine | 0.161 | – | rodenticide | |
| Thiabendazole | 0.243 | – | ||
| Thiram | 0.044 | – | ||
| Triasulfuron | 0.268 | – | ||
| Tribenuron | 0.331 | * | ||
| Triclopyr | 0.152 | – | ||
| Trifluralin | 0.359 | * | ||
| Trinexapac (R/S) | 0.287 / 0.258 | – | ||
| Triticonazole (R/S) | 0.147 / 0.197 | – | ||
| Vinclozolin (R/S) | 0.233 / 0.264 | – | fungicide | |
| Zoxamide | 0.190 | – |
| Compound | Weighted toxic potential | wTP class | Main target | Comments |
| Adrafinil | 0.246 | – | central nervous system stimulant: orafacial side effects | |
| Aristolochic acid | 0.318 | * | rodent carcinogen | |
| Aspartame | 0.401 | * | artificial sweetener | |
| Atropin (R/S) | 0.412 / 0.352 | * | anticholinergic: poisonous at high dosage | |
| Cyclosarin | 0.115 | – | nerve agent | |
| Deguelin | 0.509 | ** | GR | rotenoid: anti-cancer activity, no cytotoxicity |
| Desoxymethyltestosterone | 0.677 | ** | AR | anabolic steroid |
| Dextroamphetamine | 0.481 | * | psychostimulant: several (including severe) side effects | |
| Ethylestrenol | 0.634 | ** | AR | anabolic steroid |
| Genistein | 0.547 | ** | ERβ | phytoestrogen |
| Heroin | 0.461 | * | semi-synthetic opioid: lethal in overdose | |
| Hyoscyamin | 0.484 | * | tropane alkaloid drug: several (including severe) side effects | |
| Medroxyprogesterone | 0.475 | * | treatment of endometriosis, AMB and amenorrhea | |
| Methadone (R/S) | 0.332 / 0.446 | * | analgesic, antitussive, anti-addictive: toxic in overdose | |
| Methandrostenolone | 0.616 | ** | AR | anabolic steroid |
| N-Methylamphetamine | 0.360 | * | psychostimulant: various side effects with chronic use | |
| Methyltestosterone | 0.705 | *** | AR | anabolic steroid |
| Mifepristone | 0.424 | * | abortifacient: various serious side effects | |
| Norethisterone | 0.642 | ** | ERβ | oral contraceptive: various side effects |
| Norethynodrel | 0.578 | * | ERβ | oral contraceptive |
| Pentobarbital (R/S) | 0.095 / 0.188 | – | short-acting barbiturate: euthanasiant | |
| Pregnenolone | 0.707 | *** | ERα | steroid hormone (prohormone) |
| Quinine | 0.462 | * | antimalarial, analgesic: cinchonism | |
| 3-Quinuclidinyl benzilate | 0.553 | ** | GR | incapacitating agent |
| Scopolamine | 0.216 | – | tropane alkaloid drug: several side effects | |
| Sildenafil | 0.342 | * | lifestyle drug: rare but severe side effects | |
| Tadalafil | 0.493 | * | lifestyle drug: various side effects | |
| Tetrahydrocannabinol | 0.409 | * | psychoactive substance: mutagenic (AMES); neurobehavioral toxicity | |
| Vardenafil | 0.402 | * | lifestyle drug: various side effects | |
| Yohimbin | 0.416 | * | aphrodisiac: significant side effects; dangerous at high dosage |
| Compound | Weighted toxic potential | wTP class | Main target | Comments |
| Amiphenazole | 0.152 | – | respiratory stimulant | |
| Amphetamine (R/S) | 0.365 / 0.451 | * | performance enhancer | |
| Androstenediol (4-/5-) | 0.734 / 0.705 | *** | ERβ / ERα | steroid (metabolite of DHEA) |
| Androstenedione | 0.479 | * | steroid hormone (adrenal glands) | |
| Benzphetamine | 0.325 | * | anti-obesity drug | |
| Boldenone | 0.588 | ** | AR | anabolic steroid (developed for veterinary use) |
| Chlorphentermine | 0.343 | * | appetite suppressant | |
| Clostebol | 0.700 | *** | AR | anabolic androgenic steroid |
| Dehydrochlormethyltestosterone | 0.724 | *** | AR | anabolic steroid |
| Diethylcathinone (R/S) | 0.392 / 0.192 | – | appetite suppressant | |
| Dihydrotestosterone | 0.638 | ** | AR | biologically active metabolite of testosterone |
| Dimethylamphetamine (R/S) | 0.311 / 0.251 | * | stimulant drug | |
| Doxapram | 0.342 | * | respiratory stimulant | |
| Drostanolone | 0.671 | ** | AR | anabolic steroid |
| Ethylamphetamine (R/S) | 0.323 / 0.2392 | * | stimulant drug | |
| Ephedrine | 0.333 | * | stimulant | |
| Ethamivan | 0.446 | * | respiratory stimulant | |
| Fencamfamine | 0.561 | ** | GR | appetite suppressant |
| Fentermine (Phentermine) | 0.483 | * | appetite suppressant | |
| Fluoxymesterone | 0.509 | ** | GR | androgen to increase strength and aggression |
| Nandrolone | 0.585 | ** | AR | anabolic steroid |
| Norandrostenediol | 0.741 | *** | ERβ | anabolic steroid |
| Norandrostenedione | 0.484 | * | anabolic steroid | |
| Norethandrolone | 0.648 | ** | AR | anabolic steroid |
| Oxandrolone | 0.745 | *** | AR | anabolic steroid |
| Oxymesterone | 0.706 | *** | ERα | anabolic steroid |
| Oxymetholone | 0.666 | ** | ERβ | anabolic steroid |
| Pentylenetetrazol | 0.096 | – | respiratory stimulant | |
| Phendimetrazine | 0.177 | – | weight loss medication | |
| Phenmetrazine | 0.333 | – | CNS stimulant, anorectic drug | |
| Picrotoxinin | 0.246 | – | active component of picrotoxin | |
| Pipradol | 0.466 | * | mild CNS stimulant | |
| Prolintane (R/S) | 0.352 / 0.254 | * | psychostimulant, nootropic drug | |
| Stanozolol | 0.678 | ** | ERβ | anabolic steroid |
| Synephrine (R/S) | 0.303 / 0.238 | * | stimulant | |
| Testosterone | 0.642 | ** | AR | steroid hormone |
| Tetrahydrogestrinone (THG, "The Clear") | 0.681 | ** | AR | anabolic steroid |
| Trenbolone | 0.613 | ** | AR | synthetic steroid hormone: affects reproduction |
Last update of this page: July 28, 2010